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SPECIAL LECTURES
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Cutaneous Dendritic Cells - theWidening Spectrum
Georg Stingl
Department of Dermatology, University of Vienna Medical School,Vienna, Austria
The mammalian skin contains two indigenous populations of immunostimulatory dendritic cells, i.e.
epidermal Langerhans cells and dermal dendritic cells. They apparently derive from di¡erent sets of
precursors (CD1aþ /CD14 vs. CD1a-/CD14þ) and their relative contribution to the skin’s immune
function has yet to be clari¢ed.
Recently, other types of bone marrow-derived dendritic cells have been identi¢ed in diseased and/
or perturbed skin. These include the so-called in£ammatory dendritic epidermal cells (IDEC) and
dermal cells (IDDC) as well as a population of dendritic cells with a plasma cell-like appearance,
termed plasmacytoid dendritic cells (pDC).
The former cells have a CD1alow, FceRhigh phenotype and are particularly abundant in atopic der-
matitis lesions. Some evidence exists that IDEC/IDDC are responsible for IgE-facilitated allergen pre-
sentation and, thus, perhaps for the chronicity of the disease.
Plasmacytoid dendritic cells have so far been identi¢ed in the skin of patients with lupus erythe-
matosus, contact eczema and atopic dermatitis. They exhibit the CD123þ/MHC IIþ /CD45RAþ /
BDCA-2þ/CLAþ /CD62Lþ phenotype and many of them display signs of activation such as the ex-
pression of CD83 and CD86.
We have recently observed a population of CD4þ/CD3- cells with a similar phenotype in murine
skin treated with the immunomodulator imiquimod. Both in man and mice, these cells appear at an
early time in the evolution of the lesion and are often found in the vicinity of natural killer (NK)
cells.
This knowledge should form the basis for the isolation and functional characterization of IDEC/
IDDC as well as cutaneous pDC and, as a consequence, for our understanding of events resulting in
either the ampli¢cation or resolution of immune-mediated skin in£ammation.
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Myeloid and Lymphoid DC Di¡erentiation Pathways
Carlos Ardavin
Department of Cell Biology, Faculty of Biology, Complutense University, Madrid, Spain
Dendritic cells (DCs) are key components of the immune system owing to their essential role in the
induction and control of T cell immunity, as well as in the modulation of B cell and NK cell re-
sponses. Research on DCs over the last decade has led to the concept that the DC system comprises
a large collection of subpopulations with di¡erent functions. Functional specialization allows de¢ned
DC subsets to induce e⁄cient defence mechanisms against pathogens and tumor cells and maintain T
cell tolerance. A key question, with important implications for our understanding of the induction
and control of immunity by DCs, as well as the use of DCs for immunotherapy, is whether DC
functional diversity results from the existence of developmentally independent DC subpopulations,
or whether DC subsets sharing a common di¡erentiation origin acquire speci¢c functions in response
to environmental signals. Although a de¢nitive model of DC development remains to be established,
recent data derived mostly from in vivo DC reconstitution assays in the mouse indicate that the same
DC subpopulations, including CD8- DCs, CD8þ DCs and B220þ plasmacytoid DCs, can be de-
rived from either myeloid or lymphoid progenitors. Therefore these experiments do not support the
existence of independent myeloid and lymphoid DC subpopulations as previously proposed, but a
DC di¡erentiation model relying on a dual contribution of myeloid and lymphoid di¡erentiation
pathways. Interestingly, recent data from our laboratory suggest that during microbial infections,
blood-borne DC precursors are recruited to the reactive sites where they di¡erentiate into fully com-
petent DCs.
003
The Development, Turnover Rate and Maturation Status of Dendritic Cells and
Langerhans Cells
Ken Shortman, David Vremec, Sandrine Henri, Arun Kamath, NicholasWilson, Jose Villadangos,
Meredith OKee¡e, Lynn Corcoran, Arun Kamath, Li Wu
TheWalter and Elisa Hall Institute, Melbourne, Australia
Multiple subtypes of dendritic cells (DC), some with distinct biological properties, exist in mouse
lymphoid organs. Spleen contains three major conventional DC subtypes, plus plasmacytoid pre-DC
(pDC). Lymph nodes (LN) contain these and two additional DC subtypes that migrate in from the
lymph, one being derived from skin Langerhans cells (LC). Most lymphoid organ DC are in a quies-
cent or immature state in an uninfected mouse, and only the the migratory DC in LN behave as
mature DC. The CD8 DC have a short lifespan (3 days in spleen) while the pDC and LC DC have
a long lifespan in steady state. These DC subtypes behave as products of separate sublineages, although
some may have common precursors. The immediate precursors of these DC are under investigation.
The early bone-marrow precursors with a capacity to form DC express Flt3. They include precursors
classi¢ed as lymphoid committed and as myeloid committed. Many thymic DC and thymic and sple-
nic pDC show evidence of a lymphoid origin, containing CD3 and pTa mRNA and D-J IgH rear-
rangements in DNA. However few peripheral DC or LC DC show these relics of a lymphoid past.
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Cooperative Interaction of Myeloid and Plasmacytoid Dendritic Cells (DCs) in
Inducing CTL through Distinct Function and Tra⁄cking Pathway
Kouji Matsushima,Yanyun Zhang, Hiroyuki Yoneyama
Department of Molecular Preventive Medicine & SORST, Graduate School of Medicine,The University ofTokyo,
Tokyo, Japan
DCs are in£ammation-associated cells and a large number of both B220- and B220þ CD11cþ DC
precursor cells, expressing CC chemokine receptor (CCR)1 and CCR5, are rapidly mobilized into the
circulation during in£ammation.We describe here that the mobilization of DC precursors into the
circulation by P. acnes administration was signi¢cantly decreased in CCR5-/- B6 mice and, to a lesser
extent in CCR1-/- B6 mice. In addition, antibody to a ligand to CCR1 and 5 MIP-1a reduced the
number of DC precursors. Furthermore, intravenous administration of recombinant MIP-1a rapidly
mobilized a large number of DC precursors into the circulation. MIP-1a-mobilized-B220- , but not
B220þDC precursor cells di¡erentiated into mature DCs, when cultured in the presence of GM-CSF,
IL-4 and TNFa, and elicited melanoma speci¢c anti-tumor immunity in vivo as well as in vitro. Ta-
ken together, this study has established that MIP-1a and its receptors CCR5 and CCR1 play a critical
role in regulating the recruitment of DC precursor cells into the circulation.We also illustrate that
while B220-CD11cþ cells are tissue-seeking myeloid DC precursors (APC), B220þCD11cþ cells are
plasmacytoid DC precursors which directly bind to and transmigrate across HEVs of in£amed LNs in
an E-selectin and CXCL9 dependent manner. In a cutaneous herpes simplex virus infection model,
B220þ DC precursors readily transmigrated into the draining LNs, colocalized with B220- interdigi-
tating DCs, and helped B220- DCs to induce e¡ective anti-viral CTL. Sophisticated orchestration of
plasmacytoid and myeloid DCs apparently contributes to a host defense system.
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Regulation of Dendritic Cell Subsets Tra⁄cking by Chemokines
Christophe Caux, BeŁ atrice Vanbervliet, Nathalie Bendriss-Vermare, Catherine Massacrier, Bernhard
Homey, Odette de Bouteiller, Francine Brie' re, Giorgio Trinchieri, AlainVicari
Schering-Plough, Laboratory for Immunological Research, Dardilly, France
The recruitment of selected dendritic cell (DC) subtype conditions the class of the immune response.
Each immature DC population displays a unique spectrum of chemokine responsiveness. For exam-
ples, Langerhans cells (LC) migrate selectively in response to CCL20/MIP^3a (through CCR6), blood
CD11cþ DC to MCP chemokines (through CCR2), and monocytes derived^DC to CCL3,4/MIP^
1a,b (through CCR1 and CCR5). All these chemokines are inducible upon in£ammatory stimuli.
CCL20/MIP^3a in particular is only detected within in£amed epithelium, at site of antigen entry,
which is in¢ltrated by immature DC.
Furthermore, to reach the site of injury, sequential responsiveness might operate, blood DC precur-
sors are recruited by a set of chemokines (MIP, MCP) while within the tissue other chemokines will
direct their navigation (CCL20/MIP-3a).
After antigen uptake, upon maturation DC loose their responsiveness to most in£ammatory che-
mokines, but acquire responsiveness to CCR7 ligands due to receptor up^regulation. CCL21/SLC/
6Ckine expressed by lymphatic vessels may direct into the lymph stream, antigen-loaded maturing
DC, leaving the site of infection. Mature DC entering the draining lymph nodes might then be dri-
ven into the paracortical area, in response to the production CCL19/ELC/MIP^3b and/or CCL21/
SLC/6Ckine by cells spread over the T cell zone. In addition, CCL21 play a critical role in the entry
of naive T cells within the lymph-node from the blood through HEV.
Finally, human plasmacytoid DC (pDC), the blood natural IFNa producing cells, is controlled by
the concerted action of inducible and constitutive chemokines. pDC migrate in response to the con-
stitutive chemokine SDF-1/CXCL12 and CXCR3-ligands synergize with SDF-1/CXCL12 to induce
pDC migration. This synergy re£ects a priming e¡ect of CXCR3-ligands that independently of a
gradient decrease by 20-50 folds the threshold of sensitivity to SDF-1/CXCL12. CXCR3-ligands
and SDF-1/CXCL12 display adjacent expression both in secondary lymphoid organs and in epithelial
in£ammatory sites involving viral lesions. The cooperation between inducible CXCR3-ligands and
constitutive SDF-1/CXCL12 may regulate recruitment of pDC either in lymph nodes or at peripheral
sites of in£ammation. In agreement of a recruitment at site of in£ammation, pDC can acquire migra-
tory capacity is response to epithelial homing chemokines such as CCR6 ligand.
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Di¡erences between Murine Langerhans Cells and Dendritic Cells ^ Lessons from
Isolated Langerhans Cells
Akihiko Asahina, Hideki Fujita,Yayoi Tada, Hiroshi Mitsui,TakahiroWatanabe, Hidehisa Saeki,
Kunihiko Tamaki
Department of Dermatology, University ofTokyo School of Medicine,Tokyo, Japan
Langerhans cells (LC) are a special subset of dendritic cells (DC) integrating cutaneous immunity.
Studies on LC are limited because of di⁄culty in their isolation, and it is uncertain whether in vi-
tro-induced LC-like cells indeed behave like genuine LC.We succeeded in preparing highly-puri¢ed
LC from mice skin, allowing us to study LC function directly without interference of keratinocytes.
By employing these isolated LC, we realized some di¡erences between LC and splenic CD11cþ DC.
LC responded poorly to LPS and only at a high dose. This limited sensitivity was attributable to their
absence of CD14 and fewer TLR4 expression. Furthermore, LC produced much higher amounts of
MDC/CCL22 and TARC/CCL17 following optimal stimulation compared with splenic DC, suggest-
ing that these chemokines may be involved in Th2-type skin in£ammation such as atopic dermatitis.
In contrast, the level of IP-10/CXCL10 expression was similar between LC and splenic DC. Strong
inhibition by GM-CSF of IL-12 p70 production in stimulated LC was also characteristic to LC. Sti-
mulation with type I IFN revealed that the expression of costimulatory molecules was clearly down-
regulated in LC, while they were upregulated in splenic DC, implying that LC and DC can even
respond in the opposite way. Finally, LC failed to produce IFN-g by a number of stimuli which trig-
gered DC IFN-g stimulation. Our observations thus elucidate substantial di¡erences between LC and
splenic DC, which may be associated with their roles in the body. Our ¢ndings also indicate the ne-
cessity for usage of puri¢ed LC to study LC biology.
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Dendritic Cells Activate Immune Responses via Interaction with Microorganisms
and IL-2 Production
Francesca Granucci, Paola Ricciardi-Castagnoli
Department of Biotechnology and Bioscience, University of Milano-Bicocca, Milan, Italy
After exposure to microbial stimuli, DC undergo a gene transcription reprogramming process that
regulates an ordered sequence of maturation events with the sequential acquisition of di¡erent im-
mune regulatory activities. Using a global gene expression analysis approach, we have observed that,
during the maturation process induced by many di¡erent microbial stimuli DC acquire the ability to
produce IL-2. This capacity is a feature shared by diverse DC subtypes in vivo, such as CD8aþ and
CD8a- splenic DC and epidermal Langerhans cells. By comparing the ability of wild-type and IL-2-/-
DC to stimulate T cells in primary mixed lymphocyte reactions we have found IL2-/- DC were se-
verely impaired in their ability to induce both CD4 and CD8 Tcell proliferation, indicating that IL-2
is a key molecule in conferring the unique T cell stimulatory capacity to DC.
Recent studies have focused on the function of DC during the early phases of the immune re-
sponse and they have described a predominant DC role in natural killer (NK) cell activation. Since
IL-2 is an e⁄cient NK cell-activating factor in vitro, we have studied the relevance of DC-derived IL-
2 in NK cell priming. By comparing the ability of DC to activate NK cells in presence or absence of
IL-2, we have found that, both in vivo and in vitro, IL-2 produced by DC after microorganism-in-
fection is necessary to prime NK cell responses.
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The Langherans Cell/NK Cell Cross-talk: Signi¢cant Biological Di¡erences with
Interstitial Dendritic Cells
Christophe Borg, Magali Terme, Enguerran Mouly, Colette Dezutter, Franc ois Lemoine, Anne Galy,
Anne Caignard, Laurence Zitvogel
ERM0208 INSERM, Institut Gustave Roussy,Villejuif, France
It has been reported that CD34þ derived-dendritic cells and monocyte derived-intertitial dendritic
cells (MD-DC) trigger human resting NK cell activation at a mature stage of di¡erentiation or during
a concomittant in£ammatory stimulus. In mice, IL-4 derived-bone marrow DC display elective capa-
city to trigger mouse NK cell e¡ector functions in vitro and in vivo (in contrast to BM-DC (GM-
CSF)). We and others have reported the relevance of the DC/NK cell cross talk in tumor and viral
models. The location of the DC/NK cell interaction is not clear but we showed that sc inoculation
of BM-DC (grown in GM/IL-4 or GM/LPS) leads to recruitment and activation of NK cells residing
in the draining lymph node.We therefore adress whether Langherans cells would also be able to inter-
act with NK cells in vitro in the human setting. Surprisingly, while interstitial MD-DC do respond to
several TLR ligands and CD40L for NK cell activation, Langherans cells (LC) do not. Indeed,
CD34þ derived-LC, or skin migrating LC, while activated in the presence of LPS, IL-1b,
LPSþCD40L, or Flagellin (as assessed in Facs and allgeneic T cell reactivity), remain uncapable of
stimulating NK cells in vitro. We investigated the molecular composition and the function of the
DC/NK cell synapse following stimulation with LPS. Indeed, we found that NK cells are involved
in a functional synapse with mature MD-DC but not LC and that ICAM3 and IL-12 electively relo-
calized into the functional synapse. LC lacking DC-SIGN, we hypothetized that this b2 integrin was
critical in initiating the DC/NK cell interaction. Preliminary studies are indeed con¢rming a role for
DC-SIGN in the intial events triggering the functional DC/NK cell interaction in acute in£ammatory
processes. The clinical relevance of these ¢ndings will be discussed.
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Pathogen Recognition and Signaling Pathways of Toll-like Receptors
Shizuo Akira
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
Toll-like receptors (TLRs) detect invasion of pathogens in the body and trigger the in£ammatory and
immune responses against pathogens. Individual TLRs recogniges pathogen-associated molecular pat-
terns. TLR4 recognizes lipopolysaccharide,TLR2 recognizes lipoproteins and peptidoglycan together
with TLR1 or TLR6. TLR3, TLR9, TLR7 is involved in the recognition of double-standed RNA,
CpG DNA, and imidazoquinolines (anti-viral chemicals), respectively. Thus, TLRs recognize various
kinds of pathogens including bacteria, viruses, and parasites. TLR signaling is similar to that of IL-1R
signaling. Triggering of TLRor IL-1R recruits IL-1R associated kinase (IRAK) via adaptor molecule,
MyD88, and then TRAF6 is activated, ¢nally resulting in NF-kB activation. However, analyses of
MyD88 KO mice disclosed the presence of MyD88-independent pathway, indicating that signaling
pathways via TLRs are not identical, and di¡er each other. The MyD88-independent pathway is spe-
ci¢c in TLR3 and TLR4 signaling. Subsequent studies showed that MyD88-independent pathway
induces activation of IRF-3 and transcriptional activation of type I interferons. Besides MyD88, sev-
eral novel adaptor molecules including TIRAP/Mal and TRIF have recently been identi¢ed. Kockout
mice of these adaptors demonstrated that di¡erential utilization of these adaptor molecules provide the
speci¢city in the TLR signaling.
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IL-1a Promotes Th1-di¡erentiation and Inhibits Disease Progression in Leishmania
major-susceptible BALB/c Mice
Mark Udey1, Jan Ehrchen2,Yasmine Belkaid3, Susanna Lopez-Kostka2, Katharina M˛lle2, Jˇrgen Knop2,
Cord Sunderk˛tter4, Esther von Stebut2
1Dermatology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA
2Department of Dermatology, University of Mainz, Germany
3Department of Molecular Immunology, Children’s Hospital Research Foundation, University of Cincinnati,
OH, USA
4Institute of Experimental Dermatology, University of Mˇnster, Germany
Induction of immunity against pathogens such as Leishmania is dependent on the induction of IL-12-
dependent Th1 responses.We have previously shown that skin-dendritic cells (DC) from both resistant
C57BL/6 and susceptible BALB/c mice release IL-12 when infected with L. major, and infected BALB/c
DC e¡ectively vaccinate against leishmaniasis. To determine if cytokines other than IL-12 might reg-
ulate Th-development and disease, we quanti¢ed a variety of cytokines in DC from both strains.
BALB/c-derived skin-DC produced signi¢cantly less IL-1a/b as compared with C57BL/6 DC. In ad-
dition, IL-1a expression in vivo in lymph nodes of infected BALB/c mice wasB3-fold lower than that
of C57BL/6 mice at early time points (o96 h). Injections of IL-1a during the ¢rst 3 days after infec-
tion led to dramatic, persistent reductions in lesion sizes in both BALB/c and C57BL/6 mice. In
BALB/c mice, IL-1a administration also resulted in increased Leishmania-dependent Th1- and de-
creased Th2-cytokine production, and led to markedly decreased lesional parasite burdens. IL-1a treat-
ment was as e¡ective as administration of rIL-12 and IL-1a e⁄cacy was strictly IL-12 dependent.
These data indicate that transient administration of IL-1a acts in conjunction with IL-12 to in£uence
Th-development and attenuates progression of cutaneous leishmaniasis in susceptible BALB/c mice,
perhaps by enhancing DC-induced Th1-education. Di¡erential production of IL-1 by DC in C57BL/
6 and BALB/c mice may contribute to the disparate outcomes of infection in these strains.
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Molecular Organization and Function of C-type Lectin like Receptors on
Dendritic Cells
Carl G. Figdor
Department ofTumor Immunology, Nijmegen Center for Molecular Life Sciences (NCMLS), Nijmegen,The
Netherlands
Cells of the immune system are among the most motile cells in our body. In particular Dendritic cells
(DC), which are the professional antigen presenting cells of the immune system, have the capacity to
quickly change from an adhesive to a highly migratory phenotype. They possess the unique capacity
to take up and process antigen, migrate to the local lymph node, and present antigen to resting lym-
phocytes. How these phenotypical and functional changes are regulated is poorly understood.We are
interested in the function of C-type lectin like receptors expressed on dendritic cells. Several of these
receptors have recently been associated with antigen uptake and binding of pathogens. Major di¡er-
ences exist between C-type lectin like receptors expressed by subtypes of DC. Langerhans cells ex-
press Langerin, plasmacytoid DC express BBCA-2 and myeloid DC express DC-SIGN.
While DC-SIGN has been associated with binding and internalization of several viruses, including
HIV-1, on dendritic cells, the underlying mechanism for being such an e⁄cient phagocytic pathogen-
recognition receptor is poorly understood. By high-resolution microscopy, we demonstrate a direct
relation between DC-SIGN function as viral receptor and its micro-localization on the plasma mem-
brane.We show that these micro-domains are essential for binding and internalization of virus-sized
pathogens suggesting that the multivalent organization of DC-SIGN creates a docking site for patho-
gens like HIV-1 to invade the host.
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APC-T Cell Interactions during Antigen Presentation: Relevance of b2 Integrins
and Di¡erences between APC Types
Stephan Grabbe, Georg Varga, Mattias Gunzer
Dept. of Dermatology, University of Mˇnster, Mˇnster, Germany
Besides surface molecule composition and antigen processing capacity, the functional e⁄cacy of anti-
gen presenting cells (APC) depends on the physicodynamics of APC-T cell interaction. Antigen pre-
senting B cells form a stable ‘‘immunological synapse’’ with T cells, which is considered a prerequisite
for every productive APC-T encounter. To determine whether the physicodynamics of APC-T cell
interaction di¡er between types of APC, we compared B cells and dendritic cells (DC) with respect
to the biophysics of T cell interaction and the e⁄ciency of CD4 T cell activation.We observed two
strikingly di¡erent modes of T cell interactions. In a migration-promoting collagen matrix model,
resting B cells engaged T cells in stable, long-lasting conjugates, representing classical immunological
synapses. DC and activated B cells, however, engaged Tcells in a dynamic and transient, yet function-
ally very e⁄cient manner. Addition of a small molecule inhibitor of LFA-1 activation revealed that
synapse formation between T cells and resting B cells was dependent upon formation of active LFA-
1, whereas dynamic interactions between T cells and activated B cells or DC did not require high-
avidity LFA-1. Likewise, bone marrow-derived DC were unable to bind to ICAM-1, and DC from
CD18-/- mice, which lack functional LFA-1, had unimpaired antigen presenting capacity and migrated
normally through endothelial cell layers. The duration of DC-T cell contacts was also independent of
CD18 expression by DC, but strongly dependent on LFA-1 expression by T cells. Colocalization of
LFA-1with Cytohesin-1, a molecule required for formation of high avidity LFA-1, was seen inT cells
upon stimulation, but not in DC. In addition, DC and activated B cells, but not resting B cells and
na|«veTcells, expressed the Cytohesin-binding molecule Cytip, which prevents membrane recruitment
of Cytohesin-1.We conclude that resting B cells require active LFA-1 for activation of na|«ve T cells,
whereas the potent antigen presenting capacity of DC and activated B cells is associated with transient,
dynamic contacts toT cells and downregulation of active LFA-1.
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Dynamic in situ Behavior of Langerhans Cells Identi¢ed by Multi-photon Confocal
Imaging
Akira Takashima
Department of Dermatology, University ofTexas Southwestern Medical Center, Dallas,TX, USA
Langerhans cells (LC) represent immature dendritic cells (DC) that reside in the environmental inter-
faces (e.g., skin and cornea), where they constantly survey the integrity of surrounding epithelial tis-
sues through incompletely understood mechanisms. To identify the normal surveillance activity of
intraepithelial LC, we transplanted bone marrow cells from enhanced green £uorescence protein
(EGFP)-transgenic mice into g-irradiated wild-type mice and acquired dynamic, four-dimensional
multi-photon confocal images of EGFPþ LC in living cornea. A vast majority (490%) of intrae-
pithelial EGFPþ LC displayed a novel behavior characterized by rhythmic extension and retraction
cycling of dendrites (32 min cycle-1) through intercellular spaces between adjacent epithelial cells. Ex-
posure to IL-1, a prototypic pro-in£ammatory mediator, induced bidirectional hyper-elongation of
LC dendrites aligned in a peripheral-to-central corneal orientation. These dynamic behaviors may re-
present previously unrecognized mechanisms by which LC sample antigens actively and broadly in
epithelial tissues and respond to in£ammatory signals.
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Skin-derived Dendritic Cell Populations in Mouse Lymph Node
Kayo Inaba, Susumu Shimoyama,Tomonori Iyoda
Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
Epidermal Langerhans cells (LCs) have been well documented to home towards draining lymph
nodes (LNs) upon sensitization and to induce immune responses. However, there is no direct evidence
showing migration of dermal dendritic cells (DCs) and involvement in the induction of contact hy-
persensitivity. Therefore, we attempted to identify skin-derived DC subsets in the draining LNs after
painting with £uorescein isothiocyanate (FITC).
FITCþ DCs were found to consist of two phenotypically distinguishable populations by the ex-
pression levels of CD11c and CD11b: CD11cint CD11bint subset and CD11chi CD11bhi subset. Even
though they were comparable in the expression of MHC class II and co-stimulatory molecules,
CD11cint CD11bint subset was more potent in stimulating allogeneic CD4þ T cells to produce IFN-g
than the other CD11chi CD11bhi subset. This capacity looked consistent with the abilities to produce
IL-12. FITCþ CD11chi CD11bhi subset was negative for CD207, whereas FITCþ CD11cint CD11bint
subset comprised CD207-positive and ^negative populations. In addition, FITCþ CD207-positive
DCs were observed to stay longer than the other FITCþ DC subsets possibly derived from dermis
in the LNs. These observations imply the possibility that epidermis- and dermis-derived DCs exert
distinctive e¡ect on the induction of immune responses.
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Migration of Langerhans Cells for the Purpose of Generating Immunity or
Maintaining Tolerance
Nikolaus Romani
Department of Dermatology andVenereology, University of Innsbruck, Innsbruck, Austria
Langerhans cells (LC) and dermal dendritic cells (DC) migrate to the draining lymph nodes in order to
initiate immune responses. This generally occurs under in£ammatory circumstances, toll-like receptors
being crucial sensor molecules for pathogens. Recently, we learnt that dendritic cells may also serve to
maintain peripheral tolerance when they migrate under non-in£ammatory steady-state conditions. These
functional properties are beginning to be exploited clinically. Several important unknowns still remain,
however. The regulation of steady-state migration is not fully understood.We have studied steady-state
migration in human and mouse skin. The expression of typical maturation markers for LC (e.g. CD86,
CD208) appears not to be a good marker for the functional determination of a migrating LC. Rather,
cytokine production by LC may be more informative. In the steady-state, migrating LC make less bioac-
tive IL-12. In response to in£ammatory stimuli IL-12 is increased and, as a consequence, proliferating T
cells secrete more IFN-gamma.With regard to the clinical application of tumor antigen-loaded, ex vivo
generated DC it is clear that migration to draining lymph nodes of such DCs injected into the skin is
ine⁄cient. Possible ways to improve migration and thereby enhance subsequent T cell responses will be
discussed. Promising approaches involve the generation of an in£ammatory milieu at the injection site.
Alternatively or additionally, the use of LC-like cells, generated from hematopoietic stem cells, is being
evaluated. Mouse models for such cells may facilitate the development of these approaches.
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Dendritic Cells as Vectors and Targets for Therapy
Jacques Banchereau, Gaetan Jego, Sophie Paczesny, JosephW. Fay, Madhav Dhodapkar, Ralph Steinman,
Virginia Pascual, A. Karolina Palucka
Baylor Institute for Immunology Research, Dallas,TX, USA
Early trials in humans have shown the safety of cancer antigens-loaded DCs as well as some clinical
and immune responses. However, many issues remain to be addressed including the choice of the DC
subset to be administered and the way to generate it. The most popular way is to culture blood mono-
cytes with GM-CSF and IL-4, which yield a uniform population of immature DC resembling inter-
stitial DCs (intDCs). This contrast with hematopoietic stem cells that, when cultured with GM-CSF
andTNF, yield preparations that include intDCs as well as Langerhans cells (LCs).While GM-CSF/IL-
4 induced DCs require additional maturation factors, CD34-DCs do not as they are generated in the
presence of TNF alpha, a DC activation factor.We have vaccinated 18 HLA A0201þ patients with
stage IV melanoma with CD34-HPC-derived DCs pulsed with six Ags: in£uenza matrix peptide
(Flu-MP), KLH, and peptides derived from the four melanoma Ags: MART-1/Melan A, gp100, tyr-
osinase and MAGE-3. A single DC vaccination was su⁄cient for induction of 1) KLH speci¢c re-
sponses in 6 patients, 2) Flu-MP-speci¢c responses in 8 patients, and 3) tumor speci¢c e¡ectors to
41 melanoma antigen in 5 patients. None of these 5 patients showed early disease progression. Only
1/6 patients with rapid KLH-response experienced early disease progression. Rapid and slow Flu-MP
responders did not di¡er with regard to disease progression. Analysis at 10 weeks (after 4 vaccinations)
revealed an immune response to control antigens in 16/18 patients. An enhanced immune response to 1
or more melanoma antigens (MelAg) was seen in these 16 patients. The 2 patients failing to respond
experienced rapid tumor progression. 6/7 patients with immunity to 2 or less MelAg had progressive
disease 10 weeks after study entry, in contrast to tumor progression in only 1/10 patients with immu-
nity to 4 2 MelAg. The tumor immunity score correlated with clinical outcome. Eleven patients
received 4 additional ‘‘boosting’’ injections. Analysis of overall survival from study entry revealed that
12/18 patients were alive at year 1 and 9/18 patients were alive at year 2. Overall survival from study
entry as well as the time to disease progression were related to the level of vaccine-speci¢c immune
responses detected at 10 weeks, i.e., after the initial 4 injections, as measured by 1) the magnitude, i.e.
the number of melanoma Ags-speci¢c IFN gamma ELISPOTS, and 2) the breadth, i.e., the number
of melanoma antigens to which T cells respond.
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Dendritic Cells as Sentinels of the Immune System
Ralph M. Steinman
Laboratory of Cellular Physiology and Immunology,The Rockefeller University, NewYork, NY, USA
Dendritic cells (DCs) in the steady state, in the absence of overt infection, seem to continually capture
dying cells and environmental proteins, leading to presentation on MHC class I and II products to T
cells. Most DCs in vivo, which include Langerhans cells and a large number of DCs that bear the
DEC-205 endocytic receptor in the T cell areas, are immature. These DCs have the capacity to take
up antigens but are unable to induce immunity, i.e., the production of e¡ectorTcells and memory.We
will illustrate examples in which the model antigen, ovalbumin, is targeted to DCs in lymphoid tis-
sues either as a soluble protein, or as a conjugate linked to anti-DEC-205 antibody, or as a surrogate
antigen within dying cells. The immune response is then monitored in the absence (steady state) or
presence of stimuli for DC maturation. In the steady state, DCs e⁄ciently present antigens on MHC
class I and II molecules, but the consequence is peripheral tolerance. Many stimuli for DC maturation
are known, and we have studied two of these in vivo, agonistic anti-CD40 monoclonal antibodies,
and the synthetic glycolipid, alpha galactosyl ceramide. Both agents convert the outcome of DC anti-
gen presentation from tolerance to immunity. Interestingly, the combination of these maturation sti-
muli with antigen targeting to DCs results in immune responses in vivo that are much greater than
responses observed with current gold standards, such as complete Freund’s adjuvant and antigen-
pulsed ex vivo derived DCs.
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C1
Characterisation of Langerhans Cell-precursors in vivo in a Tape Stripping-model
Sandra Holzmann1, ChristophTripp1, Franz Koch1, Sem Saeland2, Patrizia Stoitzner1, Nikolaus Romani1
1Department of Dermatology, University of Innsbruck, Innsbruck, Austria
2Laboratory of Immunological Research, Schering-Plough, Dardilly, France
Langerhans cells (LC) originate in the bone marrow and are found as ‘‘sentinels’’ in the epidermis.
Little is known about the immigration of bone marrow-derived LC-progenitors into the skin. In this
study, we developed a murine in vivo-model, based on the tape stripping-method, to assess immigra-
tion of LC into in£amed epidermis. Tape stripping induced mechanical disruption of the epidermal
barrier, which led to emigration of LC and dermal dendritic cells from the in£amed skin. Both cell
types matured on their way to the draining lymph node and were found there in 2 to 3-fold increased
numbers. Precursors, cultured from bone marrow, were injected into the dermis of tape-stripped ear
pinnae and untreated controls. One to four days after injection, epidermal sheets were prepared and
immigrated cells were counted and characterised. Tape stripping increased immigration of precursors
three to 500-fold compared with untreated skin. Cells immigrated into in£amed epidermis mostly
one and two days after precursor injection and were arranged in clusters. They were slender with
one or two dendrites and acquired a dendritic morphology after four days. In untreated epidermis only
few single precursors were found. To determine the nature of the LC-precursor we analysed expression
of MHC II, Langerin/CD207, CD11c, and CCR6. One day after injection immigrated cells were Lan-
gerin-negative, CD11c-positive, and CCR6-positive. In conclusion, our results suggest that LC-precur-
sors that retain the ability to enter the epidermis are not fully di¡erentiated, and that this experimental
system is a valuable tool for their further characterisation. (Austrian Science Fund P-14949).
C2
The Induction of Human Langerhans Cells from Hematopoietic Progenitor Cells
without GM-CSF
Setsuya Aiba, Zia UA Mollah, Satoshi Nakagawa, Masato Mizuashi,Tomoyuki Ohtani, HachiroTagami
Department of Dermatology,Tohoku University School of Medicine, Sendai, Japan
Now it becomes clear that not only op/op mice that cannot produce functional M-CSF but also both
GM-CSF null mice and GM-CSF receptor chain null mice harbor Langerhans cells (LCs) or non-LC
dendritic cells (DCs). So, these data raised the question which cytokine, M-CSF or GM-CSF, really
functions for DC or LC development in vivo.To address this question, we replaced GM-CSF with M-
CSF from a serum-free culture containing GM-CSF, SCF, Flt3L, TNF-a, and TGF-1. This serum-
free culture medium containing M-CSF, but not GM-CSF (M-CSF culture), could induce
CD1aþBirbeck granuleþLangerinþE-cadherinþ factor XIIIa-LCs. As a control, the culture of
HPCs in this culture medium depleted of M-CSF or TGF-1 resulted in far fewer or null CD1aþ
cells, respectively. M-CSF increased the number of CD1aþ cells in a dose-dependent fashion. These
M-CSF-induced LCs were di¡erent from GM-CSF-induced LCs in their immature phenotype and
the lack of IL-10 production and the augmented production of TNF-a and IL-8 when stimulated
with IL-1 or LPS. They acquired a mature phenotype by GM-CSF,TNF-a, IL-1, or LPS. M-CSF-
induced LCs could stimulate allogeneicT cells. Interestingly, we could keep the growth and immature
phenotypes of M-CSF-induced LCs for at least 28 days of culture. In addition, we also demonstrated
that IL-3 could replace the role of GM-CSF in the same culture system, although LCs induced by IL-
3 expressed Langerin but lacked Birbeck granules. These studies revealed the redundancy of growth
factors in LC or DC development from HPCs in vitro.
C3
The Suppressed Histamine H1 and H2 Receptors on Langerhans Cells Makes a
Striking Contrast with their Functional Expression by Dermal Dendritic Cells
Tomoyuki Ohtani, Satoshi Nakagawa, Masato Mizuashi, ZIAUA Mollah, HachiroTagami, Setsuya Aiba
Department of Dermatology,Tohoku University Graduate School of Medicine, Sendai, Japan
Human monocyte-derived dendritic cells (MoDCs) have both histamine H1 and H2 receptors and can
induce CD86 expression and chemokine production by histamine. However, it has not been reported
whether human epidermal Langerhans cells (LCs) have histamine receptors or not. In this study, using
RT-PCR, we investigated the expression of H1 and H2 receptor mRNA on DCs with the features of
LCs (LC-like DCs) that were generated in vitro from CD14þ peripheral blood monocytes, LCs de-
rived from CD34þ hematopoietic progenitor cells (HPCs), and LCs obtained from human epider-
mis. We also compared the histamine-induced CD86 expression among these cells. In contrast to
MoDCs, LCs and LC-like DCs did not express H1 or H2 receptors. In addition, they could not aug-
ment the CD86 expression by histamine. Interestingly, when transforming growth factor-1 (TGF-
1) was added to the culture of MoDCs, the expression of H1 and H2 receptors and the histamine-
induced CD86 expression were abrogated in a dose-dependent fashion. Finally, in the assessment of
the cell surface expression of histamine receptors using £uorescence-labeled histamine, it was clearly
demonstrated that histamine could bind to MoDCs and dermal dendritic cells obtained from the skin,
while there was no speci¢c binding of histamine to LC-like DCs or LCs obtained from the skin.
These data suggest that LCs do not express either H1 or H2 receptors, mainly because of the e¡ect
of TGF-1. This made a striking contrast with the expression of the functional H1 and H2 receptors
on MoDCs and dermal dendritic cells.
C4
Generation and Characterization of Recombinant Soluble Mouse Langerin
Yayoi Tada, Elisabeth Riedl, Mark C. Udey
Dermatology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA
Antigen presenting cells (APC) including dendritic cells express a variety of C-type lectins. Several of
these C-type lectins have been shown to recognize carbohydrate moeities on microbial pathogens and
self glycoproteins. Thus, C-type lectins likely play important roles in the induction of innate immu-
nity and in cell-cell interactions that facilitate adaptive immune responses. Langerin is a novel type-II
C-type lectin expressed by Langerhans cells. Langerin localizes to Birbeck granules (BG) and induces
BG formation when over expressed in ¢broblasts. The Langerin extracellular region is comprised of
neck and carbohydrate recognition domains and binds to mannose-containing glycoproteins.We iso-
lated Langerin cDNA from mouse fetal skin-derived DC (FSDDC) by subtractive cloning and rapid
ampli¢cation of cDNA ends. Transfection of mouse Langerin cDNA into ¢broblasts induced BG, as
expected. To further characterize functional aspects of this protein, we expressed soluble epitope-
tagged recombinant fragments of mouse Langerin with or without the neck domain in bacteria, and
puri¢ed them using mannan-agarose a⁄nity chromatography. The neck domain of Langerin was re-
quired for e⁄cient interaction of recombinant Langerin with mannan. Recombinant Langerin bound
to mannan-agarose beads and mannose-rich yeast invertase in a calcium-dependent fashion. Langerin-
invertase binding could be blocked with mannan. This recombinant protein will faciliatate identi¢ca-
tion of additional physiologic ligands of Langerin.
C5
Di¡erential Expression and Function of Toll-like Receptor in Murine Langerhans
Cells: Comparison with Splenic Dendritic Cells
Hiroshi Mitsui,TakahiroWatanabe, Hidehisa Saeki, Hideki Fujita, Akihiko Asahina, Kunihiko Tamaki
Department of Dermatology, University ofTokyo,Tokyo, Japan
We puri¢ed murine resident epidermal Langerhans cells (LC) using panning method and studied the
expression pattern and functions of Toll-like receptors (TLRs) of LC.We found the following: (1) LC
expressed TLRs 2, 4, 9, but not 7, the pattern of which suggest LC are the closest to one of the splenic
dendritic cell (DC) lineage, CD11cþ11bþ 8a-4 -; (2) TLR4 and its accessory molecules CD14 and
Rp105 (CD180) are more highly expressed on splenic DC than on LC; (3) murine LC, similar to hu-
man LC, overall produced Th1 cytokines including IL-12p40 and IP-10 on stimulation to each ex-
pressed TLR, namely, to TLR2 with Staphylococcus aureus Cowan I (SAC), to TLR4 with
lipopolysaccharide (LPS), and to TLR9 with unmetylated CpG; only exception was IL-12p40 unre-
sponsiveness on stimulation with LPS; (4) on the other hand, the production of Th2 cytokine,TARC/
CCL17 was decreased on stimulation with these TLR stimulations; (5) the IL-6 production by LPS-
stimulated LC was signi¢cantly lower than that by LPS-stimulated DC, whereas the TARC produc-
tion was higher in LC than in DC.The di¡erence in the responsiveness to LPS between epidermal LC
and splenic DC might be due to the deviated expressions of TLR4 and its accessory molecules. These
results may represent the heterogeneity of DC lineages and functions.
C6
SHPS-1/SIRP Alpha Regulates Migration of Langerhans Cells from Epidermis to
Draining Lymphnode
Atsushi Fukunaga1, Hiroshi Nagai1,Yu Xijun1,Tetsuya Noguchi2, Takashi Matozaki3, Chikako
Nishigori1,Tatsuya Horikawa1
1Division of Dermatology, Department of Clinical Molecular Medicine, Kobe University Graduate School of
Medicine, Kobe, Japan
2Division of Diabetes, Digestive, and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe
University Graduate School of Medicine, Japan
3Biosignal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Japan
Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 (SHPS-1 or also named
as SIRP alpha ) is a member of the signal regulatory protein family, which binds to CD47 and plays
an important role in cell motility, cell attachment, cell fusion and the regulation of immune response.
SHPS-1 is expressed in myeloid cells including monocytes, macrophages, and dendritic cells.We ¢rst
con¢rmed that murine epidermal LCs in situ express SHPS-1 by both FACS and immuno£uorescent
studies. Next, we showed that in vivo adminitration of anti-SHPS-1 mAbs reduced LC migration to
the regional lymphnodes after FITC application to skin, and that this treatment signi¢cantly sup-
pressed a decrease of LC number in the epidermis after DNFB application. Anti-SHPS-1 mAb treat-
ment in vivo also inhibited TNF-alpha triggered LC migration.We further observed that migration of
LCs from skin explants into the culture media was reduced by the addition of anti-SHPS-1 mAb.
Migration of XS 52 cells, a murine dendritic cell line, was inhibited by treatments with both anti-
SHPS-1 mAb and a synthetic fusion protein CD47-Fc which binds to SHPS-1. Finally, we observed
that hapten-induced migration of LCs was impaired in SHPS-1 knockout mouse. These results indi-
cate that SHPS-1 is one of the important molecules which regulate epidermal LC migration.
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C7
Prostaglandin E2-EP4 Signaling as an Initiator of Contact Hypersensitivity by
Modulating Migration and Maturation of Langerhans Cells
Kenji Kabashima1, Kayo Inaba2, Shuh Narumiya3,Yoshiki Miyachi1
1Department of Dermatology, Kyoto University, Kyoto, Japan
2Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University, Kyoto,
Japan
3Department of Pharmacology, Kyoto University, Kyoto, Japan
Antigen-speci¢c immune responses in the skin are initiated by antigen uptake into Langerhans cells
(LCs) and the subsequent migration of these cells to draining lymph nodes. Although prostaglandin
E2 (PGE2) is produced substantially in the skin exposed to antigen, its role remains unclear. Here we
show that while Langerhans cells express all four PGE receptor subtypes, their migration to regional
lymph nodes was decreased only in EP4-de¢cient mice and in wild-type mice treated with an EP4
antagonist.Consistently, an EP4 agonist increased the number of LCs that migrated to the culture
medium from the mouse skin explants, and the number of migrated LCs towards CCL19, as a
CCR7 ligand in a trans-well assay. Moreover, an EP4 agonist signi¢cantly increased expression of
co-stimulatory molecules of LCs in the organ culture, and acted on LCs in mixed lymphocyte reac-
tion assay to enhance allogeneic T cell proliferation and activation. On the other hand, the morphol-
ogy and density of LCs in epidermal sheets in the steady state, and the endocytotic activity using
FITC-dextran are comparable between control and EP4-de¢cient mice. In vivo, contact hypersensi-
tivity to antigen was impaired in EP4-de¢cient mice and in wild-type mice treated with the EP4
antagonist during sensitization. The antigen-speci¢c T cell proliferation and Th1 cytokine production
was also signi¢cantly reduced in cells form the regional lymph nodes of EP4-de¢cient mice. Taken
together, our results suggest that PGE2-EP4 signaling facilitates initiation of skin immune responses
by promoting the migration and maturation of LCs.
C8
The Contribution of Langerhans Cells and Follicular Dendritic Cells to the
Transmission of Scrapie from the Skin to the Brain
Joanne Mohan1, John Hopkins2, Moira E. Bruce1, Neil A. Mabbott1
1Institute forAnimal Health, Neuropathogenesis Unit, Edinburgh, UK
2Royal (Dick) School of Veterinary Studies,The University of Edinburgh, Summerhall, Edinburgh, UK
Transmissible spongiform encephalopathies (TSEs) are a group of infectious neurodegerative diseases,
which are characterized by the accumulation in diseased tissues of PrPSc, an abnormal isoform of the
host prion protein (PrPc). Following peripheral exposure, infectivity and PrPSc usually accumulate in
the lymphoid tissues prior to neuroinvasion. Studies in mice have shown that skin scari¢cation is an
e¡ective means of scrapie transmission. Following inoculation via the skin a functional immune sys-
tem is critical for the transmission of scrapie to the brain, as SCID mice are refractory to infection. It is
not known which cells within lymphoid tissues replicate and accumulate scrapie infectivity following
skin scari¢cation. Here we show that following skin scari¢cation, mature follicular dendritic cells are
critical for the replication of scrapie within the spleen and subsequent transmission of infection to the
brain. In addition we show that scrapie replication in the spleen is independent of PrP expression by
lymphocytes or other bone marrow derived cells. The mechanism through which scrapie infectivity is
initially transported from the skin to the draining lymphoid tissues is not known. Data will be pre-
sented on the potential role of Langerhans cells in the transport of scrapie from the skin to the drain-
ing lymphoid tissues.
C9
Compromised Recovery of Natural Interferon-a/-producing Cells after Allo-
geneic Hematopoietic Stem Cell Transplantation Complicated by Acute Graft ver-
sus Host Disease and Glucocorticoid Administration
Toshio Kitawaki, Norimitsu Kadowaki,Takayuki Ishikawa,Tatsuo Ichinohe,Takashi Uchiyama
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Delayed recovery of the immune system is a major cause of post-transplant infection. Natural inter-
feron (IFN)-a/-producing cells (IPC) appear to play a critical role in inducing e¡ective immune
responses to a variety of microbial pathogens by producing an enormous amount of IFN-a/ and
thereafter by di¡erentiating into dendritic cells. Here, we examined the recovery of IPC as well as
other immune cells in 28 patients after allogeneic hematopoietic stem cell transplantation (HSCT) in
order to investigate the role of IPC in post-transplant immune reconstitution. In uncomplicated cases,
IPC frequency recovered to the lower range of normal values within 30 days after transplantation,
resembling the prompt recovery of other cell types in innate immunity. In contrast, the recovery of
IPC was profoundly suppressed in the cases with acute GVHD and glucocorticoid administration.The
patients with lower numbers of IPC were signi¢cantly more susceptible to viral infection.The prompt
recovery of IPC in uncomplicated cases may contribute to establishing a ¢rst line of host defense at
the early stage after allogeneic HSCT, whereas the marked suppression of IPC recovery accompanying
acute GVHD and glucocorticoid administration may increase the risk of opportunistic infections.
C10
Physiological Regulators of the Migration and Cytokine Secretion of in vitro-
derived and Blood-derived DC
Eugene Maraskovsky1,Thomas Luft2, Max Schnurr1, Michael Je¡ord1,TraceyToy1, Amanda Shin1, Ken
Shortman2, Ian Davis1, Jonathan Cebon1
1CancerVaccine Laboratory, Ludwig Institute for Cancer Research, Melbourne Australia
2TheWalter and Eliza Hall Institute of Medical Research, Melbourne, Australia
3Medizinische Klinik und PoliklinikV, University of Heidelberg, Heidelberg, Germany
Migration of Ag-loaded dendritic cells (DC) from sites of infection into draining lymphoid tissues is
fundamental to the priming of T cell immune responses. We evaluated monocyte-derived DC
(MoDC) and blood DC (PBDC) to respond to (1) pro-in£ammatory mediators, (2) CD40L, (3) intact
bacteria and (4) Adenyl nucleotides. All classes of stimuli induced DC phenotypic maturation. How-
ever, for MoDC, either PGE2-containing stimuli or ATP alone induced migratory-type DC. Thus,
immature MoDC that encountered ATP alone or either pro-in£ammatory cytokines or CD40L or
intact bacteria in the presence of PGE2 acquired migratory capacity but secreted low levels of cyto-
kines. Conversely, MoDC that encountered pathogens or CD40L alone become non-migratory, cyto-
kine secreting cells (pro-in£ammatory type). Interestingly, both migratory and pro-in£ammatory
type DC expressed equivalent levels of chemokine receptors suggesting that the role of PGE2 or
ATP was to switch on migratory function. We demonstrate that PGE2 and ATP induce migration
via speci¢c receptors and via the cAMP pathway. In contrast, CD1cþ PBDC and IL-3Rþ PBDC
rapidly acquired migratory capacity irrespective of the class of stimulus encountered and secreted low
levels of cytokines. This suggests that not all mature stages of DC are destined to migrate to lymphoid
organs and that the sequence in which stimuli are encountered signi¢cantly a¡ects which functions are
expressed. Thus, certain immature DC subsets recruited from the resting precursor pool may have
multiple functional fates that play distinct roles during the induction and e¡ector phases of the im-
mune response.
C11
Di¡erences between Murine Langerhans Cells Migrating in the Steady State and in
In£ammation
Patrizia Stoitzner1, Sem Saeland2, Nikolaus Romani1
1Department of Dermatology, University of Innsbruck, Innsbruck, Austria
2Laboratory for Immunological Research, Schering-Plough, Dardilly, France
Migrating Langerhans cells (LC) may induce immunity or - in the steady state - maintain peripheral
tolerance. Tolerogenic LC are as yet poorly characterized. A contact allergy model was employed to
investigate changes in migrating LC in steady state versus in£ammation.We applied 2,4,6-trinitro-1-
chlorobenzene (TNCB) onto skin to induce migration of LC to lymph nodes. Dendritic cells isolated
from skin-draining lymph nodes of TNCB-treated and control mice were compared in phenotype
and function. In response to TNCB increased numbers of LC, as determined by anti-Langerin/
CD207 staining, appeared in the nodes. These LC expressed slightly more CD40 and CD86 molecules
on their surfaces than LC of control mice which already expressed some CD40 and CD86 in the
steady state. Small amounts of IL-12p40 were measured (by intracellular FACS) in unstimulated
lymph node LC; increased expression was induced by the application of TNCB.When isolated lymph
node dendritic cells were further stimulated by LPS- and anti-CD40, both IL-12 p40 and p70 were
ampli¢ed in most LC. This was more pronounced in the in£ammatory situation. The augmented IL-
12 production correlated with more IFNgamma being produced by the lymph nodeTcells stimulated
by anti-CD3/CD28. Thus, phenotypical di¡erences between LC in steady state and in£ammation may
not be the predominant markers for immunogenic versus tolerogenic LC. However, cytokine pro¢les
di¡er strongly and may be a decisive factor for the immunogenicity of LC. (Supported by the Aus-
trian Science Fund P-14949.)
C12
Lack of Cytokine-induced Langerhans Cell Migration in Uninvolved Skin of
Patients with Psoriasis
Marie Cumberbatch1, HelenYoung2, Rebecca J. Dearman1, Ian Kimber1, Christopher E.M. Gri⁄ths2
1Syngenta CentralToxicology Laboratory, UK
2Dermatology Centre, University of Manchester, Hope Hospital, Manchester, M6 8HD, UK
Intradermal injection of normal healthy volunteers with tumor necrosis factor-a (TNF-a) or
interleukin-1 (IL-1) stimulates the migration away from the epidermis of a proportion (20-30%)
of Langerhans cells (LC).We have now investigated cytokine-induced LC migration in uninvolved
skin from patients with a range of severities of chronic plaque psoriasis. Six healthy volunteers (22-
55 years) and 22 untreated patients (25-57 years) each received intradermal injections containing either
TNF-a (200U or 500U) or IL-1 (50U or 100U), and a control injection of saline alone to buttock
skin; all treated sites were greater than 5cm from a psoriatic plaque. Skin biopsies (6mm) were taken 2
hours later and CD1aþ or HLA-DRþ epidermal LC densities were determined. Epidermal LC den-
sities were similar at saline-treated control sites for both normal volunteer and patient groups and fell
within a similar range of values whether analyzed on the basis of CD1a or HLA-DRexpression.Treat-
ment of normal volunteers with either TNF-a or IL-1 each stimulated reductions in LC frequencies
of approximately 25%, as reported previously. In patients with psoriasis, however, LC failed to re-
spond to either TNF-a or IL-1, with LC values remaining similar to those found at control sites.
Interestingly, both TNF-a and IL-1 induced local erythema at the injection sites in psoriasis patients
and controls. These results suggest that in uninvolved psoriatic skin, LC are unresponsive to the mo-
bilization stimuli of TNF-a or IL-1, despite the ability of surrounding cells to respond normally to
the pro-in£ammatory properties of these cytokines.
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C13
IL-23 Production by Cosecretion of Endogenous p19 and Transgenic p40 in K14/p40
Transgenic Mice: Evidence for Enhanced Cutaneous Immunity
Tamara Kopp1, Petra Lenz2, Concha Bello-Fernandez1, Robert A. Kastelein4,Thomas S. Kupper4,
Georg Stingl1
1Department of Dermatology, DIAID and Institute of Immunology, University of Vienna,
Medical School Vienna, Austria
2NCI, Bethesda, MD, USA
3DNAX, CA, USA
4Harvard Skin Disease Research Center, Boston, MA, USA
P40, the common subunit of the proin£ammatory cytokines IL-12 and IL-23 is produced by resident
skin cells.Whereas the in vivo e¡ects of IL-12 are well established, little is known about the role of IL-
23 in cutaneous immune responses. Here we show that mice, constitutively overexpressing p40 in
basal keratinocytes, spontaneously develop an in£ammatory skin disease. These mice produce IL-23
(p19/p40), but not IL-12 (p35/p40), in basal keratinocytes by cosecretion of transgenic p40 with endo-
genous p19. Repeated injections of recombinant IL-23 in littermate (LM) mice result in an in£amma-
tory skin disease similar to that of p40 transgenic (TG) mice con¢rming the proin£ammatory activity
of IL-23. Furthermore, IL-23 secretion by p40 TG keratinocytes induces elevated numbers of Langer-
hans cells (LC) with a marked upregulation of costimulatory molecules indicating advanced matura-
tion of K14/p40 LC when compared to LM LC. At the functional level, freshly isolated K14/p40 LC
greatly exceeded LC from LM animals in their capacity to stimulate allogeneic T cell proliferation. To
assess whether IL-23 regulates cutaneous immune responses in vivo we used an allogeneic skin trans-
plantation model. Full thickness skin grafts from K14/p40 donors (H-2q) transplanted across a MHC
class I and class II barrier onto BALB/c (H-2d) recipients were rejected in a signi¢cantly accelerated
fashion (mean survival time [MST]: 8.8 days) when compared to skin grafts from non transgenic LM
(H-2q) (MST: 10.7 days, po0.01). Based on these results, we propose that IL-23-induced changes of
LC may be an important mechanism in directing the outcome of cutaneous immune responses.
C14
Increased Langerhans Cell Antigen-presenting Function in vivo by Overexpression
of IL-15 in Murine Keratinocytes
Karin Loser1, Annette Mehling1, Bodo Eing2, Pietro Andres3, Hans-Christian Reinecker3,Thomes
Schwarz1, Stefan Beissert1
1Department of Dermatology, University of Munster, Munster, Germany
2Department of Virology, University of Munster, Munster, Germany
3GI-Unit, MGH-Harvard, Boston, USA
IL-15 plays a role in T- and NK cell homeostasis as well as in the in vitro development of human
Langerhans cells (LC). IL-15 is present in various cell types, including keratinocytes although it is
poorly translated and secreted. To study the e¡ects of IL-15 on cutaneous LC biology, we generated
transgenic (tg) mice using the K14 promoter, which overexpress IL-15 in basal keratinocytes. IL-15tg
mice show a uniform transgene expression in their basal keratinocytes and have normal numbers of
LC.To investigate acquired immunity in IL-15tg mice contact hypersensitivity (CHS) was performed.
IL-15tg mice have signi¢cantly enhanced CHS responses compared to controls. LC play an important
role in the sensitization phase of CHS. Therefore, wt and tg mice were epicutaneously immunized
with suboptimal hapten doses. Interestingly, only tg mice were able to mount CHS responses after
challenge when suboptimal doses were used for sensitization suggesting enhanced LC APC function
within the tg epidermis. To investigate the LC APC function in vitro, LC were allowed to migrate out
of tg epidermal sheets to be able to stimulate allogeneic T cells. LC from tg epidermis were signi¢-
cantly better allostimulators compared to LC from wt skin. However, LC from tg epidermis showed
no enhanced migratory capacity to draining lymph nodes upon epicutaneous sensitization, but LC in
tg skin were found in preliminary experiments to have up-regulated costimulatory molecules. These
data demonstrate that keratinocyte-derived IL-15 plays an important role in (cutaneous) acquired im-
munity possibly by activating the APC function of LC.
C15
Neonatal Dendritic Epidermal Leukocytes Potently Express IL-10 and Represent
the Major Source of IL-10 Protein in the Neonatal Epidermis
Souyet Chang-Rodriguez1, Rupert Ecker2, Georg Stingl1, Adelheid Elbe-Buerger1
1Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, University of Vienna
Medical School,Vienna, Austria
2Competence Center for Bio MolecularTherapeutics,Vienna, Austria
The neonatal period is marked by a higher susceptibility to infections as well as a poorer capacity to
respond to vaccines compared to adults. The mechanisms underlying reduced immune responsiveness
are not completely understood. To address whether reduced immune responsiveness results from sub-
optimal antigen presenting cell and T cell interactions, we compared neonatal dendritic epidermal
leukocytes (NDL) with Langerhans cells (LC), regarding di¡erentiation and functional capacity. For
this purpose, NDL and LC were puri¢ed (495%) from epidermal cell suspensions prepared from
newborn and adult whole body skin and cultured for three days in culture medium with GM-CSF.
During culture, NDL did not acquire the morphology and phenotype typical of LC and were inef-
fective in delivering a proliferative signal to T cells in vitro. To clarify the underlying cause, cytokine
expression of neonatal and adult epidermis was examined. The observations that NDL, but not LC
cultures expressed considerable amounts of the immunomodulatory cytokine IL-10, and that neonatal
epidermal cells partially inhibit LC maturation, suggest that endogenous IL-10 inhibits the maturation
of NDL into immunocompetent LC. These ¢ndings have important implications for our understand-
ing of mechanisms underlying reduced neonatal immune responses and neonatal tolerance.
C16
Production of IP-10/CXCL10 in Mouse Langerhans Cells is Upregulated by IFN-c
and IL-12: its Strict Regulation Compared with That of MDC/CCL21 and
TARC/CCL17
Hideki Fujita, Akihiko Asahina, Kunihiko Tamaki
Department of Dermatology, University ofTokyo,Tokyo, Japan
It is widely accepted that some chemokines are specially designed to attract mainly Th1 cells, while
others attract Th2 cells. In this study, using RT-PCR and ELISA, we investigated the capacity of Lan-
gerhans cells (LC) to produce these chemokines and their regulation by various stimuli.We prepared
highly puri¢ed LC (495%) directly from BALB/c mouse skin using panning method. The Th1-che-
mokines, represented by IP-10, I-TAC and Mig, were not expressed in fresh LC. Both IP-10 and I-
TAC, but not Mig expression were induced following 48h-culture. Incubation with IFN-g was neces-
sary for Mig expression. Interestingly, in addition to IFN-g, IL-12 up-regulated IP-10, but not Mig
production of LC. No other stimuli tested could modulate production of these Th1-type chemokines,
implying that their regulation is strict and in£uenced only byTh1 cytokines. In contrast, theTh2-type
chemokines, MDC and TARC were regulated in a more complicated fashion. Although they were
faintly expressed in fresh LC and enhanced following 48h cultutre, stimuli related to LC maturation
had either positive or negative e¡ect, and the mode of regulation was similar, but not identical be-
tween MDC and TARC. In addition, IFN-g equally down-regulated their production, thus further
indicating that this cytokine may be pivotal for skewing skin in£ammation toward Th1. The ability of
LC to produce both types of chemokines, depending on the stimuli in the microenviroment of LC,
may contribute to the pathogenesis of in£ammatory skin diseases by controlling Th1/Th2 balance.
C17
Functional Roles of Endogenous Redox Regulation Pathways in Antigen Presentation
Hiroyuki Matsue1, Dale Edelbaum2, David Shalhevet2, ChendongYang2, Mark E. Mummert2, Junichi
Oeda3, Hiroyuki Masayasu3, Akira Takashima2
1Department of Dermatology, University of Yamanashi,Yamanashi, Japan
2Department of Dermatology, University ofTexas Southwestern Medical Center, Dallas,Texas, USA
3Daiichi Pharmaceutical Co., Ltd,Tokyo, Japan
Although reactive oxygen species (ROS) have long been considered to play pathogenic roles in var-
ious disorders such as cancers, atherosclerosis, and in£ammation, convincing evidence has been pro-
vided of their physiological roles as second messengers in cellular signaling. To determine the
immunological consequence of pharmacological disruption of endogenous redox regulation in anti-
gen presentation, we used a selenium-containing anti-oxidant compound ebselen known to interfere
with the two major physiological redox regulation pathways (thioredoxin and glutaredoxin pathways).
Ebselen at 5-20 mM inhibited Con A-induced proliferation and IL-2 production by HDK-1Tcell line
as well as LPS-triggered cytokine production by XS52 dendritic cell (DC) line.Working with the in
vitro antigen (Ag) presentation system composed of bone marrow-derived DC, CD4þ T cells iso-
lated from DO11.10 TCR transgenic mice, and ovalbumin peptide (serving as Ag), we observed that:
1) both T cells and DC generate ROS upon Ag-speci¢c interaction; 2) ebselen signi¢cantly inhibits
ROS production in both cell populations; and 3) ebselen at 5-20 mM inhibits DC-induced prolifera-
tion and cytokine production byT cells as well as T cell-induced cytokine production by DC. Thus,
Ag speci¢c,bi-directional DC-Tcell activation can be blocked by interfering with the redox regulation
pathways. Allergic contact hypersensitivity (CH) responses in BALB/c mice to oxazolone, but not
irritant CH responses to croton oil, were diminished signi¢cantly by post-challenge treatment with
oral administrations of ebselen (100 mg/kg/day). These results provide both conceptual and technical
frameworks for studying ROS dependent regulation of DC-T cell interaction in Ag presentation.
C18
CD83 Function in MHC Class II Expression
Manabu Fujimoto1, SatokoYoshitake1, Hitoshi Okochi1, Thomas F. Tedder2
1International Medecal Center of Japan,Tokyo, Japan
2Duke University Medical Center, Durham, NC, USA
CD83 is a 45-kDa glycoprotein that belongs to immunoglobulin superfamily. CD83 expression is
strongly upregulated during the maturation of dendrtic cells, and thus used as a marker for mature
dendritc cells. CD83 is also expressed weakly by some germinal center lymphocytes and mitogen-
activated lymphocytes. Recently, we reported that CD83-de¢cient (CD83-/-) mice had a speci¢c
block in CD4þ single positive thymocyte development without increased CD4þCD8þ double-
or CD8þ single-positive thymocytes. Adoptive transfer experiments have also demonstrated that
CD83-/- thymocytes developed normally when transferred into wild type mice, whereas wildtype
thymocytes failed to di¡erentiate into mature CD4þ T cells in CD83-/- mice. To clarify the mole-
cular mechanisms underlying the defect, we examined MHC class II expression in CD83-/- mice.
MHC class II expression as well as CD86 expression was remarkably decreased on cell surface from
CD83-/- dendritic cells and B cells, but the intracellular expression was equivalent to wild type cells,
suggesting that CD83 is required for optimal cell-surface expression of MHC class II complex.
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Ligation of CD86 Increases Dendritic Cell (DC) Capture of Naive T Cells and Up-
regulates CD40 and MHC II Expression
Adela Cardones,Takashi Murakami, Sam Hwang
Dermatology Branch, National Cancer Institute, Bethesda, MD, USA
CD86 is expressed by maturing DC and modulates T cell function, but the e¡ects of CD86 ligation
on DC are unclear. Herein, we address whether CD86-mediated signaling modulates DC function
and surface receptor expression. Murine bone marrow-derived DC (BMDC) were added to anti-
CD80, anti-CD86, or control mAb-coated tissue culture plates. By £ow cytometric analysis, 51% of
CD86-ligated BMDC had a £uorescence intensity (FI) for CD40 of 4800, compared with only
0.62% and 2% for anti-CD80 and isotype mAb-treated BMDC, respectively. 47% of CD86-ligated
BMDC had an FI for MHC Class II above 6000, compared with 16% of CD80-ligated and 3% of
isotype mAb-treated BMDC. Ligation of CD86, but not CD80, increased mRNA expression of theT
cell chemoattractants, CCL5 and CCL17, by 5 and 4.2 fold, respectively, compared to isotype mAb. To
evaluate DC adhesion toTcells, naive T cells isolated from mouse peripheral LN were introduced into
a parallel plate £ow chamber containing BMDC that had been immobilized on anti-CD80, CD86,
and CD40 mAb-coated tissue culture plates. Interestingly, anti-CD86-immobilized BMDC captured
naive T cells two-three fold better than BMDC immobilized by CD40 or CD80 mAb (po0.0001).
DC from mouse skin explants showed similar enhancement of T cell binding after CD86 ligation.
Thus, in vitro engagement of CD86 on DC up-regulates DC maturation markers, chemokines that
can attract T cells, and DC capture of Tcells, suggesting that engagement of CD86 on DC may play a
selective role in regulating DC-T cell binding and antigen presentation in vivo.
C20
Most Lymphoid Organ Dendritic Cell Types Are Phenotypically and Functionally
Immature
Nicholas S.Wilson1, Jose A.Villadangos12, Dima El-Sukkari1, Gabrielle T. Belz12,
Christopher M. Smith12, Raymond J. Steptoe1,William R. Heath12, Ken Shortman
1TheWalter and Eliza Hall Institute of Medical Research, Australia
2Cooperative Research Center forVaccineTechnology, Australia
Dendritic cells (DC) have been thought to follow a life history, typi¢ed by Langerhans cells (LC),
with two major developmental stages: an immature stage that captures antigens in the periphery and
a mature stage that presents those antigens in the lymphoid organs. However, a systematic assessment
of the maturity of lymphoid organ DC has been lacking.We have analyzed the maturity of the DC
types found in the steady state in the spleen, lymph nodes (LN) and thymus. The DC that migrate
into the iliac, mesenteric, mediastinal or subcutaneous LN from peripheral tissues were mature and
therefore could not process and present newly encountered antigens. However all the other DC types
were phenotypically and functionally immature: they expressed low levels of surface MHC II and
CD86, accumulated MHC II in their endosomes, and could present newly encountered antigens.
These immature DC could be induced to mature by culture in vitro or by inoculation of in£ammatory
stimuli in vivo. Therefore the lymphoid organs contain a large cohort of immature DC, most likely for
the maintenance of peripheral tolerance, which can respond to infections reaching those organs and
mature in situ.
C21
Reciprocal Role of p-38 Mitogen-activated Protein Kinase in Stimulation and
Induction of Apoptosis of Monocyte-derived Dendritic Cells (MoDC) by Low
Doses of Ultraviolet B Radiation
Satoshi Nakagawa,YumikoYoshino,Tomoyuki Ohtani, Zia U.A. Mollah, Masato Mizuashi, Hachiro
Tagami, Setsuya Aiba
Department of Dermatology,Tohoku University Graduate School of Medicine, Sendai, Japan
Ultraviolet B (UVB) irradiation has been known to exert various deteriorating e¡ects on Langerhans
cells (LCs): the induction of apoptosis and suppression of co-stimulatory molecule expression and
their antigen presenting function, etc. Recently, however, we have reported that UVB stimulates hu-
man LCs to migrate from the irradiated epidermis, to up-regulate several co-stimulatory molecules
and to produce pro-in£ammatory cytokines, while retaining allostimulatory capacity. To unravel these
discrepancies, we studied the direct e¡ect of a single exposure of UVB on human monocyte-derived
dendritic cells (MoDCs). Fifty to two-hundred J/m2 of UVB stimulated the maturation of MoDCs
with 1) the augmentation of CD86 and HLA-DR expression, 2) enhanced production of IL-1b, IL-6,
IL-8, and TNF-a both at mRNA and protein levels, and 3) augmented allostimulatory capacity on a
per-cell basis as compared with unirradiated MoDCs, while UVB in a dose more than 200 J/m2 did
not stimulate maturation but rather induced apoptotic cell death. Western blot analysis of MoDCs
after 15 min of irradiation demonstrated dose-dependent phosphorylation of p38- and SAPK/JNK-
mitogen-activated protein kinases (MAPKs), but not that of IkB. The experiments using p38
MAPK-inhibitor, SB203580, and MAP-kinase kinase-1 inhibitor, PD98059, showed that p38 MAPK
played a crucial role in both UVB-induced maturation and apoptosis of MoDCs. Interestingly,
MoDCs that had undergone apoptosis exhibited augmented expression of HLA-DR antigen without
any associated change in CD86, suggesting the possibility of their tolerogenic function. Thus UVB
can stimulate the maturation or induce apoptosis of MoDCs depending on its dosage, mainly via p38
MAPK pathways.
C22
Induction of Regulatory T-cells by Dendritic Cells Infected withVacciniaVirus
Peter Thumann, Jens Humrich, Sebastian Greiner, Detlef Dieckmann, Alexander Steinkasserer, Gerold
Schuler, Lars Jenne
Department of Dermatology, University and Medical Clinic Erlangen, Germany
The ex vivo transduction of Dendritic Cells (DC) with recombinant viral vectors o¡ers the opportu-
nity to achieve a simultaneous MHC-I and MHC-II restricted presentation of chosen tumor associated
antigens (TAA).When exploring the possibilities of Vaccinia virus (VV) to transduce mature DC we
detected an incapability of VV infected DC to stimulate T-cell proliferation despite DC-T-cell inter-
actions observed by video microscopy. We thus wanted to determine, whether virally infected DC
have the capacity to induce anergic or regulatory T-cells. We found that T-cells cultured with DC
infected with the Western Reserve strain (WR), but not DC infected with the attenuated Modi¢ed
Virus Ankara strain (MVA), were anergic after one week of cultivation, as no proliferation was indu-
cible by antigen independent activation. This inhibition was overcome by the addition of high doses
(100 IU/ml) of IL-2. After two more rounds of cultivation with virally infected DC, even the addition
of IL-2 did not reinstall the proliferation of the T-cells. At this stage CD4þ T-cells cultured with
WR infected but not MVA infected DC were mostly of the CD4þCD25þ phenotype. They
synthesized IL-10 and were capable to inhibit allogenic T-cell proliferations in a contact dependant
manner to a degree comparable to CD4þCD25þ regulatory T-cells freshly isolated from PBMC
of healthy donors.Taken together, we demonstrated the induction of anergic and antigen un-speci¢c
regulatoryT-cells byWR but not by MVA infected DC. These ¢ndings highlight the e⁄cacy of VV
immune escape mechanisms directed against key features of DC.
C23
Reduced Numbers and Impaired Helper T-cell Polarizing Ability of Myeloid and
Plasmacytoid Dendritic Cells in Chronic Hepatitis C Virus Infection
Tatsuya Kanto, Michiyo Inoue, Aki Sato, Hideki Miyatake, Mitsuru Sakakibara,Takayuki Yakushijin,
Chika Oki,Tetsuo Takehara, Norio Hayashi
Department of MolecularTherapeutics, Osaka University Graduate School of Medicine, Suita, Japan
Hepatitis C virus (HCV) infection induces a wide range of chronic liver injuries, from hepatitis to
liver cirrhosis and hepatocellular carcinoma. How HCV evades the immune surveillance system re-
mains to be determined. Dendritic cell (DC) dysfunction has been implicated for the persistence
HCV; however, the roles of blood DC subsets in the pathogenesis of HCV infection are still elusive.
To address these issues, we compared the numbers and the functions of blood myeloid DC (MDC)
and plasmacytoid DC (PDC) between chronically HCV-infected patients and uninfected donors. Ab-
solute numbers of MDC, PDC and their CD34þ progenitors are lower in HCV-infected patients
than in control subjects, most signi¢cantly in those with active hepatitis. Both types of DC from
patients are impaired in the stimulation of allogeneic CD4 T-cells and the production of IL-12 p70
or IFN-a compared with healthy donors. On encounter with naive CD4 T-cells, MDC from the
patients are less able to drive the Th1 response, while PDC from them prime more IL-10 producing
cells than those from donors. Exogenous IL-12, IFN-g or IL-15 improved the ability of MDC from
the patients to drive Th1 response. IL-12 concomitantly stimulated MDC or PDC from them to in-
crease IL-10 producers, wheras IFN-g or IL-15 did not. These results demonstrate that both types of
blood DC in chronic HCV infection are reduced and contribute to the development of an impaired
Th1 and an IL-10-rich environment, of which altered T-cell polarizing ability is partly restored by
IFN-g or IL-15.
C24
The Role of MHC Class I-related Chain in Dendritic Cell Activation of Natural
Killer Cells: Impairment in Chronic Hepatitis C-infected Individuals
Masahisa Jinushi,Tetsuo Takehara,Tatsuya Kanto, Norio Hayashi
Department of MolecularTherapeutics, Osaka University Graduate School of Medicine, Suita, Japan
Dendritic cells (DCs) augment e¡ector functions of natural killer (NK) cells, but the underlying me-
chanisms are not fully understood. We demonstrated in an in vitro coculture system that human
monocyte-derived DCs enhance IFN-g production as well as cytolytic ability of NK cells when
DCs are pre-stimulated with various maturation-induced stimuli such as type I IFNs and LPS.
Whereas NK cell activation by LPS-stimulated DCs was dependent on IL-12 produced in DC/NK
coculture, MHC class I-related chain (MIC), ligands for NKG2D activating receptor, were found to
be induced on type I IFN-stimulated DCs and to be responsible for the NK activation through direct
MIC/NKG2D coligation. Furthermore, DCs recovered from chronic hepatitis C virus-infected pa-
tients (HCV-DCs) showed defects in the induction of MIC and impaired ability to activate NK cells
upon type I IFNs. As a factor involved in MIC induction on DCs in response to type I IFNs, we
identi¢ed IL-15, produced in DCs upon IFN stimulation, as a critical mediator to increase MIC ex-
pression on DCs. Indeed, type I IFN-mediated production of IL-15 was virtually absent in HCV-
infected individuals, and MIC expression was increased on HCV-DCs at similar levels to those on
N-DCs when stimulated with exogenous IL-15. These ¢ndings suggested that impaired MIC induc-
tion on DC may be one of the mechanisms by which type I IFNs can not fully exert its antiviral
e¡ects in HCV-infected individuals, and that IL-15 could restore the IFN responsiveness in these
patients.
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Transforming Growth Factor-beta1 (TGF-1) Regulates the Expression of the High
A⁄nity Receptor for IgE (FceRI) on CD34þ Stem Cells Derived Dendritic Cells
(CD34dDC)
Jean-Pierre Allam, Elisabeth Geiger,Thomas Bieber, Natalija Novak
Department of Dermatology, University of Bonn, Bonn, Germany
FceRIþ human antigen-presenting-cells (APC) are a hallmark of atopy. Although the identi¢cation
of early markers of atopy in cord blood (CB) would o¡er the possibility of e¡ective prevention, noth-
ing is known about factors regulating expression of FceRIþon CB CD34þ derived dendritic cells
(CD34dDC). FceRIþmonocyte-derived DC can be generated from atopic individuals by addition of
TGF-1 - a cytokine which has been connected to the development of atopic diseases. Thus, we in-
vestigated, whether addition of TGF-1 plays a role in regulating FceRIþ on CD34dDC generated
in response to GM-CSF,TNF-a, SCF and FLT-3. Kinetic experiments show that FceRI appears on the
surface of CD34dDC, but decreases when exogenous TGF-1 is added at high-doses (10ng/ml). In
contrast, low-dose TGF-1 (po0.5 ng/ml) stabilizes surface FceRI expression on CD34dDC.
FceRIþ /Langerinþ Langerhans cells could only be generated under addition of exogenous TGF-
1. These cells show an increased stimulatory capacity in antigen-speci¢c autologous experiments.
Futhermore, increasing TGF-1 concentrations augment the stimulatory capacity of CD34dDC to-
wards allogeneic T-cells. These data indicate that TGF-1 in£uences the functional properties of
CD34dDC. Furtheron, the development of FceRIþ CD34dDC is dependent on low-dose TGF-1
microenvironment. As a proof of concept, elimination of TGF-1 and addition of high doses TGF-1
prevent the appearance of FceRIþ DC. In view of these data a picture emerges that TGF-1 levels
play a crucial role in regulating the di¡erentiation of the ‘‘atopic’’ subtype of CD34dDC.
C26
Langerhans Cells may Present Staphylococcal Antigens to T Cells via CD1c
Robert E. Hunger1, Peter A. Sieling2, Robert L. Modlin2, Lasse R. Braathen1
1Dermatological Clinic, University of Berne, Berne, Switzerland
2Department of Dermatology, D. Ge¡en School of Medicine at UCLA, Los Angeles, California, USA
Staphylococcus aureus is a bacterium that may colonize the skin of healthy people. Under certain
circumstances, however, it may cause skin infections as impetigo contagiosa or folliculitis and it may
also cause superinfections in skin diseases as for example in atopic dermatitis. The aim of this study
was to determine if Langerhans cells may present staphylococcal antigens to T cells. To this end we
generated Langerhans cells from CD34þ progenitor cells from human cord blood. Using these cells
as APCs we were able to generate staphylococcal speci¢c T cell lines. Langerhans cells express high
amounts of CD1 molecules and CD1 molecules have been described to present lipid and lipoglycan
antigens to T cells.We therefore analysed presentation of antigens through this pathway. Using anti-
CD1c speci¢c monoclonal antibodies the proliferative response could at least partially be blocked.
These results indicate that Langerhans cells may present bacterial antigens via CD1c toTcells. Langer-
hans cells might therefore act as a ¢rst line of defense against epidermal infection by gram positive
bacteria through presentation of lipid antigens through CD1.
C27
Epidermal Langerhans Cells E⁄ciently Mediate CD1a-dependent Presentation of
Microbial Lipid Antigen to T Cells
Victor Pena-Cruz1, Susumu Ito2, Christopher C. Dascher3, Michael B. Brenner3, Masahiko Sugita3
1Inmunology and Infectious diseases, Harvard School of Public Health, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
3Brigham andWomen’s Hospital and Harvard Medical school, Boston, MA, USA
Langerhans cells (LCs) are a critical component of skin immunity, capable of capturing protein anti-
gens in the epidermis and presenting them to speci¢c T cells in the context of major histocompatibil-
ity complex (MHC) class II molecules. Recently, an MHC-independent pathway of lipid antigen
presentation has been identi¢ed and is mediated by molecules ofthe CD1 family (CD1a, -b, -c, and -
d). Because LCs are profesional antigen-presenting cells and express CD1a molecules prominently, we
hypothesized that LCs might play a role in T cell responses directed against not only peptide antigens
but also lipid antigens. Here, we show that freshly isolated immature LCs as well mature LCs that
have migrated from the epidermis were e⁄cient in presenting foreing microbial lipid antigens to spe-
ci¢cTcells whereas dermal DCs express much less CD1a molecules and function ine⁄ciently. Further,
we found that LCs migrating from epidermal sheets that were exposed to microbial lipid antigens
expressed lipid antigen-loaded CD1a molecules on the cell surface, resulting in activation of speci¢c
T cells. These results underscore an outstanding ability of LCs to mediate CD1a-dependent lipid anti-
gen presentation. Thus, LC-mediated skin immunity may involve T-cell recognition of both peptide
and lipid antigens.
C28
R5 HIV Interacts with LC through a CCR5-dependent, DC-SIGN-independent
Infection Pathway
Tatsuyoshi Kawamura1, Makoto Sugaya2, Shinji Shimada1, Andrew Blauvelt2
1Department of Dermatology,Yamanashi University,Yamanashi, Japan
2Dermatology Branch, National Cancer Institute, Bethesda, MD, USA
Langerhans cells (LC) are suspected to be initial targets for HIV following sexual exposure. Recently,
novel C-type lectins, Langerin and DC-SIGN, expressed on LC and monocyte-derived DC (mDC)
or subepithelial DC respectively, have been shown to bind HIV gp120. Therefore, we tested whether
C-type lectins were involved in HIV infection of LC using a tissue explant model system. LC were
isolated from healthy volunteers, infected with R5 HIV ex vivo, then monitored for HIV infection
levels 3 days later. Pre-incubation of epithelial sheets with PSC-RANTES completely blocked R5
HIV infection of LC, whereas anti-DC-SIGN mAb, anti-Langerin mAb, or mannan, a potent C-type
lectin inhibitor, did not a¡ect HIV infection levels in LC. As further controls, mDC were isolated
from peripheral blood of LC donors.There was partial inhibition of R5 HIV infection in mDC when
pre-incubated with anti-DC-SIGN mAb or mannan. However, pre-incubation with PSC-RANTES
blocked R5 HIV infection of mDC.We next tested whether C-type lectins were involved in HIV
transmission from LC to CD4þ T cells. Strikingly, pre-incubation of epithelial sheets with PSC-
RANTES completely blocked subsequent HIV transmission from LC to CD4þ T cells, whereas
LC-mediated transmission was not a¡ected by anti-DC-SIGN mAb or mannan. By contrast, combi-
nations of PSC-RANTES plus anti-DC-SIGN mAb were needed for complete block of HIV trans-
mission from mDC to CD4þ T cells. Thus, CCR5-mediated infection of LC, and not capture of
virus by LC, may provide a biologic basis for understanding certain aspects of host susceptibility to
initial HIV infection.
C29
Lentiviral-mediated RNA Interference of DC-SIGN Delineates a Crucial Role for
DC-SIGN in HIV Binding and Transmission to T Cells
Jean-Francois Arrighi1, Marjorie Pion1, Shahnaz Abraham1,Teunis Geijtenbeek2, Maciej Wiznerowicz3,
Didier Trono3,Yvette van Kooyk2,Vincent Piguet1
1Dpt Dermatology andVenerology, University Hospital of Geneva, Geneva, Switzerland
2VUMC, Amsterdam
3Dept Microbiology, CMU, Geneva, Switzerland
Since new HIV infections occur primarily through sexual transmission, small amounts of virus have
to cross the mucosal barrier and reach replication-competent sites. Evidence has accumulated that Lan-
gerhans/dendritic (DC) cells play a crucial role in the early events of entry into the host. DC-SIGN
can capture small amounts of virus in the periphery and transfer it e⁄ciently toT cells, where massive
viral replication occurs. Our results demonstrate that DC-SIGN is rapidly internalized from the cell
surface of DC and targets antigens for lysosomal degradation. Furthermore, DC-SIGN internalizes
antigens for presentation to T cells. However, HIV is able to escape DC-SIGN-mediated antigen pre-
sentation, by dissociating from this receptor early after internalization from the cell surface. In order to
disturb the early events of HIV infection and the pool of virus hiding in DC, we have developed
lentiviral vectors expressing stably small interfering RNA (siRNA) targeting DC-SIGN. Our results
demonstrate that siRNA targeting DC-SIGN can suppress up to 97% of the surface expression of
DC-SIGN on cell lines expressing DC-SIGN as well as in dendritic cells. Using this tool we demon-
strate that DC-SIGN is the major attachment factor for HIV and Mycobacterium tuberculosis on DC.
We will also rede¢ne the contribution played by this receptor in the trans enhancement of HIV trans-
mission to T cells by DC. Finally, lentiviral vectors expressing stably siRNA that inhibit DC-SIGN
expression could prove to be a novel weapon against HIV infection.
C30
A C-type Lectin Receptor Dectin-2 is Involved in Innate Immune Recognition
of Fungal Hyphae and in Upregulating IL-4 Gene Expression by Dendritic Cells
TatsuoYudate1, Makoto Bonkobara2, HidekazuYamada1,Tadashi Tezuka1, PD Cruz Jr2,
Kiyoshi Ariizumi2
1Department of Dermatology, Kinki University School of Medicine, Osaka, Japan
2Department of Dermatology, UT Southwestern Medical Center at Dallas, Dallas,TX, USA
Having discovered that Langerhans cells and dendritic cells (DC) express the C-type lectin receptors
(dectin-1 and dectin-2) and since dectin-1was reported to recognize -glucan expressed on yeasts, we
posited that dectin-2 may also recognize carbohydrates on microorganisms. Using Fc fusion proteins
consisting of the extracellular domain and IgGFc (Dec1-Fc and Dec2-Fc), we found that Dec1-Fc bind
to Candida albicans yeast and hyphae with higher a⁄nity to yeasts. By contrast, Dec2-Fc bound only
to the hyphae with 10-fold greater a⁄nity than for Dec1-Fc. Selective binding of Dec2-Fc to hyphae
was obtained using yeast vs. hyphae of dermatophytes and supported by its inability to bind other
microorganisms tested. To study binding fashions by Dec2-Fc, we performed competitive binding
assays. Whereas neither -glucan nor Dec1-Fc disrupted binding of Dec2-Fc to hyphae, mannan
blocked binding almost completely.We also found that dectin-2 expression on COS-1 cells leads to
internalization of hyphae. Finally, we examined ability of hyphae to stimulate Th2 gene expression by
DC following pretreatment with Dec2-Fc (to saturate its ligands on hyphae). Hyphae pretreated with
Fc control induced IL-4 and IL-10 by DC, but hyphae with Dec2-Fc showed markedly reduced abil-
ity for IL-4 but not for IL-10. Our ¢ndings indicate that DC discriminate between yeast and hyphae
of fungi via selective binding of dectin-2 to hyphae, which may lead to upregulated expression of IL-
4 by DC.
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Impaired Langerhans Cell Migration in the Hyaluronan Synthases 1 and 3 Double
Knockout Mice
Mark E. Mummert1,Todd D. Camenisch2, Diana I. Mummert1, Lesa Ellinger1, John A McDonald3,
Akira Takashima1
1Department of Dermatology, UT Southwestern Medical Center, Dallas,Texas, USA
2College of Pharmacology, University of Arizona,Tuscon, Arizona, USA
3Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
Hyaluronan (HA) is a structural component of epidermis and dermis. HA synthesis is catalyzed by
HA synthases (HAS)1, 2, and 3 (which di¡er in catalytic activities and the molecular sizes of products).
We observed that: 1) dendritic cells (DC) express HAS1, 2, and 3 mRNA, whereas keratinocytes ex-
press HAS2 and 3 mRNA, 2) DC display newly synthesized HA on their surfaces, 3) DNFB-triggered
Langerhans cell (LC) migration can be blocked by a HA inhibitor, Pep-1, and 4) Pep-1 inhibits DC-
dependent T cell activation. To directly study physiological functions of HA, we created HAS1/3 dou-
ble knockout (DKO) mice. Unlike HAS2 KO mice, showing embryonic lethality due to developmen-
tal defects in cardiac and vascular systems, HAS1/3 DKO mice exhibited no apparent abnormality.
HAS1/3 DKO mice were comparable to wild-type (WT) controls in the number or morphology of
LC in normal skin. UnlikeWTcounterparts, showing reduced densities of epidermal LC after DNFB
application, LC numbers were unchanged in HAS1/3 DKO mice before (667773 cells/mm2) and 24
hr after DNFB treatment (696784 cells/mm2). HAS1/3 DKO LC showed characteristic morphological
changes after DNFB application. Bone marrow DC cultures from HAS1/3 DKO mice were indistin-
guishable fromWT counterparts in surface HA expression and ability to activate allogeneic T cells.
Likewise,T cells from HAS1/3 DKO mice showed normal proliferation to mitogens.We propose that
HAS1 and HAS3 de¢ciency primarily a¡ects HA synthesis and expression in keratinocytes, thereby
inhibiting LC migration from epidermis, but not other LC functions.
C32
Activation Pro¢les of Transcription Regulatory Pathways in Dendritic Cells after
Sensing Diverse Biological Signals
Norikatsu Mizumoto, Francis Hui, Hiroyuki Matsue, Dale Edelbaum, David Shalhevet,
Akira Takashima
Department of Dermatology, UT Southwestern Medical Center, Dallas,Texas, USA
Dendritic cells (DCs) are uniquely equipped with many receptors, including Toll-like receptors
(TLRs) and purinergic type 2 receptors (P2Rs), to recognize microorganisms, endogenous danger
signals, and various soluble and membrane-associated immunoregulatory molecules. Ligation of these
DC-associated receptors triggers dynamic reprogramming of gene expression and cellular functions,
the process known as DC activation. To study activation pro¢les of multiple transcription regulatory
pathways during DC activation in a systematic fashion, we transduced a stable Langerhans cell-like
DC line XS106 to express the luciferase reporter gene under the control of 15 di¡erent cis-enhancer
elements for various transcription factors (TFs). Testing 14 microbial, endogenous, environmental, or
pharmacological agents with the resulting DC biosensor system has revealed striking diversity of ac-
tivation patterns of respective TFs. For example, ligands for the P2Rs (ATP and ADP) di¡ered from
those for the TLRs (LPS and CpG oligonucleotides) not only in their impact on mRNA expression,
surface phenotype, and cytokine/chemokine pro¢les in XS106 DCs, but also in the TF activation pro-
¢les. The system has further allowed us to classify these agents based on the activation pro¢les of
distinct transcription regulatory pathways (e.g., NFAT activation by P2R ligands and NFkB and
AP1 activation byTLR ligands). These results document the intrinsic ability of DCs to recruit distinct
sets of TFs upon sensing di¡erent biological signals. Our DC-based biosensor system should serve as a
useful platform to dissect underlying mechanisms by which di¡erent stimuli can control DC activa-
tion toward di¡erent directions at the level of transcriptional regulation.
C33
Activation of NKT Cells by a-galactosylceramide Rapidly Induces the Full
Maturation of Dendritic Cells in vivo and thereby Acts as an Adjuvant for
Combined CD4 and CD8 Tcell Immunity
Shin-ichiro Fujii, Kanako Shimizu, Caroline Smith, Laura Bonifaz, Ralph M. Steinman
Laboratory of Cellular Physiology and Immunology,The Rockefeller University, NewYork, NewYork, USA
It is desirable to identify adjuvants that will harness the DC system in situ for the purpose of control-
ling immunity. Prior approaches have drawn a correlation between DC maturation in vivo and the
development of cell-mediated immunity. To test if DC maturation is responsible for the action of
immune adjuvants, we have studied the glycolipid, a-galactosylceramide (aGalCer), which enhances
resistance to several tumors and intracellular infections in mice. The glycolipid is presented to NKT
cells by CD1d molecules, and is known to be an adjuvant for protective CD8þ Tcell immunity in a
murine malaria vaccine model.We ¢nd that aGalCer induces DC maturation in situ including cyto-
kine production.When DCs are isolated from mice given aGalCer together with ovalbumin, either as
a soluble protein or as cell-associated antigen, the DCs selectively acquire stimulating activity for pri-
mary antigen-speci¢c, IFN-g producing, CD4þ and CD8þ T cells in culture, and importantly,
upon transfer into naive animals. Immunization with these DCs also induces CD8þ T cell resistance
to an ovalbumin-expressing tumor. DC maturation is not induced directly by aGalCer but requires
NKT cells acting independently of the MyD88 adapter protein. Therefore, DC maturation mediates
the adjuvant function of aGalCer in vivo, including combined Th1 CD4þ and CD8þ T cell im-
munity to a nonreplicating protein antigen.
C34
A Purinergic Agonist Enhances in vivo Immunization
Richard D. Granstein,Wanhong Ding, Sreedevi Kodali, Aton Holzer, Kristina Sei¡ert, John A.Wagner
Department of Dermatology,Weill Medical College of Cornell University, NewYork, NewYork, USA
ATP signals through cell surface receptors that are either ionotrophic (P2X) or G-protein linked
(P2Y). ATP has been shown to modulate some aspects of dendritic cell function.We have recently
shown that the murine Langerhans cell (LC)-like cell line XS106 responds to purinergic agonists with
increased expression of I-A, CD80 and CD86. Furthermore, secretion of IL-1 and IL-12 stimulated
by GM-CSF/LPS was augmented by a purinergic agonist while IL-10 secretion was decreased. Also,
the hydrolysis-resistant ATP analogue ATPgS signi¢cantly augmented the ability of BALB/c (H-2d)
epidermal cells to present antigen (KLH) to a responsiveTcell clone (HDK-1).We have now examined
the ability of ATPgS to enhance vaccination of mice against tumor antigens and bacteria. CAF1 mice
(H-2a/d) were injected intradermally with a soluble extract of the S1509a spindle cell tumor (H-2a)
(TAA) mixed with 700 nanomoles of ATPgS or medium alone 3 times at 7-day intervals. One week
after the last immunization a hind footpad of each mouse was injected with TAA and 24-hour swel-
ling assessed as a measure of delayed-type hypersensitivity (DTH). ATPgS signi¢cantly increased the
DTH response. C57BL/6 mice were injected intradermally with 109 killed (freeze-thaw x 4) group A
streptococcus (GAS) mixed with 700 nanomoles of ATPgS or medium alone 3 times at 7-day inter-
vals. One week after the last immunization each mouse was challenged on the dorsum with live GAS
and lesion size scored over time. ATPgS greatly decreased lesion size. Purinergic agonists hold great
promise as a new class of immunologic adjuvants.
C35
Cellular Vaccination with Genetically Modi¢ed Dendritic Cells Derived from
Mouse ES Cells
Satoru Senju, Hidetake Matsuyoshi, Shinya Hirata,Yasuharu Nishimura
Dept. Immunogenetics, Grad. Sch. Med. Sci., Kumamoto Univ., Kumamoto, Japan
We developed a method to generate dendritic cells (DCs) from mouse embryonic stem (ES) cells.We
cultured ES cells for 10 days on feeder cell layer of OP9 in the presence of GM-CSF in the latter 5
days. The resultant ES cell-derived £oating cells were transferred to bacteriological Petri dishes with-
out feeder cells and further cultured in culture medium containing GM-CSF. In about 7 days, irregu-
larly shaped £oating cells with protrusions appeared and they expressed MHC class II, CD11c, CD80,
and CD86. They had capacity to stimulate allogeneic MLR and to process and present protein antigen
toTcells.We designated them ES-DCs, and the functions were comparable to those of DCs generated
from bone marrow cells. Genetic modi¢cation of ES-DCs can readily be done by transfection of ES
cells and subsequent their di¡erentiation to DCs. ES-DCs introduced with an invariant chain-based
epitope-presenting vector presented a PCC epitope in the context of MHC class II molecules very
e⁄ciently in vitro. We primed OVA-speci¢c cytotoxic T lymphocytes by injecting mice with ES-
DCs introduced with an OVA-expression vector, demonstrating immunization with ES-DCs geneti-
cally engineered to express antigen. To improve the capacity of ES-DCs to prime T cells in vivo, we
generated double-transfectant ES-DCs expressing a chemokine along with OVA. Immunization with
DCs expressing OVA plus SLC or Mig provided protection from OVA-expressing tumor cells more
potently than that with OVA only. The ¢ndings provide useful information for the development of a
potent DC-based cellular immunotherapy for cancers.
C36
Optimal DC Migration Is Depending on the Duration of Maturation
Peter Thumann, Lars Jenne, Julitta Urlacher, Gerold Schuler,Thomas G. Berger
Dept. of Dermatology, University Hospital of Erlangen-Nuernberg, Germany
Dendritic cells are increasingly used in clinical trials to induce speci¢c immunity against malignant
tumors. In most of these studies DC are injected into the skin, requiring an active migration of DC
into regional lymph nodes. Recent reports have demonstrated, that the upregulation of CCR7 by
PGE2-containing maturation conditions is associated with an increased migration in vitro. However,
the in vivo migration of injected DC in most reported studies is poor. Therefore we have analyzed the
in£uence of the duration of maturation on the migratory properties. In our experiments we compared
DC matured with di¡erent stimuli for various time periods. In ex-vivo migration assays DC showed
best capability to migrate against a Mip-3beta (CCR7-ligand) gradient when matured for 48h with a
cocktail including TNF-alpha, IL1-beta, IL-6 and PGE2. Maturation for only 24 hrs, but also for 72
hrs was accompanied with a signi¢cantly reduced migration. These 48 hrs-matured DC remained
fully functional regarding cytokine-production and T cell stimulation. For clinical application, the
duration of DC-maturation should be considered as important as e.g. the type of maturation stimuli
or the route and dosage of DC-application.
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Regulatory Dendritic Cells Protect Mice from Murine Acute Graft-versus-host
Disease and Leukemia Relapse
Katsuaki Sato1, NaohideYamashita2, Naomi Yamashita3, Masanori Baba4,Takami Matsuyama1
1Department of Immunology and Medical Zoology, School of Medicine, Kagoshima University, Kagoshima, Japan
2Department of Advanced Medical Science,The Institute of Medical Science,The University ofTokyo,Tokyo, Japan
3Department of Medicine,Teikyo University School of Medicine,Tokyo, Japan
4Division of Human Retroviruses, Center for ChronicViral Diseases, School of Medicine, Kagoshima University,
Kagoshima, Japan
We established a novel immunotherapeutic approach involving dendritic cells (DCs) with potent im-
munoregulatory property (designated as regulatory DCs; rDCs) for acute graft-versus-host disease
(GVHD) and leukemia relapse in allogeneic bone marrow (BM) transplantation (BMT) in mice bear-
ing leukemia. rDCs, which displayed high levels of MHC molecules and extremely low levels of
costimulatory molecules, induced allogeneic Ag-speci¢c tolerant T cells as well as the direct suppres-
sion of e¡ector T cells. A single injection of rDCs following allogeneic BMT completely protected
the recipients from the lethality caused by acute GVHD, and these recipients showed poor allogenic
T-cell responses and proin£ammatory cytokine production as well as a generation of
CD4þCD25þCD152þ regulatory T (Tr) cells. In vivo and in vitro-generated tolerant CD4þT
cells by rDCs had allogeneic Ag-speci¢c increased amount of cyclic AMP (cAMP) and expression
level of p27kip1 cyclin-dependent kinase inhibitor. Treatment of the recipients of allogeneic BMT
with rDCs caused an e⁄cient graft-versus-leukemia (GVL) e¡ect resulting in the protection of mice
bearing leukemia from tumor burden. Our ¢ndings suggest that the use of rDCs provides a novel
immunotherapeutic approach for the treatment of acute GVHD and leukemia relapse in allogeneic
BMT mediated through the control of the ability of the transplanted T cells to induce GVHD and
GVL e¡ect. Ref. Sato et al., Immunity, 18:367, 2003; Sato et al., Blood, 101:3581, 2003
C38
Topical Application of NF-kB Decoy Oligodeoxynucleotides Suppresses Delayed-
type Hypersensitivity by Inducing CD4þCD25þ Regulatory T Cells
Iwao Isomura, Akimichi Morita
Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya,
Japan
Activation and maturation of dendritic cell (DC) are crucial for the establishment of delayed-type
hypersensitivity (DTH). However, antigen presentation by immature dendritic cells (iDC) might lead
antigen-speci¢c peripheral tolerance. iDC are characterized by low surface expression of co-stimula-
tory molecules, i.e., B7-1 and B7-2. Recently, nuclear factor kappa B (NF-kB) decoy oligodeoxy-
nucleotides (ODN) has been used for heart graft transplantation by inhibiting NF-kB-related gene
expression. NF-kB plays signi¢cant roles in upregulation of co-stimulatory molecules and immunos-
timulatory cytokines. Here we investigated whether NF-kB decoy oligodeoxynucleotide (ODN)
could induce tolerance in DTH. NF-kB decoy ODN ointment (2%) was applied and sensitized by 1
mg OVA on shaved abdominal skin of BALB/c mice, and elicited by intradermal injection (0.1 mg)
into footpads 7-10 days after sensitization. NF-kB decoy ODN suppressed induction of DTH. Adop-
tive transfer of the cells from draining lymph nodes from the tolerant mice suppressed the induction
of DTH. Deletion of CD25þ T cell population by PC61 mAb abrogated the suppression of DTH.
Adoptive transfer of CD4þCD25þ T cell (Tr) from tolerant mice induced tolerance in the sensi-
tized mice. Furthermore, NF-kB decoy ODN inhibited the maturation of Langerhans cells (LC) from
skin explants. These ¢ndings indicate that NF-kB decoy ODN inhibit not only induction of DTH
but also established DTH response in vivo by inducing Tr. The topical application of NF-kB decoy
ODN would be a new tool for the induction of antigen speci¢c peripheral tolerance.
C39
Direct Expansion of Functional CD25þ CD4þ Regulatory T Cells by Antigen-
processing Dendritic Cells
Sayuri Yamazaki1,Tomonori Iyoda2, Kristin Tarbell1, Kara Olson1, Klara Velinzon1, Kayo Inaba2, Ralph
Steinman1
1Department of Cellular Physiology and Immunology, Rockefeller University, NewYork, USA
2Department of Animal Developement and Physiology, Graduate School of Biostudies, Kyoto University, Kyoto,
Japan
Thymic derived, CD25þ CD4þ regulatoryT cells provide an important pathway for immune toler-
ance, but their antigen presenting cell requirements need be identi¢ed. CD25þ CD4þ T cells are
classically anergic, unable to grow in response to mitogenic antibodies to the T cell receptor complex.
We now ¢nd that CD25þ CD4þ T cells can proliferate in the absence of added cytokines in culture
and in vivo when stimulated by antigen loaded-dendritic cells (DCs), especially mature DCs. With
high doses of DCs in culture, CD25þ CD4þ and CD25 CD4þ populations initially proliferate
to a comparable extent. The expansion of CD25þ CD4þ T cells stops by day 5, while CD25-
CD4þ T cells continue to grow. CD25þ CD4þ T cell growth requires DC-T cell contact and is
partially dependent upon small amounts of IL-2 produced byT cells and B7 costimulation by DCs.
Following expansion, the CD25þ CD4þ T cells actively suppress CD25 CD4þ T cell proliferation
to splenic antigen presenting cells. DCs also can expand CD25 CD4þ T cells in the absence of spe-
ci¢c antigen but with exogenous IL-2. In vivo, both steady state and mature antigen processing DCs
induce proliferation of adoptively transferred CD25þ CD4þ Tcells. The capacity to expand CD25þ
CD4þ T cells provides DCs with another mechanism to regulate autoimmunity and other immune
responses.
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Improved Method for the Generation of Long Lived and Functionally Active
Langerhans Cells from CD34þ Progenitor Cells
Seyoum Ayehunie, Sarah Lamore, Rachael Lappen, Kristen Bellevance, John Sheasgreen, Mitchell
Klausner
MatTek Corporation, USA
The di⁄culty in harvesting large number of cells, short survival time, and rapid phenotypic changes
in culture have prevented the widespread use of human Langerhans cells (LC) for fundamental studies
in allergenicity, immunotherapy, and microbial infection and transmission. Here we report an im-
proved method of generating LC from CD34þ progenitor cells derived from umbilical cord blood.
The method resulted in an average of 205786.02 fold increase (n¼15) in LC number. These LC ex-
press CD1a, HLADR, and costimulatory molecules, and can be cultured for over 53 days with no
signi¢cant phenotypic changes. Transmission electron microscopy showed the presence of Birbeck
granules, a key ultrastructural marker of LC, over the duration of the culture period. These cells con-
tain plasmacytoid and myeloid DC populations and can be frozen and recovered with a viability of
80^90%. Upon pulsing with external stimuli such as LPS, PMA, and IFNg, the LC showed a repro-
ducible (n¼ 4), high level of gene and protein responsiveness in terms of IL12, MIP1a, MIP3a, IL6,
and TNFa expression. Functionally, these LC can: 1) initiate allogeneic T cell proliferation, 2) induce
primary and secondaryT-cell responses to a strong allergen (FITC) but not for an irritant (SDS), and
3) be infected with HIV-1. In conclusion, we have developed a method to harvest and culture func-
tional LC that have longer life span in culture. These cells are likely to be useful in reconstruction of
skin equivalents and other experiments investigating the immunological reactions involving LC.
P2
Enumeration of Langerhans Cells During the Rana pipiens Larval Development
Miguel A. Herrera1, Beatriz Hernandez1, Enrique A. Sampedro1,2, Andres E. Castell1
1Departamento de Biologia Celular yTisular, Facultad de Medicina, Universidad Nacional Autonoma de Mexico,
Mexico, D.F., Mexico
2Servicio de Patologia, Hospital General ALM, ISSSTE, Mexico, D.F., Mexico
In recent years, dendritic cells (DC) have been identi¢ed in several organs of some species of amphi-
bians, and our group has evidenced Langerhans-like cells in di¡erent epithelia such as epidermis, cor-
nea and nictitating membrane as well as spleen, thymus and lymph nodes of frogs. At moment we
have shown LC in Rana pipiens tadpole epidermis from the beginning of larval development but it is
necessary to clarify the number of LC and the expression of ATPase and class II molecules of the
Major Histocompatibility Complex (MHC) at di¡erent developmental stages of this frog. Skin sam-
ples were taken from 40 Rana pipiens tadpoles at di¡erent stages (premetamorphosis, prometamorpho-
sis, climax and postmetamorphosis) and treated to demonstrate ATPase and class II molecules in
para⁄n and frozen sections. Other samples were processed for electron microscopy. We found that
LC density increases gradually from prematomorphosis to prometamorphosis, but at climax the num-
ber of LC diminished abruptly and once the metamorphosis has ¢nished, LC began to rise again. At
electron microscopy we observed cells with all features of mammalian LC, including Birbeck granule.
Results suggest that the diminution of LC at metamorphosis climax play an important role in the
discrimination of self and non-self antigens in this stage of reorganization where larval structures are
replaced.
P3
Serial Analysis of Gene Expression in Human Langerhans Like Cells
Shin-ichi Hashimoto, Kouji Matsushima
Molecular Preventive Medicine and SORST, School of Medicine,The University ofTokyo,Tokyo, Japan
Dendritic cells(DCs) play a key role in immune system. Human DC has been generated from
CD34þ precursor cells and also blood monocytes in the presence of GM-CSF, TNF-a and IL-4.
Moreover, it has been reported that Langerhans cells(LCs) can be di¡erentiated from monocytes in
response to GM-CSF, IL-4 and TGF-b. Human LCs share CD1a antigen expression with DCs gener-
ated in vitro. LCs speci¢cally express an epithelial antigen, E-cadherin, and a skin homing antigen,
Langerin. However, the process of di¡erentiation from monocytes to LCs has not yet been system-
atically explored. In order to molecularly de¢ne the di¡erentiation from monocytes into LCs, we con-
ducted serial analysis of gene expression (SAGE) to allow quantitative analysis of an extremely large
number of transcripts in human Langerhans like cells. A total of 56,695 tags corresponding to more
than 20,000 di¡erent transcripts were sequenced. In addition, the Long SAGE was conducted in LCs
to increase the accuracy of corresponding gene identi¢cation. Most expressed gene was identi¢ed to
be CD74 antigen. Most of the transcripts in LCs were very similar to immature DCs. Moreover, to
¢nd out speci¢c genes in LCs, SAGE tags in LCs were compared with a total of 651,197 tags in other
blood cells from Blood SAGE database (http://bloodsage.gi.k.u-tokyo.ac.jp/). Claudin 1, endocytic re-
ceptor, etc were found to be selectively expressed in LCs compared with other leukocytes. The identi-
¢cation of speci¢c gene expression in human DC provides novel ways to de¢ne DC subsets, and
maturation stage of cells of DC lineage.
P4
Langerhans Cells Serve as Photoantigen-presenting Cells in Murine Photocontact
Dermatitis to Ketoprofen
Satoshi Imai1, Kenji Atarashi2, Koichi Ikesue2, Michinori Sakai2,Yoshiki Tokura1
1Department of Dermatology, School of Medicine, University of Occupational and Environmental Health,
Kitakyushu, Japan
2Dermal Physiology Group, Fundamental Research Laboratories, Hisamitsu Pharmaceutical Co., Inc., Japan
Ketoprofen (KP) is well-known to induce photocontact dermatitis when it is applied to the skin and
irradiated with ultraviolet light (UV).We established a murine model of this photosensitivity and in-
vestigated the role of Langerhans cells (LC) in the development of the sensitivity. Mice were sensitized
with KP applied to the shaved abdomen and subsequently with UVA irradiated to the skin, and 5 days
later, they were challenged with KP plus UVA on the earlobes. The signi¢cant earlobe swelling was
observed in mice possessing H-2k, whereas mice bearing H-2d were low responders in the sensitivity.
Immune lymph node T cells from KP-photosensitized H-2k mice were puri¢ed for CD4- or CD8-
positive cells, and transferred to naive syngeneic recipients.When the recipients were photochallenged
with KP, transference of CD4þ cells resulted in the occurrence of the photosensitivity, although
transfer of both CD4- and CD8-positive cell populations induced higher sensitivity responses.When
immune T cells were cocultured in vitro with Langerhans cells photomodi¢ed with KP,T cells prolif-
erated well in response to KP-modi¢ed Langerhans cells. These results suggested that Langerhans cells
serve as photoantigen-presenting cells in KP-photosensitivity as well as other drug photosensitivities.
P5
Expression of Nerve Growth Factor Receptor in Murine Langerhans Cells
Hiroshi Mitsui,TakahiroWatanabe, Hidehisa Saeki, Hideshi Torii, Kunihiko Tamaki
Department of Dermatology, University ofTokyo,Tokyo, Japan
Neurotrophic factors regulate survival and di¡erentiation of neurons. Among these factors, nerve
growth factor (NGF) and its family members (namely neurotrophins) including brain derived neuro-
trophic factor (BDNF) and neurotrophin (NT)-3 play a crucial role in apoptosis of neuronal cells.
High a⁄nity receptors for NGF, BDNF and NT-3 are TrkA,TrkB and TrkC, respectively, and p75 is
their common low a⁄nity receptor. Recent studies disclosed that lymphocytes, monocytes, and
monocyte derived dendritic cells (DC) as well as neurons express those receptors. In this study, we
examined as to the expression of NGF, BDNF, NT-3, Trk A, B, C and p75 in murine LC. LC were
isolated from the epidermis of BALB/c mouse skin by panning method to a purity B95%. The LC
expressed mRNA of NGF, BDNF, NT-3, TrkA, TrkB, TrkC, and p75 by RT-PCR. The protein ex-
pression of NGF, BDNF,TrkB and p75 in LC was con¢rmed by immunoblotting. In addtion, NGF
secretion by LC to culture media was detected by ELISA. Most importantly, annexinV expression on
LC was signi¢cantly up-regulated when incubated with a various concentration (1, 10, or 100 ng/ml) of
NGF, which indicates NGF induce apoptosis in LC. The simultaneous expression of NGF and corre-
sponding receptor by LC suggested that NGF is one of the immunomediators which exert their func-
tion by regulating LC life span in an autocrine manner.
P6
Keratinocyte Extract Induces Proliferation and Ca2þ Signaling of XS52 Cells
Kenichi Morimoto,Yukiko Nabeshima, Mitsuru Mochizuki, Michihiro Hide
Department of Dermatology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
[Objective] We previously reported that keratinocyte extract increases serum IgE concentration in vivo
when injected subcutaneously, and enhances IgE production from spleen cells in vitro. According to
the ‘‘danger model’’, necrotic keratinocyte stimulates APCs and triggers following immune responses.
In this study, we investigated the e¡ect of keratinocyte extract on the proliferation and intracellular
Ca2þ signaling of Langerhance cells, and compare with the activity for in vitro IgE production.
[Method] Cultured PAM212 cells (keratinocyte cell-line established from BALB/c mouse) were
washed extensively by PBS, collected mechanically by a scraper, sonicated, and centrifuged to collect
soluble fraction of cytoplasm (PAM extract). PAM extract was fractioned by Superose6t gel-chroma-
tography. XS52 cells (a cognate Langerhans cell-line established from BALB/c mouse) were cultured
with or without various concentrations of PAM extract for 7 days. For the measurement of intracel-
lular Ca2þ concentration, XS52 cells were loaded with fura-2 and exposed to PAM extract or its
fractions prepared by gel chromatography. BALB/c mouse spleen cells were cultured with IL-4, anti-
CD40 antibody, and PAM extract or its chromatographic fractions for 7 days. IgE concentration of the
culture supernatant was measured by ELISA. [Result] PAM extract induced proliferation of XS52
cells and the increase of intracellular Ca2þ concentration. Gel chromatography of PAM extract
showed that both XS52 stimulating activity and IgE-synthesis-enhancing activity for spleen cells were
eluted between 1.4 kd and 17 kd. [Discussion] A factor released from keratinocytes by cell destruction
may trigger a signal for Langerhance cells in association with the enhancement of IgE production.
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Expression Analysis of Mouse Langerin and an Alternatively Spliced Isoform in
Fetal Skin-derived Dendritic Cells and Mouse Tissues
Elisabeth Riedl1,Yayoi Tada2, Mark C Udey2
1Department of Dermatology, University of Vienna,Vienna, Austria
2Dermatology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA
In order to identify genes that are preferentially expressed by dendritic cells (DC), we constructed and
sequenced a subtractive cDNA library from murine fetal skin-derived DC (FSDDC) and skin macro-
phages. Forty two of 548 informative clones were homologous to human Langerin, a C-type lectin
that is selectively expressed by human Langerhans cells (LC). cDNA corresponding to full-length
mouse Langerin (mLangerin) was obtained using rapid ampli¢cation of cDNA ends (RACE)-PCR.
Quantitation of mLangerin mRNA levels by real-time RT-PCR showed abundant amounts of
mLangerin mRNA in epidermal LC and in FSDDC. LPS-induced maturation of FSDDC led to
downregulation of mLangerin mRNA. mLangerin mRNA was also detected in thymus, spleen,
lymph node, lung and stomach. An alternatively spliced transcript (d3Langerin) that retained the in-
tracellular, transmembrane and carbohydrate recognition domains of mLangerin was detected in
RNA derived from FSDDC and epidermal cells, but not in lymphoid tissues. Mouse Langerin pro-
tein is expressed in the dermis and epidermis of wildtype mice, while TGF-b1 -/- mice lack protein
expression in the epidermis. Transfection of COS-1 cells with full length mLangerin cDNA or with
the cDNA encoding the spliced transcript led to abundant expression of C-terminal epitope-tagged
protein on cell surfaces of transfected cells and within the cytoplasm in a granular cytoplasmic stain-
ing pattern. mLangerin is one of a growing number of putative endocytic receptors that are expressed
by DC. Elucidation of the function of this novel protein and its alternatively spliced isoform may
provide new insights into LC physiology, especially antigen uptake and processing.
P8
E¡ect of UVB Radiation on the Fascin Expression of Murine Dendritic Cells and
Langerhans Cells
Akira Sugihara, Hiroyuki Okamoto,Takeshi Horio
The Department of Dermatology, Kansai Medical University, Osaka, Japan
Fascin is an actin-binding protein that regulates the rearrangement of cytoskeletal elements and their
interaction with the cell membrane. Among leukocytes, only dendritic cells (DC) have been demon-
strated to express fascin. Previous studies indicated that fascin expression is enhanced in DC upon
maturation and plays a critical role in T cell activation. In addition, fascin expression was found to
participate in the development of dendrites in mouse epidermal Langerhans cells (LC). To investivate
the e¡ect of UVB radiation on DC and LC interaction with T cells through fascin, we examined
fascin expression of murine bone mallow-drived DC (BM-DC) and LC after ultraviolet B (UVB)
irradiation and their clustering ability with allogenic T cells. BM-DC were induced by recombinant
murine GM-CSF and LPS. UVB radiation was exposed before supplement with LPS. In immunohis-
tochemical staining and £ow cytometric analysis, fascin expression in BM-DC was decreased by UVB
radiation. Epidermal cell suspensions were prepared from mouse ears and exposed to UVB radiation
at the beginning of the culture for 24h. Fascin expression in cultured LC enriched from epidermal cell
suspensions was decreased by UVB radiation. To evaluate the e¡ect of UVB radiation on DC-T cell
binding, we examined BM-DC clustering with allogeneic CD4þ T cells under confocal microscopy.
UVB radiation reduced both fascin expression and an ability of BM-DC to cluster with allogeneic
CD4þ T cells. These results suggest that the suppression of fascin expression by UVB irradiation
downregulate the rearrangement of cytoskeleton and, thereby, antigen presentation of DC.
P9
Change of Epidermal Langerhans Cells in Chemically Peeled Skin
Yuki Yamamoto, Koji Uede, Aki Sakai, Fukumi Furukawa
Department of Dermatology,Wakayama Medical University,Wakayama, Japan
Chemical peeling is one of dermatological treatments for cutaneous diseases or aesthetic improvement,
which consists of the application of one or more chemical exfoliating agents to the skin. Among many
chemical peeling agents, trichloroacetic acid (TCA) and phenol have the vissue injury e¡ects through the
papillary dermis to the upper reticular dermis. Recently, we reported the immunohistochemical distribu-
tion of human beta-1 integrin (1), tenascin (2) and classic cadherins (3) of peeled skin with phenol or
TCA. The aim of our present study is to examine the distribution pattern of epidermal Langerhans cell
(LC) in peeled skin, because the cell may contribute the allergic reaction in peeled skin. Two, 6, 12 hours,
1, 2 and 7 days after peelings, skin specimens were obtained from the upper arm of 3 healthy adults.
Phenol, 40% TCA or 60% TCA, glycolic acid (GA) as well as liquid nitrogen (LN) were treated for
adequate times and peeled sites were non-closed. CD1a positive epidermal LC were quantitatively and
qualitatively observed in LN- and GA-treated skins. TCA peeling decreased somewhat the number of
epidermal LC, but there were few number of epidermal LC in phenol treated skin during 24 hours after
peeling. Such di¡erent pattern can provide a new insight into the selection of agents and tissue repair
mechanism.1)YamamotoY et al. Aesthet Dermatol 12: 70^76, 2002. 2) ibid 13: 17^24, 2003. 3) Yamamoto
Y, et al: P-cadherin expression in the skin peeled with phenol or trichloroacetic acid (TCA), submitted
P10
E¡ects of Imiquimod on the Cutaneous Immune System
Francesca Palamara1, Petra Luehrs2, Simone Meindl, Georg Stingl, Maria Sibilia
1Department of Dermatology, DIAID/BMT, University of Vienna Medical School,Vienna, Austria
2Department of Dermatology, University of RomeTorVergata, Rome, Italy
Aim of our study was to investigate how the immune response modi¢er Imiquimod (I) exerts its
activity in the skin. Back skin and ears of C57BL/6mice were treated daily with 5% I cream or vehicle
for a total of eight days. After three days of I-treatments, we observed in£ammatory changes which
were most pronounced by day eight with spongiosis and acanthosis. Immunohistology revealed a
massive increase of CD45þ leukocytes which consisted of T cells CD3þ/CD4þ4CD8þ ), dendritic
cells (MHC-IIþ ,CD11cþ ) and macrophages (Mac-1þ,F4/80þ ). The increase in dermal dendritic cells
is partly due to the I-driven downmigration of epidermal Langerhans cells (LC). Interestingly, we
found the number of CD4þ cells to regularly exceed that of CD3þ. FACS analysis revealed that this
CD4þ cells were also MHC-IIþ /GR-1þ/CD11cþdisplaying the features of plasmacytoid dendritic
cells(pDC). To investigate the anti-tumour properties of I, melanomas induced by the injection of
M3 cells into DBA/2 mice, were treated either with I or vehicle alone. I- but not vehicle treatment
led to either a signi¢cant reduction or, even, complete resolution of the tumours. It will be interesting
to see whether the stimulatory e¡ects of I on DC, i.e. activation of LC and appearance of pDC in the
skin, are responsible for this phenomenon.
P11
Fullerene C60 Protects against Langerhans Cells Depletion Induced by DMBA
S. Judith Alvarez1, Rodrigo Leon1, Beatriz Hernandez1, Enrique A Sampedro1,2, Limei Zhang3,
Andres E Castell1
1Departamento de Biologia Celular yTisular, Facultad de Medicina, UNAM, Mexico
2Servicio de Anatomia Patologica, Hospital Regional Lic Adolfo Lopez Mateos ISSSTE, Mexico, DF, Mexico
3Departamento de Fisiologia, Facultad de Medicina, UNAM, Mexico DF, Mexico
It has been demonstrated that epicutaneous application of the carcinogen dimethyl-benz(a)anthracene
(DMBA) induce a drastically diminution of Langerhans cells (LC) in mice skin. That depletion is
inhibited by substances that have anti-carcinogen activity as retinoic acid and some antioxidants as
vitamins C and E. Nonetheless, novel antioxidants appeared recently as the carboxifullerenes. Carbox-
ifullerene are polymers that have 60 or more carbons that protect some cells to injury induced by pro-
oxidants. Taurine has the same e¡ect of the carboxifullerene. The objective of this study is to search if
carboxifullerene C60 and taurine have a protective role against DMBA induced LC depletion. Balb/c
mice were treated epicutaneosly with 50 ul of DMBA (0.5 mg/ml) or with DMBA plus 50 ul taurine
(40 mg/ml) or 10 ul C60 (1:100 in distilled water). Controls were intact mice or mice treated with
DMBA plus retinoic acid or vitamin C. Epidermal sheets were processed to demonstrated class II
molecules of the MHC. Other mice received the same treatments, but at day seven were sensibilized
and challenged with DNFB in order to quantify the hypersensitivity contact response.We observed
the number of LC in mice treated with DMBA plus C60 was similar to the intact mice, however was
not the case for mice treated with DMBA plus taurine because the diminution was more pronounced.
The response to DNFB in mice treated with DMBA plus C60 was similar to the response generated
by DNFB only.Results suggest that C60 is e¡ective to protect against induced-DMBA depletion LC.
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Measurement of the Amount of Skin Antigen Tra⁄cked into Regional Lymph
Nodes
MiyaYoshino1, Hidetoshi Yamazaki1,2,Takahiro Kunisada3, Shin-Ichi Hayashi1
1Division of Immunology, Department of Molecular and Cellular Biology, School of Life Science, Faculty of
Medicine,Tottori University, Japan
2Division of Regenerative Medicine andTherapeutics, Institute of Regenerative Medicine and Biofunction,Tottori
University Graduate School of Medical Science, Japan
3Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Japan
We have established two transgenic mice (Tg) strains; human keratin 14 promoter-driven mast cell growth
factor (hk14-Mgf)-Tg and hepatocyte growth factor (hk14-Hgf)-Tg bearing melanocytosis in their epidermis
and dermis, respectively. Skin regional lymph nodes (LNs) of these Tg were pigmented under any situa-
tion, even SPF condition, by melanin granules (MGs). The MGs were laden both dendritic cells (DC)
and macrophages in the regional LNs; however the antigen-transporting cells from skin were onlyTGF-
b1-dependent DC-lineage cells including Langerhans cells.We regard these mice as good tools to inves-
tigate skin antigen-tra⁄cking. MGs is insoluble and accumulated constitutively in regional LNs. There-
fore, in this study, to assess the amount of skin antigen-tra⁄cking to regional LNs, we measured dose of
MGs containing each LNs by the spectrophotometric method of solubilized MGs. This developing sys-
tem enables us to know the total amount of tra⁄cking skin antigen through a life.
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Immunophenotypic Characterization of Dermal Dendritic Cells in the Connective
Tissue Follicles of Human Scalp
Masahiko Toyoda, Motokazu Nakamura, Masaaki Morohashi
Department of Dermatology,Toyama Medical and Pharmaceutical University,Toyama, Japan
While a heterogeneous network of cell components is present within the connective tissue follicles,
few data are available for their phenotypes and functional properties in normal human scalp. A group
of cells with a dendritic morphology located in the dermis have been recognized as important mem-
bers of the dermal immune system.We examined the organization of dermal dendritic cells including
monocyte/macrophage system and dermal dendrocytes in the connective tissue follicles of human
scalp using immunocytochemical staining method. There was marked heterogeneity in morphology,
localization and surface marker expression in the connective tissue follicles. Quantitative comparative
analysis revealed the following di¡erences in the density of dermal dendritic cells with diverse immu-
nophenotype; 1) the interfollicular versus the perifollicular areas (CD34, Mac387), 2) the upper versus
the lower perifollicular areas (CD68, CD14, CD11b, CD11c, CD34, CD1a, Factor 13a), 3) sexual di¡er-
ences (CD34, HAM56), 4) the frontal and the occipital scalp (CD68, CD36, CD34, CD168), and 5) the
scalp versus the facial skin (CD11b, CD1a, Factor 13a). In addition, there were immunophenotypic
di¡erences in the perifollicular dermal dendritic cells between normal scalp and male pattern alopecia
(CD68, CD34, HAM56). This study demonstrates chatacteristic organization of dermal dendritic cells
in the connective tissue follicles and provides a basis for investigating functional roles and the altera-
tions of localization of these cells in cutaneous hair-associated disorders.
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Preferential Occurrence of Di¡erent In£ammatory Dendritic Cell Subsets in
Contact Hypersensitivity and Atopic Dermatitis
Christine Bangert, Georg Stary, Georg Stingl,Tamara Kopp
Department of Dermatology, DIAID, University of Vienna Medical School,Vienna, Austria
By investigating the number and the distribution of di¡erent dendritic cell (DC) subsets in contact hy-
persensitivity and atopic dermatitis (AD), we sought to obtain information about the nature of the patho-
genetically relevant antigen-presenting cells in these two diseases. To pursue this aim, we compared, by
immuno£uorescence, DC subpopulations of biopsies obtained from 72h epicutaneous patch tests (EPT;
n¼10), AD lesions (n¼ 5) and normal human skin (NS; n¼ 5). Langerin was used as marker for Lan-
gerhans cells (LCs), CD1c for dermal dendritic cells (DDCs), CD1a/CD1c for in£ammatory dendritic
epidermal/dermal cells (IDECs/IDDCs) and CD123/BDCA-2 for plasmacytoid dendritic cells (pDCs).
In NS, Langerinþ cells were located predominantly in the epidermal (25.9/mm basement membrane)
and CD1cþ cells in the dermal compartment (28.6/mm2). Only few cells were CD1aþ /CD1cþ and
CD123þ/BDCA-2þ . In EPT and AD lesions the number of dermal Langerinþ cells (14.5/mm2 and
10.5/mm2) was augmented at the expense of their epidermal counterpart (18.1/mm and 16.4/mm), and
CD1cþ cells represented the major dermal population (100.8/mm2 and 44.7/mm2). Among the non-indi-
genous DC subsets of human skin, pDCs were the dominant cell population in EPT lesions (49.5/mm2
dermis) as opposed to IDECs/IDDCs in AD (50% of dermal and 86% of epidermal CD1cþ cells). Our
results demonstrate profound di¡erences in the content and number of di¡erent DC subpopulations in
eczema when compared to NS.The predominance of pDCs in EPT - and IDECS/IDDCs in AD lesions
may speak for the existence of diverse DC-drivenT-cell di¡erentiation pathways in these skin diseases.
1244 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
P15
Distribution of Some C-type Lectin Receptors on Human Langerhans Cells and
Dermal Dendritic Cells in situ and in Culture
Susanne Ebner1, Philipp Schwingshackl1, Sandra Holzmann1, Zita Ehammer1, Markus Forstner2, Peter
Fritsch1, Nikolaus Romani12
1Department of Dermatology, University of Innsbruck, Innsbruck, Austria
2Kompetenzzentrum MedizinTirol, Innsbruck, Austria
We studied in detail the distribution of DEC-205/CD205 and BDCA-2 in clinically normal appear-
ing human skin in relation to other dendritic cell markers such as Langerin/CD207 for Langerhans
cells (LC), DC-SIGN/CD209 for dermal dendritic cells, and DC-LAMP/CD208 for mature dendritic
cells in general. LC in situ expressed low but detectable levels of DEC-205. Expression was upregu-
lated upon maturation in skin organ culture, both in situ (as determined by immuno£uorescence) and
on the surface of LC that had migrated from skin explants (as determined by FACS). Emigrated LC as
well as dermal dendritic cells were uniformly DC-LAMPþ. No BDCA-2 expression was found in
the vast majority of LC in the epidermis on cryostat sections, in epidermal sheets, and on epidermal
emigrant cells. As described, Langerin and DC-SIGN were expressed in a mutually exclusive fashion -
Langerin on LC; DC-SIGN on dermal dendritic cells. Numerous DEC-205þ cells were found in the
dermis. Most of them co-expressed DC-SIGN and thus quali¢ed as dermal dendritic cells. Emigrated
dermal dendritic cells displayed similar levels of DEC-205 on their surfaces as did emigrated LC.
Interestingly, in most samples we detected few dermal BDCA-2-reactive cells that were conspicuously
situated close beneath the basement membrane. In double-labeling experiments they turned out to be
immature, i.e., DC-LAMP-negative. They did also not co-express Langerin.We conclude that normal
appearing human skin harbors di¡erent subsets of dendritic cells including few scattered BDCA-2-
expressing cells, presumably plasmacytoid dendritic cells.
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Adult Langerhans Cell Histiocytosis with Unusual Systemic Fibrosis: a Histological
and Immunohistochemical Analysis of an Autopsy Case
Kunihiko Maeda1, KirikoWada1, Mikio Matsuda2,YuyaTakakubo1, Akihiro Ishida1, Mitsunori
Yamakawa1
1Division of Pathology, Department of Developmental and Bio-Defending Medicine,Yamagata University School of
Medicine,Yamagata, Japan
2Department of Nursing, School of Health Science,Yamagata Prefectural University of Health Science,
Yamagata, Japan
The patient was a 71years old, Japanese man. He noted weight-loss and skin eruptions of forearms and
trunk from 18 months before death. Fever, appetite loss, and progressive respiratory discomfort were
added to his symptoms and his chest X-ray examination revealed irregular reticular shadows in both
lungs 10 months after onset. Blood examination indicated leukocytosis. Biopsies of the erupted skin
lesions and the enlarged axillar lymph node were undertaken inYamagata University Hospital, one by
one. The histological observation of the specimens revealed unusual proliferation of Langerhans cells
in both tissues (adult Langerhans cell histiocytosis; LCH). The patient’s course in the hospital went
rapidly downhill without aggressive therapy and he expired approximately 2 months after admission.
The autopsy, which were performed within 2 hours after death, revealed di¡use or focal proliferation
of Langerhans cells and/or other histiocytes in the interstitium of lungs and pancreas and severe ¢bro-
sis of both lungs (720 g, 900 g), liver (1,280 g), spleen (170 g), kidneys (170 g, 140 g) and bone marrow.
Although several reports described that signi¢cant interstitial ¢brosis complicated with adult pulmon-
ary LCH, no report mentioned extensive ¢brosis involved multi-systemic organs as well as the present
case. This case suggested a unique variant of LCH, which may produce certain factors to induce di-
rectly or indirectly systemic cellular reactions and ¢brosis.
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An Unusual Case of Unclassi¢able Malignant Histiocytic/Dendritic Cell
Neoplasms Causing Death
Akira Kuramochi1,TetsuyaTsuchida1, Eiichi Arai2,Takanori Hirose2, Michio Shimizu2,
Miki Akiba3, Masami Bessho3
1Department of Dermatology, Saitama Medical School, Saitama, Japan
2Department of Pathology, Saitama Medical School, Saitama, Japan
3Department of Hematology, Saitama Medical School, Saitama, Japan
A 70-year-old Japanese man presented with a 3-year history of cutaneous lesions and 2-year history of
severe general fatigue associated with pancytopenia. He had no medical attention for past three years.
When he came to a hospital near his residence, his cutaneous lesions consisted of brown scaly papules
with severe purpuras and petechias mainly on the trunk and buttock, which coalesced to form erythe-
matous plaques. He had high fever, anemia, severe general fatigue, appetite loss, lymphadenopathy and
hepatosplenomegaly. Cutaneous biopsy suggested mycosis fungoides in division of dermatology and
bone marrow aspiration suggested chronic myelomonocytic leukemia in division of hematology.
After he came to our hospital his cutaneous and bone marrow’s lesions were thought to be the same
histiocytic malignancy. He had chemotherapy, but died of splenic rupture by massive involvement of
tumor cells. Systemic involvement was con¢rmed by autopsy. The important and unique point of this
case is that the in¢ltrating cells were di¡erent immunophenotypically in various organs. In¢ltrating
cells of skin and lymph nodes were positive for CD1a(þ þ þ ), S-100(þ þ þ ) and CD68(þ ), and
those of colon and spleen were positive for CD1a(þ ), CD68(þ þ ) and negative for S-100, though
those of bone marrow were pasitive for S-100(þ þ ), CD68(þ þ ) and negative for CD1a. We
thought this was a case of unclassi¢able sarcomatous lesion and it was derived from malignant trans-
formation of precursor cells of both Langerhans cell lineage and monocyte-macrophage lineage.
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The High A⁄nity IgE Receptor Mediates IL-16 Production by Monocyte-derived
Dendritic Cells in Patients with Atopic Dermatitis
Norito Katoh, Fujiko Soga, Kouji Masuda, Saburo Kishimoto
Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto,
Japan
IL-16 serves as a natural ligand of CD4 molecules, and induces chemotaxis in CD4-expressing cells
such as Tcells, eosinophils, dendritic cells, and monocytes. To estimate the role of dendritic cells in the
recruitment of in£ammatory cells after antigen stimulation, we examined IL-16-producing capacity of
monocyte-derived dendritic cells (MoDC) after engagement of the high a⁄nity IgE receptor (FceRI)
in adult patients with atopic dermatitis (AD). Though the expression of FceRI was reduced during
culture for generating immature MoDC with IL-4 and GM-CSF for 5 days, the percentage of FceRI-
positive MoDC was signi¢cantly higher in patients with AD when compared with non-atopic
individuals. MoDC prepared from patients with AD showed enhanced capacity to produce IL-16 fol-
lowing aggregation of FceRI both in exacerbation status and after conventional treatment. MoDC
generated in the presence of 2mg/ml IgE (833 IU/ml) revealed not only signi¢cantly higher FceRI
expression but also more potent IL-16 producing capacity induced by engagement of the receptor.
IL-16 producing capacity decreased signi¢cantly in AD patients after topical treatment with corticos-
teroids or tacrolimus. These results suggest that IL-16 produced by dendritic cells after antigen stimu-
lation plays a role in the exacerbation of chronic AD.
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Kinetics of CCR3(þ ) Dendritic Cells and Eotaxin Production in Atopic
Dermatitis
Yuichiro Akiyama, Sang Jae Bae, Hiroyuki Murota,Yasuhiro Horiuchi, Ichiro Katayama
Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
It is widely accepted that Langerhans cells play key roles in initiation of both Th1 and Th2 immune
responses in the skin. Therefore, inhibition of Langerhans cell-migration towards the draining lymph
nodes is therapeutic target of cutaneous allergic in£ammation. In addition to Langerhans cells,
FceRI(þ ) dendritic cells are increased in number in the epidermis of atopic dermatitis. Recently it
was reported that human dendritic cells express CCR3 (receptor for eotaxin) and might migrate to
Th2 skewed-allergic in£ammatory sites in response to eotaxin in a similar manner to eosinophils.
However little is known about kinetics of eotaxin production and distribution pattern of CCR3 po-
sitive dendritic cells in atopic dermatitis during the immunomodulatory therapies. As results, we ob-
served that CD1(þ ) Langerhans cells and FceRI(þ ) dendritic cells are increased in the epidermis and
upper dermis of the skin lesions of atopic dermatitis or other Th2 skewed skin diseases and decreased
after the topical immunomodulatory therapies.We also observed that eotaxin production is upregu-
lated in the lesional ¢broblasts which may contributes to the accumulation of CCR3(þ ) dendritic
cells in atopic dermatitis. Our results may suggest that inhibition of eotaxin production is a key target
for the treatment of refractory atopic dermatitis.
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TARC Production in Monocyte-derived Dendritic Cells from Patients with Atopic
Dermatitis
Koichiro Nakamura1, Hirotoshi Furukawa1, Akiko Nishibu1, Fumio Kaneko1,Takashi Kakinuma2,
Yuichiro Tsunemi2, Hidehisa Saeki2, Kunihiko Tamaki2
1Department of Dermatology, Fukushima Medical University, Fukushima, Japan
2Department of Dermatology, University ofTokyo, Japan
Background: Thymus and activation regulated chemokine (TARC) is a CC chemokine that attracts
CCR4þ T cells. We reported previously that TARC is an important chemokine that de¢nes Th2
imbalance in the pathogenesis of atopic dermatitis (AD). Objectives: This study was undertaken to
clarify the e¡ects of dust mite-allergen extract (DME) and di¡erent immunosuppressive drugs (Ta-
crolimus (FK506), cyclosporin (CsA), dexamethasone (Dex)) on TARC production by PBMCs and
monocyte derived dendritic cells (MoDCs) from AD patients. Methods: PBMCs were cultured with
or without DME and/or immunosuppressive drugs (Tacrolimus, CsA, Dex) for 7 days and TARC
levels were measured. Results: PBMCs from AD patients which were cultured with DME stimulation
for 7 days showed signi¢cantly higher levels of TARC production than those from healthy controls.
RT-PCR demonstrated that TARC mRNA was expressed in CD4þ T cells, CD8þ T cells and
MoDCs. MoDCs from AD patients showed higher levels of TARC compared to those of healthy
controls. Tacrolimus, CsA and Dex di¡erentially suppressed TARC production by PBMCs from AD
patients which were co-cultured with DME for 7 days. Gel shift analysis revealed di¡erential inhibi-
tory e¡ects of these immunosuppressive drugs on NFkB activity in PBMCs from AD patients. Con-
clusion: Our data demonstrate the important role of DME on TARC production by MoDCs from
AD patients, that can regulate Th2 chemokine signaling in the pathogenesis of AD.
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Di¡erent Dendritic Cell (DC)-migration Mechanisms between Papillary Carcino-
ma and Follicular Carcinoma
Kaori Tsuge1, Mitsunori Yamakawa1, Kunihiko Maeda1, Hiroaki Takeda2, Sumio Kawata2
1Division of Pathology, Department of Developmental and Bio-Defending Medicine,Yamagata University School of
Medicine.Yamagata, Japan
2Department of the Second Internal Medicine,Yamagata University School of Medicine,Yamagata, Japan
Papillary carcinoma (PAP) rather than follicular carcinoma (FOL) in the thyroid gland frequently has
dense in¢ltration of DCs. The ¢nal goal of this study is to clarify the di¡erence of the DC-migration
mechanisms between both carcinomas. [Methods] Resected thyroid tissues obtained from patients
with PAP and FOLwere used for immunostain of some DC markers, chemokines and their receptors,
and adhesion molecules. The expression of mRNA of chemokines and their receptors was also eval-
uated by RT-PCR and in situ hybridization (ISH). Binding assay was done using frozen tissue sections
and neutralized antibodies to adhesion molecules. [Results] The results were summarized as follows:
(1) PAP than FOLwas in¢ltrated by more DCs, of which the majority were CD1a-positive immature
DCs. (2) The expression of the protein and mRNA of MIP-3a was con¢rmed in PAP but not FOL
by immunostaining, RT-PCR and ISH. Similarly the localization of CCR-6-positive DCs in PAP
was con¢rmed. (3) PAP rather than FOL had often ICAM-2-positive blood vessels mainly adjacent
to cancer margin and more DC-SIGNþ DCs. (4) Binding of DCs to thyroid tissue sections was
signi¢cantly inhibited by pretreatment of neutralized antibodies to ICAM-2 and DC-SIGN, respec-
tively. [Conclusion] These data clearly indicated that PAP rather than FOLwas more frequently in¢l-
trated by immature DCs expressing CD1 and CCR-6, and this event may be caused by some factors
including the secretion of MIP-3a by carcinoma cells and the dense localization of ICAM-2-positive
blood vessels in PAP, compared to FOL.
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Di¡erential Regulation by Interleukin-10 of Langerhans Cell Migration Stimulated
in Mice by Chemical Contact and RespiratoryAllergens
Marie Cumberbatch, Kirsty Clelland, Rebecca J. Dearman, Ian Kimber
Syngenta CentralToxicology Laboratory, UK
Divergent immune responses characteristic of preferential T helper (Th)1- and Th2-cell activation are
observed following prolonged topical exposure of BALB/c strain mice to chemical contact and re-
spiratory allergens, respectively. Recently we have reported that contact allergens, such as dinitrochlor-
obenzene (DNCB), stimulate epidermal Langerhans cell (LC) migration and draining lymph node
dendritic cell (DC) accumulation more rapidly than do respiratory allergens, such as trimellitic anhy-
dride (TMA).We have now investigated whether interleukin-10 (IL-10), a cytokine implicated in the
negative regulation of LC migration, may be involved. Intradermal administration to BALB/c strain
mice of neutralizing anti-IL-10 antibody prior to application of TMA enhanced LC migration, result-
ing in a 33% reduction of MHC class IIþ LC numbers within 4 hours of exposure, compared with
only 9% at sites pre-treated with isotype control antibody. In contrast, anti-IL-10 antibody was with-
out e¡ect on the approximately 30% decrease in LC densities provoked by DNCB. In subsequent
experiments, supernatants derived from skin explants excised from mice exposed in vivo for 2-4 hours
to TMA, DNCB or to vehicle alone were analyzed by ELISA for IL-10. Preliminary results reveal
elevated IL-10 production in supernatants derived only from explants exposed to TMA. These data
suggest an early role for IL-10 in the regulation of LC migration provoked by TMA, an event that
may be important for the development of a Th2-type immune response to this chemical.
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Increased Circulating CD11bþCD11cþ Dendritic Cells in a Murine Model for SLE
which can be Matured by TNF-a into BLC Producing Dendritic Cells
Sho Ishikawa,Taku Sato,Toshihiro Ito, Kenji Akadegawa, HideoYurino, Hiroyuki Yoneyama, Kouji
Matsushima
Dept. of Molecular Preventive Medicine, Faculty of Medicine,The Univ. ofTokyo, Japan
We previously reported aberrant high expression of B lymphocyte chemiattractant (BLC/CXCL13) by
DCs in aged BWF1 mice, a murine model for SLE. We found in the present study that
CD11bþCD11cþ cells were markedly increased in the peripheral blood (PBL-DCs) in aged BWF1
mice, but not in simularly aged NZB and NZWmice. They appeared in the circulation as early as 5
month of age when lupus nephritis does not develop in these mice. Some PBL-DCs showed typical
dendritic morphology and expressed MHC class II molecules, and had a weak, but signi¢cant antigen
presenting activity in MLR. PBL-DCs were chemoattracted to several chemokines including SLC,
LARC, RANTES, MIP-1awhereas splenic DCs from aged BWF1mice were preferentially chemoat-
tracted towards SLC. BLC production was induced when PBL-DCs were cultured in vitro in the
presence of TNF-a for 3 days. BLC expression was also induced in bone marrowderived-DCs when
they were di¡erentiated into mature DCs in the presence of TNF-a or IL-1b, while both IFN-a and
IFN-b failed to induce BLC expression in bone marrow derived-DCs. These results suggest that
recruitment of DCs in the circulation and maturation into BLC producing DCs in the target organs
may be the key step to initiate autoimmune responses in BWF1 mice.
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CCR7 Ligands Induce Rapid Endocytosis in Mature Dendritic Cells with Conco-
mitant Upregulation of Cdc42 and Rac Activities
Yoshiki Yanagawa, Kazunori Onoe
Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Hokkaido, Japan
While chemokines are well known to function in chemotaxis, additional roles for these molecules in
the immune system are not well understood. Dendritic cells (DCs) developmentally regulate the ex-
pression of chemokine receptors to facilitate their migration from the peripheral tissues to regional
lymph nodes. CCR7 are selectively expressed on mature DCs but not immature ones. DCs also de-
velopmentally regulate the ability of antigen uptake. Immature DCs exhibit vigorous acquisition of
£uid-phase molecules, whereas mature DCs captures only low levels of exogenous antigens because of
the downregulation of endocytic processes constitutive in immature DCs. In the present study, we
examined the e¡ects of two CCR7 ligands, CCL19 and CCL21, on endocytosis of £uorescein isothio-
cyanate (FITC) dextran by murine DCs. Both CCL19 and CCL21 markedly induced rapid uptake of
FITC-dextran by mature DCs but not immature DCs. CCL19-induced endocytosis could be comple-
tely blocked by Clostridium di⁄cile toxin B, which inhibits the Rho GTPase proteins, Rho, Rac and
Cdc42. This process was not abrogated by Y-27632, a speci¢c inhibitor of Rho-associated kinase. In
addition, CCL19 rapidly enhanced Cdc42 and Rac activity in mature DCs. It is suggested that CCR7
ligands activate Cdc42 and Rac, thereby inducing the endocytosis in mature DCs. Our ¢ndings reveal
that mature DCs can e⁄ciently acquire antigens in the presence of CCR7 ligands.
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CCR7 Positive Tolerogenic Dendritic Cells Have Critical Role in Oral Tolerance
Katsuya Nagatani,Yudo Tanno, Kayo Sagawa,Yoshinori Komagata, KazuhikoYamamoto
Department of Allergy and Rheumatology, Graduate School of Medicine, University ofTokyo,Tokyo, Japan
Orally administered antigen induce systemic hyporesponsiveness to the antigen. Oral tolerance has
been used successfully to treat autoimmune disease in several animal models. It is well known that
oral tolerance is mediated by CD4 positive T cells, but the role of dendritic cells (DCs) in the periph-
eral lymphoid tissues or the GALT for the induction of oral tolerance is not well de¢ned. We fed
ovalbumin (OVA) to Balb/c mice 5 times every other day and transferred whole splenocytes or DC-
depleted splenocytes of these mice, followed by immunization with OVA in CFA. Oral tolerance to
OVAwas abrogated in the mice transferred with DC-depleted splenocytes compared to whole sple-
nocyte. Next we transferred CD11c positive splenic DCs from OVA-fed mice and then immunized.
Tolerance to OVAwas induced in the mice transferred with OVA-fed mice DCs. Additionally transfer
of CD11c positive splenic DCs from OVA-fed mice suppressed delayed-type hypersensitivity (DTH).
Furthermore we veri¢ed that adoptive transfer of DCs in Peyer’s patch (PP) and mesenteric lymph
nodes from OVA-fed mice also suppressed response to OVA stimulation. To examine what population
of DC is most important for the induction of oral tolerance, we transferred CCR6-depleted or
CCR7-depleted splenic DCs and DCs in PP from OVA-fed mice. Oral tolerance to OVAwas drama-
tically abrogated by CCR7 depletion, not by CCR6 depletion from splenic DCs and DCs in
PP.These results suggest that CCR7 positive DCs in the peripheral lymphoid tissues and the GALT
play a critical role in oral tolerance.
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Thymus and Activation-regulated Chemokine (TARC/CCL17) Produced by
Mouse Epidermal Langerhans Cells is Upregulated by TNF-a and IL-4 and
Downregulated by IFN-c
Hidehisa Saeki1,Ting Xiao1,2, Hideki Fujita1, Hiroshi Mitsui1, Makoto Sugaya1,Yayoi Tada1,Takashi
Kakinuma1, Hideshi Torii1, Koichiro Nakamura3, Akihiko Asahina1, Kunihiko Tamaki1
1Department of Dermatology, Faculty of Medicine, University ofTokyo,Tokyo, Japan
2Department of Dermatology, No.1Hospital, China Medical University, Shenyang, China
3Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan
Thymus and activation-regulated chemokine (TARC/CCL17) is a Th2 type chemokine and its recep-
tor CC chemokine receptor 4 (CCR4) is preferentially expressed on Th2 cells. Langerhans cells (LC)
are immature dendritic cells (DC) in the epidermis of the skin and play vital roles in immune re-
sponse. In this study, we investigated TARC expression by murine freshly isolated LC and 48 hr cul-
tured (mature) LC, and the regulation of TARC production in cultured LC by various cytokines.
Murine LC was prepared using a panning method from BALB/c mice. RT-PCRwas performed using
fresh and cultured LC to evaluate TARC mRNA levels. ELISAwas carried out using supernatant of
cultured LC to calculate secreted TARC protein levels. The levels of costimulatory molecules on the
cell surface of cultured LC were measured using £ow cytometry. TARC mRNAwas strongly upre-
gulated during maturation of murine LC.TARC production by murine LC was upregulated byTNF-
a and IL-4 and downregulated by IFN-g, dose-dependently. CD80 and CD86 levels of cultured LC
were upregulated byTNF-a and IL-4, suggesting that upregulation of TARC by these cytokines may
be partially due to further maturation of cultured LC. In conclusion,Th1 and Th2 cytokines recipro-
cally regulate the production of Th2 type chemokine TARC by murine LC. Th2 cytokine microen-
vironments in skin may increaseTARC production by mature LC, providing attraction of Th2 cells in
skin. This may be an ampli¢cation circuit in Th2-dominant in£ammatory skin disease like atopic
dermatitis.
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Type 1 Interferons Inhibit Maturation/Activation of Mouse Langerhans Cells and
Up-regulate the Production of In£ammatory Chemokines
Hideki Fujita, Akihiko Asahina,Yayoi Tada, Kunihiko Tamaki
Department of Dermatology, University ofTokyo,Tokyo, Japan
Type 1 interferons (IFNs) are immunomodulatory cytokines which link innate and adaptive immune
responses. It is well known that IFN-a/b-treatment of immature dendritic cells (DC) induces pheno-
typic and functional maturation of these cells. However, it is still unclear whether stimulation by these
cytokines in£uences functions of Langerhans cells (LC) resident in the skin. In this study, we used
highly-enriched (495%) LC directly obtained from mouse epidermis. Type 1 IFN-treated LC exhib-
ited impaired ability to produce IL-12 and in£ammatory cytokines IL-6 and TNF-a. In addition, IL-
10 production was not augmented by type 1 IFN stimulation. On the other hand, type 1 IFNs up-
regulated expression of in£ammatory chemokines CXCL9, CXCL10, CXCL11, CCL3, CCL4 and
CCL5, and down-regulated those of CCL17 and CCL22. Surprisingly, in sharp contrast to splenic
DC, IFN-b-treated LC exhibited reduced expression of CD40, B7-1, B7-2, ICAM-1, CD44, and
NLDC145 compared with unstimulated LC. Furthermore, IFN-b-treated LC had reduced costimula-
tory activity for anti-CD3-induced proliferation of T cells. These results indicate that type 1 IFNs in-
hibit maturation/activation of LC, which seems to be speci¢c for LC among DC subsets. Our
observations suggest that LC are not able to act as potent antigen presenting cells compared with other
DC subsets under particular settings such as viral infection.
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A Shift fromType 1 to Type 2 Cytokines in the Chronic Contact Hypersensitivity Is
Associated with Decreased Number of IL-12-producing CD11cþ Dendritic Cells
Yuichi Teraki,Tetsuo Shiohara
Department of Dermatology, Kyorin University School of Medicine,Tokyo, Japan
Our previous reports have demonstrated that repeated elicitation of contact hypersensitivity (CHS)
results in a shift in the time course of Ag-speci¢c CHS from a delayed-type hypersensitivity response
to an early-type response, which re£ects a shift from type 1 to type 2 cytokines in the cutaneous sites
and skin-draining regional lymph nodes. However, the mechanisms that lead to type 2 cytokines in
the chronic CHS remain unclear. In this study, we examined IFN-gamma- and IL-4-producing cap-
abilities by CD4þ and CD8þ T cells, and IL-12 producing capabilities by CD11cþ dendritic cells
in the skin-draining regional lymph nodes at a single cell level. In the acute phase of CHS, a high
percentage of IFN-gamma-producing CD8þ Tcells and a few IL-4-producing CD4þ Tcells were
found. In the chronic phase of CHS, although the percentage of IL-4-producing CD4þ T cells was
signi¢cantly increased, the percentage of IFN-gamma-producing CD8þ T cells remained un-
changed. The percentage of CD11cþ dendritic cells in the chronic phases of CHS remained un-
changed, however, the percentage of CD11cþ dendritic cells capable of producing IL-12 was
signi¢cantly decreased. These results suggest that IFN-gamma-producing CD8þ T cells are silenced
in the chronic contact hypersensitivity by an expansion of IL-4-producing CD4þ T cells and de-
creased number of IL-12-producing dendritic cells.
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Integrin Dependent Interaction between Human DC and T-cells Is Regulated by
CYTIP, a Protein Induced by DC Maturation
Susanne Hofer, Margit Au⁄nger,Van Anh Nguyen, Christine Heu£er
Department of Dermatology, University of Innsbruck, Innsbruck, Austria
The maturation process of dendritic cells (DC) is an important step in the initiation of immune re-
sponses and is partially controlled by cell-cell contact and by reversible interactions of integrins with
intracellular signalling molecules.We found a protein, termed CYTIP, which is induced during ma-
turation of both human CD34þ stem cell-derived DC grown with GM-CSF and TNF alpha and
monocyte-derived DC propagated with GM-CSF and IL-4. The molecule is predominantely ex-
pressed in hematopoietic cells, lymph nodes and spleen, but weakly in thymus and bone marrow.
There is no expression in fetal liver. CYTIP is located in the cytoplasm and interacts with cytohe-
sin-1. Cytohesin-1 binds to the beta-2 integrin LFA-1 and has been implicated in activation of the
receptor. Overexpression of a GFP-CYTIP-fusion protein in DC leads to the translocation of CYTIP
into the nucleus when cocultured with T cells. Nuclear location of the protein does not take place, if
transfected DC are cultured without T-cells. We suppose that DC-T-cell interaction is regulated by
CYTIP. This novel pathway of controlling integrin mediated adhesion could play a role in the regula-
tion of DC motility.
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Mechanisms of Enhanced Macrophage-mediated Prostaglandin E2 Production and
its Suppressive Role in Th1 Activation in Th2-dominant BALB/c Mice
Etsushi Kuroda, Uki Yamashita
Department of Immunology, University of Occupational and Environmental Health, School of Medicine,
Kitakyushu, Japan
PGE2 has been known as one of suppressive factors in Th1 responses. In this communication, we stu-
died the strain di¡erence of mice in PGE2 production by macrophages and its relation to Th1 activa-
tion. Macrophages from BALB/c mice, known as Th2-dominant strain, produced greater amounts of
PGE2 than those from any other strains of mice, including C57BL/6 mice known as Th1-dominant
strain, after LPS stimulation. In accordance with the amount of PGE2 produced, macrophage-derived
IL-12 and T cell-derived IFN-g productions were more strongly suppressed in BALB/c mice in
C57BL/6 mice.When macrophages were treated with indomethacin or EP4 antagonist,Th1 cytokine
productions were more markedly increased in macrophages and T cells from BALB/c mice than in
those from C57BL/6 mice. Although cyclooxygenase-2 was expressed similarly after LPS stimulation
in those mouse strains, the release of arachidonic acid and the expression of typeV secretory phospho-
lipase A2 mRNAwere greater in BALB/c macrophages. However, exogeneous addition of arachidonic
acid did not reverse the lower production of PGE2 by C57BL/6 mice. The expression of microsomal
PGE synthase, a ¢nal enzyme of PGE2 synthesis, was also greater in BALB/c macrophages. These
results indicate that the greater production of PGE2 by macrophages, which is regulated by secretory
phospholipase A2 and microsomal PGE synthase but not by cyclooxygenase-2, is related to the sup-
pression of Th1 and the activation of Th2 in BALB/c mice.
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Role of Calcitonin Gene-related Peptide in Lipopolysaccharide or Tumor Necrosis
Factor -a-induced Maturation of Human Monocyte-derived Dendritic Cells
Qijie Chen,Yoichi Moroi, Hiroshi Uchi,Takeshi Nakahara, Kazunori Urabe, Masutaka Furue
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Calcitonin gene-related peptide (CGRP) is a neuropeptide with immunosuppressive activities. CGRP
is released from peripheral nerves in the skin that are in close physical association with dendritic anti-
gen presenting cells (APC). In this study, we investigated the e¡ects of CGRP on either lipopolysac-
charide (LPS) or tumor necrosis factor (TNF)-a-induced-human dendritic cells (DC) maturation.
Immature DC, derived from human monocytes that had been cultured for 5 days with interleukin
(IL)-4 and granulocyte-macrophage colony stimulating factor (GM-CSF), were pretreated with
CGRP and subsequently stimulated with either LPS or TNF-a. In the presence of LPS, CGRP in-
hibited TNF-a and bioactive IL-12p70 production by DC in a dose-dependent manner. CGRP de-
creased the surface expression of CD83 and CD86, but did not a¡ect the downregulation of £uorescein
isothiocyanate (FITC)-labeled dextran uptake by mature DC that had been stimulated with LPS. DC
treated with CGRP and LPS were most potent in stimulating allogeneic T cell proliferation. Conversely,
pretreatment of immature DC with CGRP resulted in increased expression of CD83 and CD86, but did
not induce the production of bioactive IL-12p70 in DC stimulated withTNF-a. In addition,TNF-a and
CGRP treated DCs retained the ability to downregulate uptake of FITC-labeled dextran and to stimulate
allogeneicTcell proliferation. Our data suggest that CGRP contributes to the maturation of human den-
dritic cells that are stimulated with either LPS or TNF-a by di¡erent mechanisms.
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Induction of Tolerance by Ultraviolet B does not Only Induce T Regulatory Cells,
but Also Causes the Induction of T E¡ector Cells
Yoshinori Aragane1, Akira Maeda1,3,Tadashi Tezuka1, Kiyoshi Ariizumi2,Thomas Schwarz3
1Department of Dermatology, Kinki University School of Medicine, Japan
2Department of Dermatology, Southwestern Medical Center, University ofTexas, USA
3Department of Dermatology, University of Muenster, Germany
Epicutaneous application of haptens induces hapten-speci¢c T e¡ector cells. Sensitization, however,
does not only result in the induction of e¡ector T cells but also of suppressor/regulatoryT cells (Treg)
preferentially belonging to the CD4 type. Ultraviolet B light (UVB) induces tolerance which is due
to the induction of hapten-speci¢cTreg. Here, we asked whether induction of tolerance by UVB does
not only result in the induction of Treg but also of e¡ector T cells. C3H/HeN mice were tolerized by
painting dinitro£uorobencene (DNFB) onto UVB-exposed skin. In addition, we utilized a soluble
form of the protein Dectin-2 (sDec2). sDec2 binds to UVB-induced Treg since depletion of sDec2-
bound T cells obtained from UVB-tolerized mice results in the loss of transfer of suppression. FACS
analysis of T cells revealed that sDec2 only bound to CD4þ T cells. sDec2-bound CD4þ T cells
were mainly positive for CD25, a phenotype similar to Treg. CD4þ T cells from UVB-tolerized
mice were fractionated into sDec2-bound or -unbound fractions and injected i.v. into naive syngeneic
mice. Recipients receiving sDec2-bound Tcells could not be sensitized against DNFB, indicating that
sDec2-bound, CD4þCD25þ T cells transfer UVB-induced tolerance. In contrast, recipients receiv-
ing sDec2-unbound T cells could be normally sensitized. A speci¢c ear swelling response could be
induced in the recipients of sDec2-unbound T cells when the animals were not sensitized but only
challenged with DNFB. Together, these data indicate that induction of tolerance by UVB does not
only induce Treg but also causes the induction of T e¡ector cells.
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Tolerogenic Phenotype after Transient Maturation of Dendritic Cells
Kiichi Kajino, Ichiro Nakamura, Hiromichi Bamba,Yuri Kajino, Kazumasa Ogasawara
Department of Pathology, Shiga University of Medical Science, Shiga, Japan
It is generally considered that mature dendritic cells (DC) present antigens and activateTcells, whereas
immature DC induceTcell tolerance. However, the mechanism of the DC maturation process remains
elusive.We have investigated the rapid maturation and subsequent de-maturation of myeloid DC, de-
rived from bone marrow cells, after stimulation via various toll-like receptors including LPS. The ex-
pired DC were similar to immature DC except high levels of MHC class I expression and increased
IL-10/TNFa production. Such expired DC were unable to stimulate naive CTL, rather they induced
anergy in CTL. The expired DC were also induced from splenic DC by stimulation with CpG oligo
deoxynucleotide. These results may provide some insight into immune regulation.
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Exogenous Heat Shock Protein 90-peptide Complexes-loaded Dendritic Cells E⁄-
ciently Elicit Cross-presentation to Cytotoxic T Lymphocytes
Yasuaki Tamura, Gosei Ueda,Toshihiko Torigoe, Noriyuki Sato
Department of Pathology, Sapporo Medical University, School of Medicine, Hokkaido, Japan
Heat shock proteins (Hsps)-peptide complexes have been demonstrated to undergo receptor-mediated
uptake by antigen presenting cells (APC) with subsequent representation of the Hsp-associated pep-
tides on APC MHC class I molecules. Although it is well established that Hsp-peptides complexes
elicit antitumor responses in prophylactic and therapeutic immunization protocols, the precise immu-
nological basis for this phenomenon is remain to be elucidated. Immunity could be achieved after
vaccination with tumor cells that could not directly present antigen to T cells because of MHC mis-
matching. This phenomenon is known as cross priming and it is conceivable that this phenomenon
could be mediated by naturally released Hsp-peptide complexes. In this study, we examined the roles
of HSP90 in the MHC class I-restricted cross-presentation using bone marrow derived dendritic cells
as APCs.We show that HSP90-peptide complexes enter the endocytic pathways and associated pep-
tides might be transferred onto endosomal MHC class I molecules. Moreover, we show that HSP90-
peptide complexes-loaded dendritic cells e⁄ciently cross-prime cytotoxic T lymphocytes. Interest-
ingly, this presentation is TAP independent and follows endocytic pathways. Our data provide novel
insights into the role of HSP90 in cross priming and peptides-based cancer immunotherapy.
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CD70-dependent but CD4þ T Cell-independent Activation of Allogeneic CD8þ
T Cells by a Human Langerhans/Dendritic Cell-like Cell Line, ELD-1
Sanju Iwamoto1, Hirohiko Sueki2, Masahumi Iijima2, Akira Miyazaki1
1Department of Biochemistry, School of Medicine, Showa University,Tokyo, Japan
2Department of Dermalotogy, School of Medicine, Showa University,Tokyo, Japan
We established a human Langerhans cell/dendritic cell (DC)-like cell line. The cells, termed ELD-1,
possessed Birbeck granules, a marker speci¢c for Langerhans cells, and expressed mRNA speci¢c for
DCs such as DEC205 and DC-LAMP. Interestingly, ELD-1 cells lacked ability to stimulate allogeneic
CD4þ T cells, but could stimulate production of interferon (IFN)-g by allogeneic CD8þ T cells
without help of CD4þ T cells. Blocking study of the CD8þ T cell activation by using neutralizing
antibodies showed that ELD-1 cells needed HLA-ABC, HLA-DR, CD54, CD58, IL-2, and IFN-g
even if CD80, CD86, and IL-12 were not expressed. Further, by cDNA array analysis using active and
inactive subclones of ELD-1 cells, CD70 was found to be the key molecule for determining the ability
of ELD-1 cells to stimulate CD8þ Tcells. The role of CD70 was con¢rmed by transfection of CD70-
encoding complimentary DNA into the inactive subclone. The results indicate that CD70 expression
are required for ELD-1 cells to stimulate CD8þ T cells to generate IFN-g without help of CD4þ T
cells. Thus, CD4þ T cell-independent CD8þ T cell activation by ELD-1 cells provides a model for
the alternative generation of cytotoxic T lymphocytes by dendritic cells bearing CD70.
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Induction of Human Immunode¢ciency Virus (HIV) p24-speci¢c Cytotoxic
T Lymphocytes (CTL) with Bone Marrow-derived Dendritic Cells (BMDC)
Transduced byTat Protein Transduction Domain (PTD)-conjugated HIV p24
In-Soo Choi1, Chang-Hyun Kim1,Yong-Soo Bae1,2
1Creagene Research Institute, Creagene Inc., Daejeon, Korea
2Department of Microbiology, Hananm University, Daejeon, Korea
HIV Tat protein transduction domain (PTD) is known to mediate transduction of exogenous peptides
or proteins conjugated to it into cells. In this study, PTD protein delivery system was employed to
induce HIV p24-speci¢c cellular immune responses using bone marrow derived dendritic cells
(BMDC) as antigen presenting cells. T lymphocytes derived from mice that were immunized with
BMDC transduced by PTD-conjugated HIV p24 antigen demonstrated more e⁄cient proliferation
in an antigen-speci¢c manner than those from non-immunized ones. Cytotoxic T lymphocytes in-
duced in immunized mice killed HIV p24-expressing target cells. In addition, the CTL response was
mediated by CD8þ T lumphocytes in an MHC class I-restricted fashion.When cell culture super-
natants were examined for the presence of IFN-g or IL-4, a much more IFN-g was demonstrated in
the e¡ector cells derived from immunized mice than in those of non-immunized ones. However, the
di¡erence in production of IL-4 was not seen between the immunized and non-immunized mice. In
the respect of antibody responses against HIV p24, the titer of IgG2a was higher than that of IgG1 in a
PTD-HIV p24-immunized group. Taken together, these results indicate that BMDC transduced with
PTD-HIV p24 antigen preferentially induceTh1 type immune responses in immunized small animals.
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Aberrant Dendritic Cells from HTLV-I Carriers and ATLL Patients as a Cause of
ATLL Development
Shigeki Takemoto, Ziyad M. Al-Dahoodi, Hisanori Machida, Hirokuni Taguchi
Department of Hematology and Respiratory Medicine, Program ofTumor Biology and Regulation, Kochi Medical
School, Nankoku, Japan
We describe the generation of monocyte-derived DC (Mo-DC) from HTLV-I infected individuals
and rabbits and investigate their functions. Furthermore, we show the role of DC in ATLL develop-
ment. Four HTLV-I infected rabbits were made and rabbit DC were generated. To examine the func-
tion, analysis of phagocytosis (pinocytosis), cell proliferation assay and cytotoxicity assay were
performed and migration of DC was detected by £uorescence microscopy.We also analyzed human
Mo-DC from HTLV-I carriers as well as ATLL patients. LN biopsy was performed in 6 lymphoma-
type patients and they were examined pathologically. Autologous Mo-DC worked as APC for cellular
immune response. Generated DC exhibited a signi¢cantly low expression of CD1a and HLA-DR in
HTLV-I carriers. No response of T cells with Mo-DC was seen in half of HTLV-I carriers as well as
ATLL patients. In half of cases, EBV positive cells were detected in LN we investigated, and the pro-
liferation of ATLL cells was seen around CD40 and fascin-positive EBV-infected giant cells in two of
them. Our results indicate that rabbit and human Mo-DC work as potent APC in vitro as well as in
vivo. However, functional impairment of Mo-DC occurs in HTLV-I carrier stage and activation of T
cells by aberrant DCmay initiate monoclonal proliferation of ATLL cells in a part of lymphoma cases.
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Sustained Upregulation of Dendritic Cell Function in Patients with Chronic
Hepatitis B Treated with Lamivudine, an Antiviral Agent
Sk. Md. Fazle Akbar, Norio Horiike, Shinya Furukawa,Teru Kumagi, Kojiro Michitaka, Morikazu Onji
TheThird Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan
Antiviral drug like lamivudine causes rapid fall of hepatitis B virus (HBV) DNA in patients with
chronic hepatitis B (CH-B), however, the immune modulatory capacity of this drug has not been well
addressed.To address this, 30 patients with CH-B received lamivudine at a dose of 100 mg, daily, for 12
months, and the function of DCs were evaluated before, one, three and 12 months after the start of
lamivudine therapy. DCs were isolated from the peripheral blood as lineage-, HLA DRþ , and
CD4þ cells by magnetic cells sorting. T cells were isolated from a normal volunteer by using an
a⁄nity column. The stimulatory capacity of DCs were estimated in allogenic mixed leukocyte reac-
tion, and the levels of IL-12 and IFN-gamma in allogenic cultures were measured by ELISA. The
allostimulatory capacity of DCs increased one month after the start of lamivudine therapy compared
to that of before the start of therapy (po0.05). The allostimulatory capacity of DCs remained sus-
tained elevated at 3 months and 12 months after the start of lamivudine therapy. DCs from lamivu-
dine-treated patients induced signi¢cantly higher levels of IL-12 and IFN-gamma compared to those
from patients before therapy (po0.05). In conclusion, lamivudine may have direct e¡ect on the im-
mune modulator capacity of DCs. On the other hand, the antiviral e¡ect of lamivudine may have
contributed to improved DC function. Lamivudine along with DC modulator may have potent ther-
apeutic e¡ect in CH-B patients.
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Selective Ampli¢cation of DC Signaling in Response to Double Stranded RNA or
Virus Infection by IFN-a/b
Kenya Honda, Shinya Sakaguchi, Chigusa Nakajima,Tadatsugu Taniguchi
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University ofTokyo,Tokyo,
Japan
Maturation of dendritic cells (DCs) is critical event for T cell priming in response to invading patho-
gens. Toll-like receptors (TLRs) recognize molecular patterns associated with pathogens, and TLR
activation in DCs is considered to be central for their maturation. However, little is known about
the molecular basis for the coordinated DC activation tailored for defense against various organisms.
We show the selective ampli¢cation of DC signaling in response to double stranded RNA (ds-RNA)
or a virus by IFN-a/b, cytokines known to be essential for innate antiviral immunity. DCs defective
in the IFN signal fail to mature in response to ds-RNA or virus infection. DCs are activated in a
biphasic manner by ds-RNA or a virus, wherein IFN-a/b are induced and act to amplify the late
phase of maturation signaling as revealed by sustained NF-kB activation. We will also provide the
evidence that DCs can migrate into the T cell zone of the spleen but will not mature in the absence
of the IFN signal, upon stimulation by ds-RNA or infection by a virus, indicating that DC migration
and maturation are two separate steps during course of DC activation. Our study suggests that the
immune system has acquired this signal ampli¢cation mechanism so as to ensure robust antiviral re-
sponses, and provides a new link between innate and adaptive antiviral immunities.
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Down-regulation of Toll-like Receptor Expression in Monocyte-derived Langer-
hans Cell-like Cells: Implications of Low-responsiveness to Bacterial Components
in Epidermal Langerhans Cells
Junko Takeuchi1, Eiji Watari1, Eiji Shinya1,Yoshihiko Norose1, Misako Matsumoto3,Tsukasa Seya3,
Masahiko Sugita1, Seiji Kawana2, Hidemi Takahashi1
1Department of Microbiology and Immunology, Nippon Medical School,Tokyo, Japan
2Department of Dermatology, Nippon Medical School,Tokyo, Japan
3Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
In the skin, there are unique dendritic cells called Langerhans cells, however, it remains unclear why
this particular type of dendritic cell resides in the epidermis. Langerhans cell-like dendritic cells (LCs)
can be generated from CD14þ monocytes in the presence of GM-CSF, IL-4, and TGF-b1.We com-
pared LCs with monocyte-derived dendritic cells (DCs) generated from CD14þ monocytes in the
presence of GM-CSF and IL-4 and examined the e¡ect of exposure to two distinct bacterial stimuli
viaToll-like receptors (TLRs) such as peptidoglycan (PGN) and lipopolysaccharide (LPS) on LCs and
DCs. Although stimulation with both ligands induced a marked up-regulation of CD83 expression
on DCs, PGN but not LPS elicited up-regulation of expression CD83 on LCs. Consistent with these
results, TLR2 and TLR4 were expressed on DCs, whereas onlyTLR2 was weakly detected on LCs.
These ¢ndings suggest the actual feature of epidermal Langerhans cells with low-responsiveness to
skin commensals.
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Dendritic Cells Are Decreased in Blood and Accumulated in Granuloma in
Tuberculosis
Kazutaka Uehira1, Ryuichi Amakawa1,Tomoki Ito1,3, Kenichirou Tajima1, Shinsuke Naitoh1,Yoshio
Ozaki1,Toshiki Shimizu1, Kazuyuki Yamaguchi1,Yoshiko Uemura2, Hiroyuki Kitajima1, SeibunYonezu1,
Shirou Fukuhara1
1The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
2Surgical Pathology, Kansai Medical University, Osaka, Japan
3Dept. Immunology, MDAnderson Cancer Center, Houston,TX, USA
Immunity against tuberculosis consists of innate and adaptive immune responses. In this study, we
investigated the dynamics of dendritic cells (DC), which are known to elicit a variety of immune
responses, in patients with tuberculosis. CD11cþ peripheral blood DC were decreased in patients with
tuberculosis. Immunohistochemical analyses demonstrated that a number of fascinþ , CD11cþ , HLA-
DRþ DC were in¢ltrating in the lymphocytes areas of the tuberculous granulomas (tubercles). Im-
munohistochemical analyses demonstrated that interferon-g-producingTh1 cells were increased in the
tubercles of the patients, indicating the presence of Th1 polarization at least in the context of in£am-
matory tissues. In vitro co-culture of autologous naiveTcells with CD11cþ or CD11c DC pretreated
with Bacillus Calmette Guerin augmented the production of Th1 cells. These ¢ndings suggested that
the tra⁄cking of DC from the peripheral blood into the tubercles caused a dominant Th1 balance and
thus play an essential role in the immunity of tuberculosis.
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Analysis of Dendritic Cells in Sarcoidosis
Maiko Ota1, Kazutaka Uehira1,Yoshiko Date1, KazuhiroYamaguchi1,Yoshiko Uemura2, SeibunYonezu3,
Ryuichi Amakawa1, Shirou Fukuhara1
1The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
2Surgical Pathology, Kansai Medical University, Japan
3Department of Internal Medicine, Hyogo Prefectural Amagasaki Hospital, Japan
Background: Dendritic cells (DCs) are specialized antigen-presenting cells and function as the master
regulator of immune responses. Accumulating evidence shows that DCs play critical roles in the
pathophysiology of various diseases. Recently, we put forward a hypothesis that blood DCs are re-
cruited to in£ammatory tissues and subsequently cause speci¢c immune responses in chronic in£am-
matory diseases such as Sjogren syndrome and tuberculosis. In this study, we examined whether this
hypothesis may also be applicable for sarcoidosis, a granulomatous disease of unknown etiology.
Methods:We analyzed the number of blood DCs in 24 patients with sarcoidosis and performed im-
munohistochemical staining on the biopsied specimens from 4 patients with sarcoidosis. Results and
Discussion: We found that the number of total blood DCs were signi¢cantly decreased in patients
with sarcoidosis. Analysis of blood DC subsets demonstrated that both myeloid and lymphoid subsets
were signi¢cantly decreased. Furthermore, we found that a number of mature DCs were in¢ltrating
in the sarcoid granuloma. In addition, we showed that anatomical interaction occurred between DCs
and T cells. These ¢ndings suggest that recruitment of blood DC subsets to in£ammatory lesions
might occur in sarcoidosis. However, the dynamics of blood DCs seem to be di¡erent between tuber-
culosis and sarcoidosis. In tuberculosis, the number of myeloid DCs, but not lymphoid DCs, was
signi¢cantly decreased in the blood, whereas in sarcoidosis, both DC subsets were extremely de-
creased, implicating a di¡erent level of involvement of DCs in the pathophysiology of the two gran-
ulomatous diseases.
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Association of Balance between Blood CD123þ (lymphoid) and CD11cþ
(myeloid) Dendritic Cells with Th2 Polarization in Atopic Dermatitis
Hideo Hashizume, Hiroaki Yagi, Masahiro Takigawa
Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Dendritic cell (DC) is a professional antigen-presenting cell in the di¡erentiation of pre-Th cells into
Th1 or Th2 cells. In human, two DC subsets, DC1 and DC2, are identi¢ed regarding origin, pheno-
type and function, and DC2 provides the milieu favoring Th2-biased immune reactions. Atopic der-
matitis (AD) has characteristic features of marked Th2 polarization such asTh2 cytokine expression in
the lesional skin and enhanced IgE production and eosinophilia in the blood.We found that lower
ratio of circulating DC1/DC2 subsets in AD as compared with psoriasis and normal subjects. It was
also closely associated with the extent of Th2 polarization, as exempli¢ed by serum levels of total and
speci¢c IgE,Th1/Th2 cytokine production of peripheral blood cells and the disease severity estimated
by SCORAD. Therefore, the imbalance of blood DCs suggests a critical factor for Th2 polarization
in AD.
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Induction of Cutaneous Delayed-type Hypersensitivity Reactions in Mice after
Sensitization with Intragastric Hapten Administration: I. Activation of Gastric
Langerhans Cells in the Sensitization Phase
Hiromi Kobayashi1, Naoko Fujita2, Kazuhoshi Yamanaka1, Hisashi Tamiya1, Ko Ishina1, DaisukeTsuruta1,
Haruo Kutsuna1, Hiroyuki Teramae1, Nobuyuki Mizuno1, Ikuyo Sakaguchi2, Norikazu Ikeda2,Yoshikou
Kato2, Miki Minamino2, Kenji Kaneda3, Masamitsu Ishii1
1Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
2Institute of Cosmetic Science, Club Cosmetics Co., Ltd., Japan
3Department of Anatomy, Osaka City University Graduate School of Medicine, Osaka, Japan
Several allergic diseases develop based on immunological relationship between the gastrointestinal
tract and skin.While epicutaneous application of haptens makes individuals sensitized for the devel-
opment of allergic reactions or delayed-type hypersensitivity (DTH) reactions, oral administration
usually induces immunological unresponsiveness called ‘‘oral tolerance’’. Gautam et al. have found that
DTH reactions are induced in the skin when elicitated at 5 days after oral administration. However,
there are few studies about Langerhans cells (LCs) in the development of DTH reactions after oral
sensitization.We induced cutaneous DTH reactions after intragastric administration of hapten in mice
reproducibly. Using this murine model, we aimed to reveal the role of gastric LCs in the sensitization
phases of cutaneous DTH reactions to intragastrically administered hapten. BALB/c mice, which were
subjected to intragastric administration of 2,4,6-trinitrochlorobenzene (TNCB) 5 days before, received
the elicitative challenge of the same hapten to the ear skin. Sections of the ear were immunostained
for CD4 and CD8. Epithelial sheets of the fore-stomach were immunostained for I-A and observed
under a confocal laser scanning microscope. Cutaneous DTH reactions were induced in mice as de-
monstrated by the increase in ear thickness and a prominent in¢ltration of CD4- and CD8-positive
lymphocytes at 24-36 h after the elicitative challenge. In the sensitization phase, gastric LCs increased
in size at 2 h, became round at 6 h, and decreased in number at 24 h, possibly representing the sequen-
tial events of LC activation and migration from the epithelium.
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Induction of Cutaneous Delayed-type Hypersensitivity Reactions in Mice after
Sensitization with Intragastric Hapten Administration: II. Activation of Epidermal
Langerhans Cells in the Elicitation Phase
Kazuhoshi Yamanaka1, Hiromi Kobayashi1, Naoko Fujita2, Hisashi Tamiya1, Ko Ishina1, DaisukeTsuruta1,
Haruo Kutsuna1, Hiroyuki Teramae1, Mizuno Nobuyuki1, Ikuyo Sakaguchi2,Yoshikou Kato2, Miki
Minamino2, Kaneda Kenji3, Masamitsu Ishii1
1Departments of Dermatology, Graduate School of Medicine Osaka City University, Osaka, Japan
2Institute of Cosmetic Sciences, Club Cosmetics Co., Ltd., Japan
3Departments of Anatomy, Graduate School of Medicine, Osaka City University, Osaka, Japan
We had con¢rmed that peroral trinitrochlorobenzene (TNCB) in BALB/c mice can evoke cutaneous
hypersensitive reaction as percutaneous sensitization. The aim of our experiment is to reveal the im-
munological reaction between skin and gastrointestinal tract from sensitization to elicitation, and this
presentation mainly shows about elicitation phase. BALB/c mice were sensitized with 1% TNCB or-
ally or vehicle alone for control using oral feeding needles. They were challenged topically with
TNCB 5 days after sensitization for induced swelling of ear. In order to examine the reaction of eli-
citation phase, the section of swelling ears was stained with hematoxylin and eosin (H & E), and im-
munostained for CD4 and CD8 with labeled streptoavidin-biotin method (LSB). Cytokine levels in
swelling ear were quanti¢ed with ELISA. Morphological alterations of epidermal Langerhans cells
(LCs) were investigated by immuno£uorescence microscopy for I-A of the epidermal sheets prepared
at 24 h after elicitation. Twenty-four hours after challenge, in¢ltration of neutrophils in H & E and
signi¢cant increase of dermal CD4, CD8 positive cells in LSB was observed in compared with con-
trol. Interleukin-4 levels were increased both in sensitized and non-sensitized mice. Cell sizes of LCs
in the sensitized mice both with intragastric administration and with epicutaneous application were
more increased in 24 hours after challenge than those in non-sensitized mice. Cutaneous reaction in
mice sensitized with intragastrically administered hapten induced similar morphological change of
LCs in elicitation phase to that with epicutaneous application.
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The Presentation of Haptenated Proteins in the Mesenteric Lymph Nodes by
Dendritic Cells in the TNBS Colitis Rat
Yoh Ishiguro1, Hirotake Sakuraba1, Kazufumi Yamagata1, Hiroto Hiraga1, Satoko Emina1, Akihiro
Munakata1, Akio Nakane2
1First Department of Internal medicine, Hirosaki University School of Medicine, Hirosaki, Japan
2Department of bacteriology, Hirosaki University School of Medicine, Hirosaki, Japan
Dendritic cells (DC) are central to induction of the antigen (Ag)-driven immune response. In this
paper, we describe the role of DCs in aspects of T-cell activation at the mesenteric lymph nodes
(MLN) in trinitrobenzene sulfonic acid(TNBS) induced colitis. In the OX-62-positive DC fraction
of MLN, interleukin (IL)-2 production was enhanced in a dose-dependent manner by bovine serum
albumin (BSA) coupled with TNBS, whereas in the OX-62-depleted fraction this enhancement was
not apparent. The same antigen (BSA-TNBS) also resulted in elevated IL-12 production, and IL-12
transcripts were present in puri¢ed OX-62 cells, whereas analysis of the negative fraction of OX-62
cells showed IL-2, IL-10 and IFN-gamma transcripts. The presence of either the foreign haptenated
antigen or the autologous haptenated antigen enhanced IL-2 production. These results suggest that
an antigenic-immune response is induced at the MLN in a hapten-induced colitis and that dendritic
cells are the a¡ected cell type. Haptenated macromolecules are likely to induce cross-reactivity.
Further, we assessed the e¡ect of GRO/CINC-1 on MLN DC maturation, and the result showed that
in the presence of TNBS, GRO/CINC-1 strongly enhanced the expression of costimulatory-mole-
cules on DC, suggesting that cross-linking and GRO/CINC-1 have synergistic e¡ect for DC matura-
tion.
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Pseudotype Hepatitis C Virus Infects Immature Myeloid Dendritic Cells through
the Interaction with Lectin
Aki Sato1,Tatsuya Kanto1, Chang Kwang Limn2,Yasumasa Komoda2,Tetsuo Takehara1,Yoshiharu
Matsuura2, Norio Hayashi1
1Department of MolecularTherapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
2Research Center for Emerging Infectious Diseases, Research Institute for Microbial Diseases, Osaka University,
Osaka, Japan
Hepatitis C virus (HCV) causes persistent infection that leads to liver cirrhosis and hepatocellular car-
cinoma. One of the mechanisms for HCV persistence is the ability of HCV to suppress dendritic cell
(DC) function. Direct HCV infection to blood DC has been implicated for DC dysfunction, however,
it is yet to be determined which DC subsets are susceptible to HCV. To address this issue, we used
pseudotype vesicular stomatitis virus (VSV) coated with chimeric HCVenvelope glycoproteins, which
enables us to identify infected cells by expression of green £uorescent protein (GFP).We demonstrate
that pseudotype VSV enters myeloid DC (MDC) and monocyte-derived DC (MoDC) but not plas-
macytoid DC (PDC) recovered from HCV-negative donors.The highest e⁄ciency of pseudotypeVSV
or authentic HCV entry was observed with MDC cultured with GM-CSF. Such e⁄ciency decreased
with the treatment of IL-4 or CpG oligodeoxynucleotide, showing that MDC lose susceptibility to
pseudotypeVSVas they mature. Furthermore, mannan inhibited pseudotype VSVentry to MDC in a
dose-dependent manner, suggesting that lectin-containing molecules are critically involved in pseu-
dotype VSV entry. These results show that HCV infects immature MDC through interaction with
lectins, resulting in their functional impairment.
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Dendritic Cells Can Be Used as an in vitro Predictive Indicator of Contact Sensitizers
Jong Lan Shin, Min Geol Lee
Department of Dermatology and Cutaneous Biology Research Institute,Yonsei University College of Medicine,
Yonsei University, Seoul, Korea
To develop an in vitro predictive assay using dendritic cells(DCs) for the detection of contact sensiti-
zers, we investigated the changes of phenotypes, endocytotic activity and apopotosis by £ow cytome-
try; cytokine production by ELISA and RT-PCR; and chemotactic migration in the human
monocyte-derived DCs with contact sensitizers (2,4 -dinitrochlorobenzen(DNCB), trinitrobenzen
sulfonic acid (TNBS), dinitirobenzene sulfonate(DNFB), NiSO4, oxazolone) and irritants (sodium
dodecyle sulfate(SDS) and dimethyl sulfoxide (DMSO)). These chemicals were cultured with imma-
ture DCs for 24 hours. Cytokine cocktail (GM-CSF, IL-4,TNF-a, IL-1b, IL-6, PGE-2) was used for
the maturation of DC as a positive control. Among the sensitizers, DNCB,TNBS, DNFB and oxa-
zolone slightly induced the expression of CD80, CD86, CD54, CD83 and HLA-DR. However,
NiSO4 induced marked expression of CD80, CD86, CD54, CD83 and HLA-DR and down-regulated
the endocytotic capacity as much as the cytokine cocktail. These e¡ects were not observed with irri-
tants (SDS and DMSO). NiSO4 could induce as much IL-12 production (647.74 pg/ml) as mature
DCs cultured with cytokine cocktail (1047.65 pg/ml). Among these chemicals, only NiSO4 and oxa-
zolone induced apoptosis. Exposure to NiSO4 and cytokine cocktail resulted in up-regulation of IL-8
mRNA and oxazolone also induced the IL-8 and TNF-a mRNA expression. In chemotactic assay,
DCs treated with DNCB,TNBS, and NiSO4 responded to MIP-3 and those treated with SDS re-
sponded to MIP-3a. According to the results shown above, DCs can be utilized as an in vitro tool to
identify sensitizing potential of chemicals, therefore excluding the necessity of the classical animal
assay.
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Antigen Targeting to Fcc Receptors on Bone Marrow-derived Dendritic Cells E⁄-
ciently Elicits Humoral Response and Cytotoxic T Lymphocytes in vivo
Shota Endo1, Kenichi Akiyama1,2, Ayumi Yada1, Shin Ebihara1, Kimio Matsumura1,Tsutomu Maeda1,
Akira Nakamura1, Setsuya Aiba3,Toshihiro Nukiwa2,Toshiyuki Takai1
1Department of Experimental Immunology and CREST Program of JST, Institute of Development, Aging and
Cancer,Tohoku University, Sendai, Japan
2Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging and Cancer,
Tohoku University, Sendai, Japan
3Department of Dermatology,Tohoku University School of Medicine, Sendai, Japan
One of the critical features of Fc receptors for IgG (FcgRs) is their ability to enhance antigen presen-
tation for IgG-immune complexes of antigen-presenting cells such as dendritic cells (DCs) and
macrophages, leading to activation of antigen-speci¢c T cells. Here we report an e⁄cient vaccination
of naive mice by adoptive transfer of bone marrow-derived DCs pulsed in vitro with ovalbumin
(OVA) complexed with IgG. The antigen targeting to FcgRs on DCs successfully elicited humoral
responses consisting of anti-OVA IgG production in vivo.We found that the pulsed DCs from wild-
type mice but not from FcgR null animal could also activate OVA-speci¢c cytotoxic T lymphocytes
(CTLs) in vivo, indicating a pivotal role of FcgRs for e⁄cient MHC class I-restricted presentation of
exogenous antigens.We made IgG-opsonized apoptotic tumor cells (ATC-ICs) and tartgeted them to
FcgRs on DCs. We found that ATC-ICs were e⁄ciently internalized by DCs via FcgRs, and this
process e⁄ciently induced maturation of DC. Importantly, ATC-IC loading was shown to be more
e⁄cient than ATC alone in its capacity in inducing anti-tumor immunity in vivo, in terms of CTL
induction and tumor rejection. These data indicate that FcgR-mediated antigen uptake can enhance
antigen presentation of DCs to activate both CD4þ and CD8þ Tcells, implying therapeutic bene¢ts
of antigen-targeting to FcgRs on DCs for elicitation of speci¢c immune responses in immunode¢-
ciencies, infectious diseases and cancer. The protocol using ATC-IC may overcome the limitations and
may enhance the immune response of current ATC-based DC vaccination therapy.
P50
Phenotype of Epidermal Langerhans Cells in Denerved Skin
Junichi Hosoi, Chie Nariai, Kaori Inoue, Nobuko Akutsu,Toru Tsuchiya
Life Science Research Center, Shiseido, Japan
We have studied the association of epidermal LC and nerves in the skin.Various neuronal factors have
been reported to regulate LC functions. We have examined LC phenotype in neonatally capsaicin-
treated mice. Neonatal injection of capsaicin causes peripheral denervation. Those mice were grown
for 4 weeks and used in the following experiments.We con¢rmed that the contact hypersensitivity
reaction induced by TNCB was augmented in capsaicin-treated mice. Same level of the contact hy-
persensitivity reaction was caused in na|«ve mice by transfusion of lymphocytes isolated after TNCB
sensitization from either capsaicin- or vehicle-treated mice. Epidermal sheets were taken from capsai-
cin-treated or vehicle-treated mice, stained for I-A molecules, and analyzed with confocal laser scan-
ning microscope. There was no signi¢cant di¡erence in LC number or I-A-intensity. After painting of
TNCB, the intensity of I-A, number of dendrites, and area per cell were increased in both vehicle- or
capsaicin-treated mice. The increase in these parameters in neonatally capsaicin-treated mice was sig-
ni¢cantly higher. The response to the single painting of sodium dodecylsulfate was similar or less in
capsaicin-treated mice. These results suggest that allergens stimulate nerve system as well as LC and
induce negative feedback of allergic reaction with neuropeptides.
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Quanti¢cation of Dendritic Cells in Human Chronic Apical Periodontitis
Rodolfo Gomez1, S. Judith Alvarez2, Gabriel Loranca1, Dolores Jimenez1, Juan C.Hernandez1, Andres E.
Castell2
1Division de Estudios de Posgrado e Investigacion, Facultad de Odontologia, UNAM
2Departamento de Biologia Celular yTisular, Facultad de Medicina, UNAM
The human chronic apical periodontitis disease (CAP) is the response generated by the dental sur-
rounding tissue to various noxious stimuli. This response frequently develops a granuloma (GR) or
periapical cyst (PC) lesions. In past years, there has demonstrated the presence of dendritic cells (CD)
in rats periapical lesions, suggesting that DC are involved in the pathogenesis of that therefore the
objective of this study is to determine the number and distribution of DC in de that lesion. Biopsies
of 14 patients having GRwith epithelial proliferation, 4 with simple GR, 4 with PC and 4 normal
periodontal tissue, as controls, were taken and processed to demonstrate the expression of class II mo-
lecules of the major histocompatibility complex (MHC) and the protein S-100 by immunohisto-
chemistry.We observed a signi¢cant increased of de DC in all pathological cases with respect to the
control samples. The DC number in GRwith epithelial proliferations was 134,54 by mm2, for simple
GR was 109.82 by mm2, for PC 112,40 by mm2 and for controls was 0. Results suggest that it is
possible that LC are involved in the generation and permanence of the CAP.
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Autoantigen-speci¢c CD25þCD4þ T Cells Expanded with Antigen and Bone
Marrow Derived Dendritic Cells Can Block Diabetes Pathogenesis
Kristin Tarbell, Sayuri Yamazaki, Kara Olson, Ralph Steinman
Rockefeller University, NewYork, NY, USA
CD25þCD4þ regulatory T cells are important for maintaining peripheral tolerance to self.
CD25þCD4þ prevent proliferation of naive CD25-CD4þ T cells, and are themselves anergic un-
der most conditions. However, Sayuri Yamazaki and colleagues have recently shown that
CD25þCD4þ cells will proliferate and expand when cultured with their cognate antigen and bone
marrow-derived dendritic cells (BMDCs). This expansion may be important for preventing autoim-
munity by maintaining proper levels of CD25þCD4þ cells. In this study, we have assessed both the
ability of CD25þCD4þ T cells from autoimmune NOD mice to expand in response to autoanti-
gen presented by BMDCs, as well as the function of these expanded cells. NOD mice develop an
autoimmune diabetes which has a similar pathogenesis as human type I diabetes. BDC2.5 mice express
aTCR transgene derived from a diabetogenicTcell, and BDC2.5 Tcells respond to both islet cells and
a mimetope peptide. CD25þCD4þ T cells puri¢ed from BDC2.5 mice proliferate and expand
when cultured with NOD BMDCs and mimetope peptide. This indicates that no defect in either
dendritic cells or CD25þCD4þ T cells from NOD mice prevents proliferation of these cells. Ex-
panded CD25þCD4þ cells were able to suppress proliferation of CD25-CD4þ T cells in vitro at
lower doses when compared to freshly-isolated CD25þCD4þ cells. BMDC-expanded
CD25þCD4þ T cells from NOD.BDC2.5 mice also can block diabetes in two distinct diabetes
models mediated by diabetogenic cells with either the same T cell speci¢city (from BDC2.5 mice) or
with a diverse repertoire (from NOD mice).
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Dynamics of Dendritic Cells and Cytokine Pro¢le in Chronic GVHD
Kengo Nakamura, Masashi Takebayashi, Kenichiro Tajima,Tomoki Ito, Katsuhiro Zen,Yuji Kishimoto,
Ryuichi Amakawa, Shiro Fukuhara
The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
[Background] Chronic graft versus host disease (cGVHD) occurs in approximately 60^80% for those
who survive over 100 days after allogeneic hematopoietic stem cell transplantation, which is associated
with the reduced overall survival. However, the mechanism of cGVHD is largely remains to be clar-
i¢ed. [Method] We examined absolute numbers of peripheral blood dendritic cells (DC) and also
evaluated cytokine production of T cells using intracellular cytokine staining method and ELISA of
sera and culture supernatants of peripheral blood T cells. [Result] Absolute number of blood myeloid
DC in patients with cGVHD was signi¢cantly lower than that in patients without cGVHD (p¼ 0.03).
In addition, both myeloid and lymphoid DC in patients with cGVHD were signi¢cantly lower than
those in normal control subjects. On the other hand, the percentage of INF-g- and TNF-a -produ-
cing CD8þT cells in patients with or without cGVHD was signi¢cantly higher than that in normal
control subjects (po0.001). The percentage of IL-4-producing CD8þT cells was signi¢cantly higher
in patients with cGVHD than in patients without cGVHD and normal control subjects (po0.001).
[Conclusion] Blood DCwere signi¢cantly decreased in patients with cGVHD, leading to a hypothesis
that blood DC are actively recruited to tissues and thus form a basis of induction of cGVHD. On the
other hand, IL-4 producing CD8þ Tcells were shown to be closely associated with the occurrence of
cGVHD. This T cell subset might constitute the e¡ector cells that evoke cGVHD.
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Both Dermal Dendritic Cells and Mast Cells are Related to Development of Scler-
oderma
Emi Yokoyama1,Toshiko Kumagaya1,Yoshiaki Hamamoto1, Masahiko Muto1,Toshiaki Manabe2
1Department of dermatology and Biomolecular Recognition,Yamaguchi University School of Medicine,Yamaguchi,
Japan
2Laboratory of Anatomic Pathology, Kyoto University Hospital, Kyoto, Japan
Dermal dendritic cells (DDCs) and mast cells (MCs) play a key role in tissue remodelling and ¢brosis.
In the present investigation, we tentatively de¢ned DDCs as all the cells in the connective tissue,
which morphologically exhibit assume dendritic shape. These ¢broblast-like cells have been classi¢ed
into following groups:(1) true ¢broblasts, (2) myo¢broblasts, (3) CD34þDDCs, (4) factor
XIIIaþDDCs and (5) others. Fibroblasts are regarded as those cells positive only for vimentin, while
myo¢broblasts as those positive for both vimentin and smooth muscle actin (SMA). DDCs are di-
vided into CD34þ and factor XIIIaþDDCs. To elucidate the participation of DDCs and MCs in
the ¢brosing and mucinotic lesions such as scleroderma and dermatomyositis, we examined cases of
22 sclerodermas, 8 dermatomyositis and 15 normal skin histologically and immnohistochemically.
Sections from scleroderma patients (14 systemic and 8 localized) were histologically classi¢ed into
three groups: early, fully developed and late stage. DDCs in the sections were immunohistochemically
evaluated by CD34, alfaSMA, factor XIIIa, vimentin and desmin.We then quanti¢ed the MCs using a
toluidine blue, astra blue, and tryptase and chymase immunohistochemical staining. In the periadnex-
al matrix of the early stage of scleroderma, increased MCs were remarkably observed. In the late stage,
the number of MCwas decreased. As in£ammation subsided and sclerosis started to replace, the num-
ber of CD34þ DDCs became decreased and alfaSMAþ DDCs increased. This study suggests that
both alfaSMAþDDCs and MCs in scleroderma may take part in the development of atrophy of the
adnexal organs.
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Peripheral Blood Dendritic Cells in Patients with Sjogren’s Syndrome
Yoshio Ozaki1, Ryuichi Amakawa1,Yonsu Son1, Masashi Takebayashi1, Minori Nagahama1,Tomoki Ito1,
Yoshiteru Konaka2, Shirou Fukuhara1
1The First Department of Internal Medicine, Kansai Medical University, Moriguchi, Japan
2Department of Clinical Immunology and Hematology,Tazuke-Kofukai Medical Research Institute, Kitano
Hospital, Osaka, Japan
The pathogenesis of Sjogren’s syndrome (SS) has remained unclear. It has reported that there were at
least two fractions of human peripheral blood (PB) DCs including monocyte-associated DC (MDC;
lineage negative / HLA-class II þ / CD11cþ ) and the lymphoid-associated DC (PDC; lineage negative
/ HLA-class II þ / CD11c). Recently,We reported that numbers of PB-MDC were decreased in pa-
tients with primary SS (p-SS). Immunohistochemical staining demonstrated that fascinþ /CD11cþ /
HLA-DRþ mononuclear cells were present and scattered among numerous fascin-hyper¢ltrating cells
in SS patients. Here, we attempted to determine whether these alteration of PBDCs universally occurs
in other collagen disease including secondary SS (s-SS).We analyzed peripheral blood DCs from 23 p-
SS, 11 SLE, 12 SSc, 10 RA, 19 s-SS untreated with immunosuppressant, and 32 normal volunteers as
control. Group of s-SS includes 4 SLE with SS, 6 SSc with SS and 9 RAwith SS. Total amount of
PB-MDC was signi¢cantly decreased in p-SS and SLE. On the other hand, PDC were signi¢cantly
decreased in only SLE patients. In SSc, RA and s-SS patients, neither fraction of the circulating DC
was signi¢cantly altered. However, in detailed investigation, the numbers of MDC and PDC showed
alterations similar to those of underlying diseases. These data suggest that DCs participate in the
pathogenesis of p-SS and s-SS in di¡erent way.
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Anticancer E¡ect of Novel CpG Oligodeoxynucleotide, KSK-13, via Innate
Immune Modulation
Soo Kie Kim1, Seung Kyu Park2, Soo Jung Park1, Hyun Chul Cho1, Kyu Jae Lee2, Dan Jin1
1Department of Microbiology,Wonju College of Medicine,Yonsei University,Wonju, Korea
2Department of Parasitology,Wonju Medical College, IFBB,Yonsei University,Wonju, Korea
CpG oligodeoxynucleotide (ODN) containing unmethylated CG sequence is one of most potent ac-
tivator on vertebrate immunocytes. Depending on the sequences £anked to CpG motif, CpG ODNs
shows selective stimulatory e¡ects on various immune cells. Previously, we devised and reported the
screening system of monocyte-activaiting CpG motifs using various cell lines. Of screened CpG mo-
tifs, KSK-13 was selected as potent immune activator against murine monocytes or human myeloid
cell lines. Based on this, we hypothesized that novel K type CpG motif may block cancer metastasis
via activation of monocytes or NK cells. However, direct evidence is elusive. To clarify this issue, we
exploited B16 melanoma system responsive to monocyte or NK cell activation. KSK-13 CpG ODN
clearly abrogated lung metastasis of B16 melanoma in C57BL/6 mice compared to saline or non-CpG
motif treated group. To unravel the antimetastatic mechanism of KSK-13, we measured NK activity
using NK-riched splenic fractions or whole splenocytes against YAC-1. NK activities in splenocytes
treated with KSK-13 were two fold as high as normal control. Consistently FASCs analysis revealed
that KSK-13 enhanced human or mouse NK cell as well as monocyte marker activation. Innate cyto-
kine pro¢les (TNF-a, IFN-a, IL-6, IL-18 and IP-10) of puri¢ed human monocytes treated with KSK-
13 may contribute to Th1 type immune enforcement. Collectively, these results indicate that novel
CpG motif, KSK-13 is inhibitory or therapeutic on tumor metastasis via innate immunomodulation.
This study was supported by a grant of the National Cancer Control R&D Program 2002, Ministry
of Health &Welfare, Republic of Korea
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Immunotherapy of Melanoma Patients with Tumor Lysate-pulsed Dendritic Cells
Takeshi Nakahara1, Hiroshi Uchi1,Yohichi Moroi1, Chikage Obata1, Hong Duan1, Shuji Fukagawa1,
Kazunori Urabe1, Masutaka Furue1,Tetsuya Koga2
1Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
2Department of Dermatology, Fukuoka Redcross Hospital, Fukuoka, Japan
Metastatic melanoma responds poorly to treatment and is the main cause of death in patients with
skin cancer. Dendritic cells (DCs) are the most potent antigen-presenting cells; they are specialized
to induce a T-cell response and are considered to be promising adjuvants for inducing antitumor im-
munity. So we used mature, monocyte-derived DCs to treat advanced malignant melanoma. Patients
were eligible if they had stage4 cutaneous malignant melanoma that was not curable by resection and
was progressive despite chemotherapy. Immature DCs were generated in the presence of granulocyte /
macrophage-colony stimulating factor (GM-CSF) and interleukin 4 (IL-4) from peripheral blood
CD14þ monocytes, which were then pulsed with tumor lysate. Subsequently immature DCs were
stimulated withTNFa (or IFNg and IL-1b) for 48 hr to obtain mature DCs. The tumor lysate-pulsed
mature dendritic cells were injected subcutaneously close to the inguinal lymph nodes (or cervical
lymph nodes, axillary lymph nodes). Five patients received the vaccine and were assessed for e¡ective-
ness and safety. To assess whether DC vaccination induces tumor-speci¢c immunity, we used DTH
reactions as a conventional method for detecting antigen-speci¢c immunity. Four patients showed
no DTH responses in the course. One patient demonstrated a weak DTH response but that was tem-
porary. Except for only one axillary lymph node metastasis that was minimally reduced in one pa-
tient, all metastatic lesions progressed. Furthermore, new metastatic lesions appeared in all patients.
One patient experienced the onset of vitiligo after the vaccinations. None of the patients showed
any adverse e¡ects.
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Circulation and Homing of Melanoma-reactive T Cell Clones to both Cutaneous
and Visceral Metastases Following DC-vaccination
Thomas G. Berger1, Ina Haendle1, David Schrama2, Matthias Lueftl1, Lars Oestergaard-Pedersen3,
Beatrice Schuler-Thurner1, Per thor Straten3, Gerold Schuler1, Juergen C. Becker2,3
1Dept. of Dermatology, University Hospital of Erlangen-Nuernberg, Germany
2Dept. of Dermatology, Julius-Maximilians-University,Wuerzburg, Germany
3Dept. ofTumor Cell Biology, Danish Cancer Society,DK 2100 Copenhagen, Denmark
Dendritic cell vaccination aims at the induction of tumor-speci¢c T cells which should kill tumor
cells. The e¡ector cells should therefore not only exert cytotoxic activity, but also home to and in¢l-
trate the tumor site. Hence, monitoring of immune modulating therapies should not be restricted to
the circulating pool of peripheral blood lymphocytes but also include tumor in¢ltrating lymphocytes,
as well as the correlation of these ¢ndings to the clinical course.We performed a longitudinal immu-
nological workup of a patient receiving vaccinations with peptide-pulsed autologeous dendritic cells.
This patient ¢rst experienced an objective response to therapy, followed by a period of stabilisation,
but ¢nally succumbed to disease progression and died. The immunological analysis revealed that fully
functional tumor-speci¢c T cells were not only induced in the peripheral blood of this patient, but
that these cells were also accumulated at cutaneous and visceral tumor sites. T cell receptor (TCR)
repertoire analyses further demonstrated that identical T-cell clonotypes were detectable in both cuta-
neous and visceral metastases. Furthermore, comparative clonotype mapping of PBL andTIL depicted
an overlapping TCR repertoire usage among these two compartments. This notion was further sub-
stantiated by an association of the decline of the number of tumor-reactive T cells in circulation with
¢nal disease progression. In conclusion, this thorough immunological workup of a melanoma patient
validated the immune monitoring of PBL as a surrogate marker for in situ immune responses within
the tumor which is of particular importance as the latter will remain restricted to selected patients.
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Development of a Combined Therapy with Holmium-166 and Dendritic Cells for
Mouse Malignant Melanoma
Tae Hyung Lee,Young-Hun Cho, Jong Doo Lee,Woo Gil Chung, Min-Geol Lee
Brain Korea 21 Project for Medical Sciences, Department of Dermatology,Yonsei University College of Medicine,
Seoul, Korea
Although the injection of Ho-166, the beta emitter, in malignant melanoma of C57BL/6 mice re-
sulted in decrease in size and growth rate, it could not reach a complete remission. Therefore, combi-
nation therapy with dendritic cells (DCs) was investigated to improve the therapeutic result.
Malignant melanoma in mice was induced by inoculating B16F10 cell line subcutaneously.Thirty-four
mice were divided into 3 groups : 1) non-treated (10 mice), 2) treated with Ho-166 (11 mice) and 3)
treated with immature DCs after Ho-166 injection (13 mice), and changes in tumor size and survival
rates were observed.After 18 to 19 days, the mean size of tumors in group 1, 2 and 3 were
672273485mm3, 234272215mm3, and 112571169mm3, respectively. The control group lived up to
28 days, but 3 of 11 (27.3%) mice in group 2 and 6 of 13 (46.2%) mice in group 3 are still alive on
day 42.We observed signi¢cant decrease in tumor size and increase in survival in group 3 treated with
Ho-166 injection and DCs.When B16F10 cell line was reinjected into the other side of the back of the
survivors, much slower growth was observed in group 3, in which Ho-166 and DCs were adminis-
tered. Immunologic studies of the mice are being investigated. The results suggest that combination
therapy using Ho-166 and immature DCs could be used in the treatment of unresectable malignant
melanoma or as an adjuvant therapy after surgery.
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Antitumor Immunity Utilizing Melanoma Cells Fused with Dendritic Cells
Derived from MHC Class I & II Knocked Out Mice
Yuko Takagi1,Tetsuro Kikuchi23,Tsuneya Ohno2, Michihito Niimura1
1The Department of Dermatology, Jikei University School of Medicine,Tokyo, Japan
2Department of Oncology, Institute of DNA Medicine, Jikei University School of Medicine,Tokyo, Japan
3Department of Neurosurgery, Jikei University School of Medicine,Tokyo, Japan
Antitumor e¡ects of dendritic cells fused with mouse B16 melanoma cells have been reported pre-
viously. MHC class I & II in addition to tumor associated antigen, co-stimulatory molecules are
known to be involved in crosstalking between tumor cells and DCs. To assess whether MHC class I
& II play an important role in induction of antitumor immunity by DCs, DCs derived from MHC
class I & II knocked out mice as well as wild type were fused with B16 melanoma cells as previously
described. FACS analysis demonstrated that levels of surface markers and phagocytosis of both wild
and MHC knocked out DCs were not signi¢cant. Animals were immunized by wild type or knocked
out DCs fused with melanoma cells twice every week followed by challenging of B16 mouse mela-
noma cells. Outgrowth of implanted B16 melanoma cells was not signi¢cant between wild and
knocked out DCs. These results suggest that the levels of MHC class I & II on DCs may not have
any e¡ects on fusion cells based antitumor immunotherapy.
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Prevention of Metastatic Liver Cancer by Dendritic Cells Fused with Cancer Cells
Masaru Harada1, Mitsunori Yamakawa1, Kunihiko Maeda1, Hiroaki Takeda2, Sumio Kawata2
1Division of Pathology, Department of Developmental and Bio-Defending Medicine,Yamagata University School of
Medicine.Yamagata, Japan
2Department of the Second Internal Medicine,Yamagata University School of Medicine.Yamagata, Japan
The aim of present study is to evaluate the e⁄cacy of dendritic cells (DCS) fused with murine colonic
cancer cells in experimental liver metastasis model. [Materials and Methods] Bone marrow-derived
DCs, which were cultured under GM-CSF supplementation for 9 days, were fused with tumor cells
at a 3:1 (DC: tumor cell) ratio and stimulated with LPS for 1 day. Firstly, the destination of £uores-
cence-labeled fused DCs injected intraperitoneally was investigated in BALB/C mice. Secondly, the
mice were received 3105 Colon 26 tumor cells intrasplenically to establish liver metastasis on day
0, immunized intraperitoneally with 1106 fused DCs twice on days 3 and 7, and then killed on day
14. Thirdly, another mice were immunized intraperitoneally twice with 1106 fused DCs before tu-
mor cell challenge in the spleen. [Results] Fused DCs injected intraperitoneally accumulated in the
milky spot, and mesenteric, hepatic hilar and pulmonary hilar nodes. Whereas the mice in control
groups developed more than 50 liver metastases, almost all mice immunized with fusion DCs not
only before but also after the intrasplenic tumor cell challenge had no detectable liver metastasis or
fewer than ¢ve micronodules. [Conclusion] Vaccination with the fusion DCs provides an e¡ective
strategy for the treatment of liver micrometastasis of colonic cancer.
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Increased Survival and Decreased Tumor Size Due to Intratumoral Injection of
Ethanol Followed byAdministration of Immature Dendritic Cells
Teru Kumagi, Sk. Md. Fazle Akbar, Shinya Furukawa, Norio Horiike, Morikazu Onji
TheThird Department of Internal Medicine, University of Ehime, Ehime, Japan
Background: Antigen-presenting dendritic cells (DC), loaded in vitro with tumor associated antigens
(TAAs), are now used for antitumor therapy. However, little is known about an interaction between
DC and TAAs within tumor microenvironment. This study was conducted to evaluate if antitumor
immunity can be induced by injecting immature DC into necrotized tumor tissues. Material and
methods: A mouse model of colon cancer was established by subcutaneous injection of CMT-93 cell
in the £ank of C57BL/6 mice.When the tumors became about 10 mm in diameter, tumor nodules
necrotized by injecting 100% ethanol. Bone marrow-derived immature DC from syngenic mice were
injected into the tumors, 48 hours after ethanol injection. The size of the tumor and the survival time
of the mice were studied. Immunohistochemical methodology was employed to detect injected DC
and to evaluate check the levels of maturation of DC. Results: Tumor-bearing mice injected with
ethanol plus DC survived longer than untreated mice (po0.05). Three weeks after therapy, the sizes
of the tumor nodules were reduced compared to untreated mice. Forty-eight hours after injection, the
injected DC were detected in the spleen. The stimulatory capacity of spleen DC isolated from mice
treated with ethanol plus DC were signi¢cantly higher than untreated mice (po0.05). Mature DC
expressing CD86 were detected in cancer nodule after injecting ethanol plus DC, however, these were
almost absent in tumor-bearing mice in situ. Conclusions: Taken together, direct administration of
ethanol plus DC in the tumor nodules represents a new therapeutic approach for antitumor immu-
notherapy.
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Bone Marrow Dendritic Cell-based Immunotherapy against Renal Cell Calcinoma
in Mouse Model
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Several reports have shown that DC-based immunotherapy still has a lot of obstacles to be solved for
general application to tumor therapy. DC-based immunotherapy was not so e¡ective as expected in
most of the solid tumors, particularly in renal cell carcinoma even in murine model. Our investigation
was initiated to identify what causes the limitations of the DC-based immunotherapy to the solid
renal cell carcinoma.We have investigated the antigen-pulsed Bm-DC migration, Ag-speci¢c T cell
proliferation, Th1 response, and T cell in¢ltration into tumor mass when vaccinated with Renca ly-
sate-pulsed Bm-DC in solid tumor-bearing mice.We have also studied the expression pro¢les of che-
mokine receptors in the presence of an immune suppressive agent secreted from the tumor. In these
experiments, we found that the limitations of DC-based immunotherapy to solid renal cell carcinoma
was likely due to the tumor-mediated hindrance of CTL in¢ltration rather than the insu⁄cient im-
mune induction. Nevertheless, the CTL induced by DC therapy was very functional for the inhibi-
tion of tumor recurrence after surgery or of tumor metastasis when induced by iv injection of tumor
cells. These data strongly suggest that the DC immunotherapy would be very e⁄cient to slow down
or block the disease progression in tumor patients by inhibition of the tumor recurrence and/or tumor
metastasis after surgery.
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E¡ective Induction of Acquired Resistance to Listeria monocytogenes by Immuniz-
ing Mice with in vivo-infected Dendritic Cells
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Dendritic cell (DC) is known as a potent antigen-presenting cell.We investigated the potential of DCs
obtained from Listeria monocytogenes-infected mice in induction of acquired resistance to the infection
as an immunogen. Splenic DCs obtained from mice at 48 h after L. monocytogenes infection exhibited
up-regulation of CD80 and produced higher titers of gamma interferon (IFN-g) and interleukin-12
(IL-12) than did DCs obtained from uninfected mice. Mice immunized with DCs obtained from
mice that had been infected with L. monocytogenes 48 h before acquired host resistance to a lethal in-
fection with L. monocytogenes at 4 and 8 weeks after immunization. Immunization with DCs from
heat-killed L. monocytogenes failed to induce antilisterial resistance. Acquired antilisterial resistance is
pathogen-speci¢c, since the immunized mice could not be protected from Salmonella enterica serovar
Typhimurium infection. Infected DCs stimulated proliferation of naive CD4 and CD8 cells in vitro,
suggesting that in vivo-infected DCs activate CD8 T cells, which are critical in acquired antilisterial
resistance, as well as CD4 T cells. When wild-type mice were immunized with DCs from IFN-g-
de¢cient mice, they were protected against a lethal L. monocytogenes challenge. In contrast, when mice
were immunized with DCs from anti-IL-12 p40 monoclonal antibody-injected mice, they failed to
gain acquired antilisterial resistance. These results suggest that DC-derived IL-12, but not IFN-g, may
play a critical role in induction of acquired antilisterial resistance. Our present results suggest that
splenic DCs obtained from mice infected with L. monocytogenes in vivo may be an e¡ective immuno-
gen inducing antigen-speci¢c immunity.
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E⁄cacy of a Dendritic Cell Vaccine against Hepatitis B Virus Infection in Immune
Suppressed Mouse
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The traditional vaccine that contains hepatitis B surface antigen (HBsAg) and other HBV-related pro-
teins cannot not provide protection against hepatitis B virus (HBV) infection in 5-10% of otherwise
normal individuals. Moreover, the e⁄cacy of this vaccine is limited in immunosuppressed individuals.
The aim of this study was to develop a more potent vaccine for HBV infection using antigen-present-
ing dendritic cells as adjuvant.Immunosuppression was induce in normal C57BL/6 by injecting 2 mg/
kg of FK-506(Fujisawa), intraperitoneally, daily. Spleen DCs were isolated from normal C57BL/6 mice
by density centrifugation, plastic adherence, and depletion of lymphocytes and were cultured with
HBsAg (100 mg) for 48 hours to produce HBsAg-pulsed DCs. Two weeks after administration start
of FK-506, the immunosuppression of mice was by their low production of IL-2 and IFN-g. Immu-
nosuppressed C57BL/6 mice were randomly assigned to receive either intraperitoneal injection of tra-
ditional commercial vaccine containing HBsAg in alum or HBsAg-pulsed DC vaccine, once in every
two weeks for 2 times. Two or three injections of traditional vaccine containing HBsAg (1^4 mg) in
alum did not induce anti-HBs in any immunosuppressed normal C57BL/6 mice (n¼12). However,
injection of HBsAg-pulsed DCs induced anti-HBs in all immunosuppressed normal mice. The levels
of anti-HBs were also very high. All mice remained positive for anti-HBs for a period of 6 months
after the end of second vaccination. This study indicates that HBsAg-pulsed DC vaccine can be used
in conditions when traditional vaccines cannot achieve proper prophylactic e¡ect.
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